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Abstract

Conventional radiation therapy coupled with chemotherapy and surgery has proven
unsuccessful for Glioblastoma Multiforrne (GBM) patients. A binary treatment therapy such
as boron neutron capture therapy (BNCT) may be promising.

The Monte-Carlo based

simulation environment for radiation therapy (SERA) software is used to simulate the dose
administered to a patient undergoing BNCT. The boron concentration used to determine the
boron component of the dose has been measured directly during surgery. Point sampling and
averaging of the tumor tissue resulted in an estimate of a uniform boron concentration scaling
factor of 3.5.

This factor is used to scale the boron component of the dose linearly and

homogenously within the tumor and target volumes. Current methods should be improved.
The average dose to the tumor cells by such a method could be improved by better methods of
quantifying the in-vivo boron biodistribution. A better method of determining the in-vivo IOB
biodistribution includes radiolabeling para-Boronophenylalanine (p-BPA) with 18F and
imaging the pharmaceutical using positron emission tomography (PET). This biodistribution
of 18F-BPA can then be used to better predict the average dose delivered to the tumor and
target regions.
To incorporate the PET IOB biodistribution within treatment planning, several patients
are selected, and a dynamic PET study is performed. The last frames of the PET images are
registered with Tl-weighted MRI images using the Statistical Parametric Mapping Algorithm
(SPM-99). The registered '8F-BPA PET images are then coupled with SERA results in a new
computer software, PET2MRI.m, to linearly scale the boron component of the dose based on
the in-vivo lOB biodistribution determined from the PET image. A qualititative and
v

quantitative assessment of the dose contours is presented using the two approaches. Tumor
volume, tumor axial extent, and target locations are compared between using MRI or PET
images to deﬁne the tumor volume. In addition, peak-to-normal brain value at tumor axial
center is determined for pre and post surgery patients using 18F-BPA PET images.

The

differences noted between the registered GBM tumor volumes (range: 34.04 — 136.36 %),
tumor axial extent (range: 20-150%), and the beam target location (1.27 — 4.29 cm) are
signiﬁcantly different in using T1 MRI images to deﬁne the volumes when compared with
using 18F-BPA PET images.
For all GBM patients, the '8F-BPA PET based tumor volumes and tumor axial extents
are Signiﬁcantly larger when compared with MRI based tumor and target volumes. The peakto-normal brain values are also determined at the tumor axial center using the 18F-BPA PET
images. The peak-to-normal brain values using the last frame of the pre-surgery study for the
GBM patients ranged from 205-34. The peak-to-normal brain values for time-weighted PET
data ranged from 1.71-4. For post surgery time weighted PET data, the peak-tO-normal brain
value in the residual parts of the tumor ranged from 1.5-1.7. The PET based peak-to-normal
brain values are signiﬁcantly different when compared with the current value of 3.5 used in
treatment planning within SERA. Qualitatively, boron dose contours are greatly shifted using
PET images when compared with MRI images. Collectively, these differences can lead to
signiﬁcant reorientation of the beam and can signiﬁcantly impact current BNCT treatment
planning.
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I. Introduction
About half of all tumors of the central nervous system are malignant cerebral gliomas
which affect about 7000 Americans each year with only about 3% surviving past 5 years when
treated with the most aggressive treatment protocols [1, 2].

With the most aggressive

treatments including surgery together with chemotherapy and conventional photon
radiotherapy, the survival time after diagnosis of a high-grade glioma may range from 9-12
months [3,4]. Recent advances in new treatment protocols such as boron neutron capture
therapy (BNCT) may be promising not only for gliomas, but as well as for metastatic
melanomas, and others. For reviews regarding the need for BNCT and its potential in future
treatments for multiforme glioblastoma (GBM), multiple melanomas (MM), as well as other
forms of cancers, the following references are suggested [1-12].

1.1 BNCT BASICS
Boron neutron capture therapy is a binary form of targeted radiotherapy

ﬁrst

suggested by Locher in 1936, shortly after the discovery of the neutron by J. Chadwick in
1932 [5]. BNCT uses pharmaceuticals that contain a stable isotope of boron, '0B, which
preferentially localizes within the tumor cells. The cells are then irradiated with low energy
neutrons.

Because B-10 has a relatively high thermal neutron capture microscopic cross

section (3837 barns @ .0253 ev), irradiation results in the capture of a neutron followed by a
subsequent disintegration of the B-11 into an alpha particle (4He) and a lithium particle (7Li).
As a result of this n-alpha (n,OL) reaction and the slowing down of highly charged particles, a
large amounts of kinetic energy are locally deposited within the tumor cells. With the
combined range of the alpha and the lithium particle being around 14 microns, much of the
1

energy is deposited within a cell diameter or two [8]. If the particle path traverses the cell
nucleus, then the probability of stopping subsequent mitosis and perhaps even killing the
tumor cell is high. Thus, BNCT is selective in killing tumor cells while sparing surrounding
normal cells. The key to effective BNCT is the preferential accumulation of 10B within the
tumor cell followed by adequate irradiation. Shown in equation 1 is the (n,oc) reaction and the
subsequent release of about 3 MeV of energy.

“’13 + 'n -> “B 9 7Li +4He+2.34 Mev+0.48 MeVy

(1)

Shown in Figure 1 is a pictorial overview of BNCT as it occurs at the cellular and subcellular levels.
In 1951, Sweet and his colleagues ﬁrst demonstrated in animals that certain B-10
compounds concentrated in human brain tumor cells relative to normal brain cells [11].
Shortly after, clinical trials were begun in 1951 and 1952 at Brookhaven National Lab (BNL)
and in 1961 and 1962 at the Massachusetts Institute of Technology (MIT) research reactor.
The B-10 compound used during these early trials was sodium tetraborate (Na2B4O7*10HzO).
Clinical trials were also conducted in Japan in the 1960’s.

Cell
Nucleus

DNA

Figure 1: Cellular Level View of BNCT
2

Unfortunately, early clinical trials within the United States were unsuccessful for two reasons:
(1) thermal neutrons used in the early trials only penetrated about 3-4 cm in tissue, thus deep
seated tumors were spared, and (2) sodium tetraborate and other early compounds were
diffusible, low-molecular weight, and those compounds that did selectively concentrate in the
tumor cells had large background blood values. Hence, normal cells were radiated in large
amounts along with the tumor cells [2].

Combined with thermal beam impurities, high

background photon ﬂuxes, deep situated tumors, and diffusible and low selectivity of the
compounds in earlier clinical trials, patient health was jeopardized in some cases. This lead to
the shutting down of earlier BNCT clinical trials within the United States in favor of further
basic research and understanding of BNCT. Since 1968, over 150 patients with high-grade
glioblastomas have been treated with BNCT in Japan.

Reports of long-term survival in

selected GBM patients in Japan, better beam designs, better pharmaceutical developments,
and early success in rats with GBM spurred a keen interest in restarting BNCT clinical trials
within the United States in the 19903.
Recently, BNCT underwent Phase I/II clinical trials at Harvard Medical School and
MIT (H/MIT) and at BNL. The Objectives of the trials were: to evaluate the safety of a
stepwise increase in BNCT dose to the normal brain using p-Boronophenyalanine (BPA) and
epitherrnal neutrons, to evaluate any diverse effects of BNCT at each dose level, and to
evaluate the therapeutic effectiveness of each BNCT dose level in patients with GBM. Shown

Figure 2: Molecular Structure of p-Boronophenylalanine (BPA) Compound
Currently Used in BNCT Clinical Trials at H/MIT and BNL
in Figure 2 is the molecular structure ofpara-Boronophenylalanine (BPA), which was used
within these Phase I/II clinical trials at BNL and H/MIT.
BPA is an amino acid analog Of the naturally occurring essential amino acid,
phenylalanine, needed for building of proteins. It is thought that since BPA is molecularly
similar to an essential amino acid needed for protein synthesis, the growing tumor cells will
readily take up this compound in larger concentrations when compared with normal nonproliferating brain cells. It has been shown in several studies that BPA concentrates in tumor
cells (viable dense zones of tumor cells) by a factor of about 3-4 times relative to normal cells
within the brain. However, this ratio of 3-4 is very variable in-vivo. This variability is seen
within the tumor from the same patient as well as across patients [8-10]. Currently, there is no
precise method for determining the in-vivo boron biodistribution within tumor cells. The best
methods tend to average the concentration as determined from histological sampling during
debulking.
Results from the initial dose escalation studies within the US demonstrated that BNCT
doses used to date are safe. Patient survival after a single BNCT dose is slightly better than
survival after six weeks of standard radiation therapy with or without chemotherapy, and
patient quality of life after BNCT is better than with standard therapy [8,12]. Current results

from the phase I/II clinical trials have shown that the mean survival time with BNCT are
around 13.5 months with an average recurrence time of about 6 months post debulking [13].
Based on initial phase I/II results and lessons learned, there is a continued need for
improvement within BNCT if BNCT is to become fully acceptable as a treatment alternative
for GBM and other cancers in the future.

Better beam ﬁlter designs, puriﬁcation of the

neutron beam, a higher epithennal ﬂux, coupling of epithermal BNCT with fast neutron
therapy, better pharmaceuticals and understanding of the kinetics associated with these new
pharmaceuticals, a better understanding of the macro- and microdosimetry, and a better
understanding of the underlying biological mechanisms are just some of the basic research
which continues to drive BNCT. Perhaps the biggest setback to BNCT today is the cost of
having BNCT relative to standard chemotherapy and irradiation. However, this may change
as more individuals Opt to undergo BNCT, and if BNCT is shown to be successful in other
cancers besides GBM.

1.2 NEUTRON TRANSPORT BASICS
The boron-neutron interactions at the cellular level can be modeled as an engineering
system with various parameters and mathematical equations that describe the transport of
neutrons through the materials before interacting with the boron atoms (and depositing some
or all of their energies in the process). The general framework of the physics of such a process
and a detailed mathematical description of neutron transport and their interactions with various
materials can be found elsewhere [14, 15]. General neutron transport mathematics and physics
can be readily implemented on biological systems with some modiﬁcations.

l
V

‘aa—¢+QCVCD +2, (F, E)¢(F9E9§9t)_
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Where,

E
F
t
v
S
v

= Neutron energy (J)
= Position of Neutron (cm)
= Time (s)
= Neutron Velocity (cm s")
= External Neutron Source (cm'3 s")
= Mean Number ofNeutrons Produced Per Fission

Zia = Macroscopic Fission Cross Section (cm'l)
ZS = Macroscopic Scattering Cross Section (cm'l)
2f =Macroscopic Fission Cross Section (cm")
2, = Macroscopic Total Cross Section (em!)
Z = Normalized Fission Spectrum
(15 = Forward Neutron Fluence Rate (cm'2 s")
O = Unit Direction Vector
V = Gradient Operator

Figure 3: Boltzmann Transport Equation
The roots of transport theory date more than a century to the Boltzmann equation ﬁrst
formulated for the study of the kinetic theory of gases [14].

In

19405, the Boltzmann

transport equation was used to model neutron interactions as applied to nuclear reactors. The
neutron transport equation that describes interaction between neutrons and materials and the
physics behind such processes is derived from these kinetic equations developed earlier by
Boltzmann, and hence the neutron transport equation is more commonly referred to as the
Boltzmann transport equation. The Boltzmann transport equation is shown in Figure 3.
Several assumptions are made during the derivation of the time-independent non-multiplying
neutron transport form of the Boltzmann equation. These assumptions are described in detail
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elsewhere and brieﬂy discussed here [14]. The assumptions include treatment of particles as
points, particles travel in straight lines between collisions, particle-particle interactions are
neglected, collisions are considered instantaneous, material properties are assumed to be
isotropic, properties of nuclei and material compositions are generally assumed to be known
and time-independent, and it is only the mean value of the particle density distribution that is

considered.
With an understanding of such concepts as cross sections, particle distributions and
statistics, ﬁssioning of neutrons, primary and secondary (and scattered) particle streaming in
three dimensions and the mathematics which describe this streaming in various coordinate
systems, and applying certain boundary conditions, one can arrive at the time-independent
neutron transport equation:

[9°V+0(F,E)IW(F,QE)=q.,.(F,QE)+ jdE jar‘za.<r,E—>E,fzos‘2>w<afz,Em)
where,
A

0' represents the direction in which particles are traveling,
Q represents the direction in which particles are scattered,
A

dQ' represents the solid angle from which the particles are scattered into,
—.

V represents the gradient operator which describes the movement of particles in and
out of a particular volume element in three dimensional space,
911(1", O, E) represents the angular ﬂux,
7 is the three dimensional position in space,
E’ represents the initial energy of the particles,
E represents the energy of the particles after collision,

qex (17, SA), E) represents an external source,
0'(F , E) represents the total cross section,
0",.(17, E'—) E, SAT-O)

represents particles which scatter into energy E and angle O.

O 0 V represents the loss of particles due to streaming,

a(?, E)t//(F, O, E) represents the reaction rate (or collision density),
q“ (F, O, E) represents the extemal source, and
[dE . jdé'as.(F,E'—> E9Q'.é)V/(;§,é',E') represents particles traveling with
energy E’ about dE’, at an angle O' about 662' , and scatter into energy E and angle

fr.
Thus, balancing loss of particles with gain of particles within a given 3D volume element and
applying various assumptions, one arrives at the time-independent non-multiplying form of
the Boltzmann transport equation listed above.

1.3 MONTE CARLO METHODS
The neutron transport equation can be computationally simulated in at least three ways,
using deterministic methods, integral transport methods, or Monte Carlo methods.

In

deterministic methods, the energy variable is generally discretized and hence is commonly
referred to as the multi-energy-group approximation. The discrete ordinates methods deal
with space and angular variable in such a way as to yield systems of simultaneous equations
suitable for solution on a computer by discretizing the space and angular variables. Details of
the discrete ordinates methods (and certain anomalies such as ray effects which can arise as a
result of discretizing space and angle) and the integral transport methods used to solve the
Boltzmann transport equation can be found elsewhere [14,15].
The most common and preferred method for complex three-dimensional geometries
encountered in medicine is the Monte Carlo method. There are several advantages to using
Monte Carlo methods for medical purposes. For one, complex geometries can by easily
represented within Monte Carlo. Monte Carlo methods also avoid other systematic errors that

arise in discrete ordinates methods by making no discretization approximations regarding the
treatment of energy, space, and angle.

Errors with Monte Carlo tend to be stochastic in

nature.
Monte Carlo methods consist of simulating a ﬁnite number of particle histories (N),
through the use of a pseudo random number generator.

In each particle history, random

numbers are generated and used to sample appropriate probability distributions for scattering
angles, track length distances between collisions, and so on.

A history of the particle is

terminated when the particle being tracked is captured or escapes the geometry of interest.
However, if a particle is scattered, then a new energy is determined by conservation of energy
and momentum principles. This process can be repeated until either the particle is absorbed or
escapes from the medium (like in a void) or if the weight of the particle drops below some
threshold value (the Russian roulette cut off weight). Because Monte Carlo methods tend to
be stochastic in nature, large number of particle histories and batches must be run in order to
assure reasonable uncertainty in the results. In most cases, the uncertainty decreases in
proportion to NW. For example, in a BNCT simulation, if one used 2X106 particles, and 1%
of them, or 2X104 are detected by a detector, then the error will be on the order of 0.7 % (i.e,

1/(2E4)"”2. Because of the stochastic nature of the process and for large geometries with
small detector sizes, one may ﬁnd it useful to use certain variance reduction techniques.
Advantages of the stochastic methods like Monte Carlo is apparent when modeling
complex three- dimensional objects which may be difﬁcult to represent in discrete ordinate
methods. This is especially true for the medical images in which tumor regions, certain brain
Objects like the optic chiasma, and other regions of interest that might be too complex to

represent in discrete ordinates methods. However, Monte Carlo suffers in the fact that detailed
distribution of a dependent variable, such as spatial proﬁles of ﬂux or power may not be easily
obtained since these quantities are generally not calculated at a point. They are only estimated
from the number of collisions, particle track lengths, or from some other quantity in some
incremental volume or phase space. Thus if one needed detailed spatial proﬁles, the problem
would have to be divided into many small volume elements and the ﬂux estimated in each of
these cells. (Note that by reducing the size of the volume elements increases the amount of
histories needed to get similar statistics). Thus, the statistical uncertainty grows in relation to
the size of the volume element in Monte Carlo methods. A description of the Monte Carlo as
applied within treatment planning and the statistical uncertainty with the estimated doses
within treatment planning is described in a later section.
1.3.1 HISTORY OF MONTE CARLO METHODS

The Monte Carlo technique is a statistical approach. It was ﬁrst used in the earlyl8th
century.

The development of the method is contributed to the French historian and

mathematician, Georges Louis Leclerc Comte de Buffon, who in 1768 performed an
experiment in his house.

In the experiment he took loaves Of bread Of length L and threw

them over his shoulder. He then looked to see if they crossed the lines on his tile ﬂoor, which
had a spacing D. For L less than or equal to D, he obtained that the probability that the loaf
intersected the tile is given by:

P = 2L/(1t*D)

(3)

If the loaves are dropped N times and R intersections are counted then the total
probability is estimated to be:
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P = R/N;

(4)

With this procedure, one can estimate rtthrough statistical methods:

it = 2LN/(RD)

(5)

A key feature of this method is the fact that the absolute error of the estimate decreases
as N'l/z, where N is the number of times that the procedure is repeated. Thus a good estimate
for it can be estimated if one repeats the experiment enough times. Perhaps the real use of the
Monte Carlo technique was shown in 1948 when Fermi, Metropolis, and Ulam Obtained a

solution of the Schroedinger wave equation with this method. The Monte Carlo technique is
also used for macrodosimetry simulations and patient treatment planning within this work.
Thus a basic understanding of the Monte Carlo process is essential to be able to use the
treatment planning software in a meaningful manner and to be able to produce results that are
statistically acceptable.

1.4 OVERVIEW OF SERA
Use of neutron radiation in clinical BNCT necessitates the use of computational
software that allows for detailed 3D-volurne reconstruction from medical images followed by
radiation transport calculations that simulate the neutron transport equation to determine a
certain quantity of interest. This quantity of interest may include the dose, the dose rate, the
ﬂux, reaction rate, or other quantities of interest.

Investigators have utilized various

approaches for 3D-volume rendering from medical images so that the geometry could be
incorporated into Monte Carlo. At least three have been discussed in a recent paper [16]. At
least two approaches are available to simulate the Boltzmann transport equation that describes
transport of particles and their interactions in a given volume of interest. The resulting ﬂuxes
11

and doses to the tissues can be determined by either discrete ordinates methods
(DORT/TORT) or via the use of statistical methods like Monte Carlo.
Idaho National Engineering Environment Lab (INEEL), in conjunction with the
Montana State University (MSU) computer science department, has developed a BNCT
speciﬁc computational package (Simulation Environment for Radiotherapy Applications, or
SERA) to simulate the solution to the Boltzmann transport equation using Monte Carlo
techniques. SERA uses a modiﬁed non-uniform rational B-Spline (NURBS) combinatorial
geometry (CG) method to reconstruct the detailed 3D uniform volume element (univels)
geometry from 2D medical images followed by Monte Carlo methods to determine the dose to
particular volumes of interest. The Older version of SERA, or BNCT radiation treatment
planning environment (BNCT_RTPE), did not allow for three-dimensional image rendering
and visualization Options as is currently implemented in SERA.

However, the basics of

transport calculations using Monte Carlo are the same in both simulation codes. Treatment
planning and the resulting doses as described in various publications which used
BNCT_RTPE for modeling is essentially the same since the Monte Carlo module of
BNCT_RTPE did not signiﬁcantly change with recent migration to SERA.

The earlier

BNCT_RTPE module has been benchmarked and tested against the MIT version of BNCT
treatment planning software elsewhere [17].

It is SERA, which is the latest version of

BNCT_RTPE that is used within this work to deﬁne the appropriate parameters and to
simulate the transport equation to determine the doses to various regions of interest like the
tumor, target, brain, scalp, and skull.
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1.5 PHASE I/II PATIENT SELECTION GUIDELINES AND TREATMENT
LIMITS
Selection of patients for BNCT was based on certain FDA approved guidelines for
BNL’s phase I/II clinical trials before radiation treatment planning could be administered. The
guidelines by which patients were selected for Phase I/II clinical trials are shown in Table 1.
These guidelines have been followed rigorously with treatment planning presented in this
work. Further details pertaining to these guidelines can be found in the reference published by
BNL physicists and medical personnel who conducted the BNCT treatments [8].
During phase I/II BNCT treatment, the administered dose of BPA-F is about 250 mg
BPA/kg delivered as a 2 hour intravenous infusion.

After infusion, irradiation is started

approximately one hour after complete administration of F-BPA [8].

Blood boron

concentration at the beginning of irradiation and during the midpoint of irradiation is
measured to determine the duration of irradiation.

The tumor-to-blood boron ratio is

measured histopathologically by point sampling during debulking. This tumor-tO-blood ratio
along with the blood boron concentration is used to determine the boron component of the
dose to the tumor regions. Generally, neutron irradiation is administered as a single

Table 1: BNCT Eligibility Criteria
1. Supratentorial lesion for which most likely clinical diagnosis is glioblastoma multiforme
and diagnosis conﬁrmed histopathologically.
2. Tumor must be unilateral and unifocal

3. Deepest portion of tumor margin <= 6.0 cm from skin surface
4. No prior radiation therapy (immunotherapy and or itrathecal chemotherapy excluded)
5. >18 yrs.
6. NO pacemaker, metal prostheses, or metal implant in the head/neck region. (Dentures are
allowed)
7. Karnofsky Performance Status >70.
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fractionation/single ﬁeld that lasts around 40-50 minutes (@ 2 MW thermal) using the BNL
reactor [8]. Duration of irradiation is determined from the treatment setups and alignment of
the beam to insure that certain FDA dose criteria are fulﬁlled with a particular treatment setup.
Some technical considerations during beam alignment and duration of irradiation include
insuring adequate dose to the tumor regions while minimizing dose to healthy tissue.
In addition to the patient selection guidelines, several dose limits were also set under the
FDA phase I/II approved clinical trials. These dose limits were observed during the treatment
session and served as key indicators for the validity of the treatment plan setup. These dose
limits helped to determine the duration of the irradiation for a given treatment setup. For one,
the irradiation time was adjusted such that no more than about 10.5 Gy-Eq would be delivered
to the peak-dose volume within the normal brain endothelium.

However, in recent

publications and in some dose escalation studies, this limit was increased to 12.5 Gy-Eq.
Other conditions that were observed are listed in Table 2 and are reprinted from Coderre [8].
When determining the dose to patients using BNCT, a special boron “GrayEquivalent” quantity is deﬁned. It uses a relative biological effectiveness of 3.2 for fast and
thermal neutrons ( l4N (n,p) 14C reaction) , 0.5 for photons since a long irradiation time is
involved, 1.3 for B-10 within normal brain tissue, and 3.8 for brain tissue. These values are

used for treatment planning at BNL [13, 18, 19]. These RBE values are derived from cell
survival data using the 9L rat gliosarcoma cells that were irradiated at BNL [19].
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Table 2: Irradiation Limits Observed During Clinical BNCT Treatments (*
reprinted from Coderres)
1. Prescribed absolute peak dose (to a 1 cm3 volume) will be 10.5 Gy-Eq (12.5 in recent
studies)

2. The peak dose rate will be kept below 27 cGy-Eq/min so as not to exceed that used by
others for photon irradiation of the whole brain.
3. The average dose to the whole brain volume will not exceed 7.5 Gy-Eq.
4. The maximum dose to the scalp will not exceed 20 Gy-Eq.
5. The total radiation dose to the deepest part of the contrast-enhancing region of tumor
should be >20 Gy-Eq.
1.6 RADIATION TREATMENT PLANNING OVERVIEW
Treatment planning using SERA is accomplished by providing patient speciﬁc 2D
medical images in various formats, preferably in the RAW 8 bit 256X256 format or the QSH
format. QSH is the standard internal format supported by SERA and developed by Macguire
and N02 [40]. However, it will allow for other American Association of Physicists in
Medicine (AAPM) standard formats (like Digital Imaging and Communications in Medicine
(DICOM) format) to be converted to QSH. Once medical images are inserted into SERA, one
can go about picking various points on the image to demarcate the boundaries of a given
volume of interest. After the volumes are created, one can specify various materials that
compose those volumes of interests. The materials and tissue properties are Obtained from
International Council or Radiation Units (ICRU) publication number 46 for brain, tumor,
target, scalp, skull, optic chiasma, sinus, as well as other tissues of interest.

Figure 3 demonstrates the step by step picking of points in the SERA Model by using
various threshold techniques or by manually painting a region of interest. Once individual
points or regions are picked, one can volume render the regions of interest. Results of
demarcating a volume of interest and using the modiﬁed NURBS combinatorial geometry
method to volume render speciﬁc regions of interest are shown in Figure 4.
15

After volume rendering and generating a patient speciﬁc combinatorial geometry (CG) ﬁle,
one can setup a Monte Carlo input using the SERA MC module wizard or enter it in
manually. An example of a Monte Carlo input (described in detail in a later section) is
included in the appendix section (Appendix A). In addition to the CG geometry ﬁle, one must
also specify the source and the position of the beam within the input ﬁle. The source ﬁle used
for BNCT treatment planning at BNL is a 12 cm disk source that consists of 47 neutron
groups and 20 gamma groups. The source is predominantly an epithennal neutron beam with
a maximum intensity of 4.94 X 109 neutrons/ cmZ/MW-Min occurring between 10 and 30
electron Volts, as is shown in Figure 5. The advantage of an epithermal neutron source is that
one can get further penetration in tissue while preventing thermal ﬂux depression in deeper
parts of the tumor caused by attenuation in scalp and other superﬁcial tissue.
Positioning of the beam is accomplished automatically or manually by providing the
z-separation between the scalp and the beam aperture and specifying the azimuthal and polar
angles of rotation. The azimuthal angle and the polar angle Of rotation correspond to the
rotation from the top of the head to the back of the head, and from the right side Of the head to
the left, respectively. An example of beam positioning as visualized within SERA is shown in
Figure 6. The saggital, coronal, and axial views of patient geometry coupled with the beam
geometry can be used to determine if the beam overlaps or conﬂicts with patient geometry. In
the case where the beam overlaps certain boundaries of the patient geometry, erroneous results
can be expected.
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In most cases, too many particles will tend to get lost since there are overlapping
boundaries. This can lead to increased statistical uncertainty in the dose estimates since many
of the particles in overlapping regions will not be tallied. Thus beam alignment plays a critical
role in the treatment planning and one should exercise careful examination of Figure 6. In
addition to the losing of particles, alignment of the beam also plays a signiﬁcant role in
generating dose contours such that most of the 80% and 90% dose contours cover the center
parts of the tumor while allowing for sparing of the normal brain.

1.7 TREATMENT PLANNING RESULTS OVERVIEW
Once the position of the beam and the source spectrum are speciﬁed, this information
can be coupled with the geometry data, materials data, and cross section data to generate the
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Figure 6: Beam Positioning -Axial, Sagittal, and Coronal Views of the Beam
minimum amount of input data needed to complete a Monte Carlo simulation. SeraMC
module allows for these ﬁles to be used in combination and to simulate the boron neutron
interaction to determine a statistically simulated solution of the Boltzmann transport equation.
Results of the transport calculation include dose volume histograms that demonstrate the
percentage of a given volume receiving more than a speciﬁed dose. In addition, the results of
SeraMC also include individual dose contours (in 40X40, 128x128, or some other user
speciﬁed grid size) that overlay the individual image planes. Shown in Figures 7 and 8 are
dose volume histograms and a dose depth proﬁle, respectively, for a treatment setup using one
of the MRI patient data. The results shown in Figures 7 and 8 are for the BNL 2 megawatt
reactor with a 50 minute exposure time and a maximum allowable limit to normal brain set at
12.5 Gray-Equivalent. Figures 7 and 8 can be used to assess the efficacy of the treatment plan
to ensure that any treatment plan set follows the FDA approved guidelines for the BNCT

clinical trials. Doses and dose rates shown in Figures 7 and 8, respectively, include relative
biological effectiveness (RBE) factors and a boron concentration factor. Thus, the doses and
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the dose rates displayed are more commonly referred to as “boron dose equivalent” or “boron
dose rate equivalent” and can be used to compare with conventional photon therapy. The
terms, “boron dose equivalent” and “boron dose rate equivalent” are a departure from the

traditional sense of dose equivalent and dose rate equivalent since the relative biological
effectiveness (RBE) of 3.8 and the boron concentration factors of 3.5 are used to compute the
“boron dose equivalent” or the “boron dose rate equivalent”. The terms “dose equivalent”
and “dose rate” equivalent used throughout this work only refer to the dose derived from using
BNCT to reach some end objective in mind. Since BNCT is tumor speciﬁc, there tends to be a
larger amount of dose delivered to the tumor relative to normal brain when compared with
conventional photon therapy.
The dosimetry data can also be shown as either a contour plane that overlay an
individual plane or three dimensionally with volume rendering with SERA, as is shown in
Figures 9 and 4, respectively. However, note that the dose contours in Figures 4 and 9 do not
include the boron scaling factors, thus the dose contours are seen as smooth oval like in nature.
However, after applying “correction” factors such the boron concentration factor, Relative
Biological Effectiveness (RBE) factor, and the normalization factor, the dose would be

“scaled” in a fashion as that shown in Figures 7 and 8. More speciﬁcally, one can notice that
as a result of the “homogeneous” scaling of the dose, one gets a sharp discontinuity in the dose
depth proﬁle for the boron component of the dose at the target/normal brain boundary, as is
evident from Figure 8. Such discontinuity in the dose in the tumor and target volumes may
not represent the actual tissue level boron distribution and hence the dose within those regions.
Thus, the dose shown in these Figures for the tumor and target regions may not be patient
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speciﬁc and non-representative of the macroscopic heterogeneous localization of B-10. One
of the ways to resolve such discrepancy and to get patient speciﬁc boron dose which accounts
for this heterogeneous localization of the dose is to utilize registered 18F-BPA PET images
during treatment planning and dose prediction.

1.8 HOMOGENEOUS VS. HETEROGENEOUS ASSUMPTION
During the “correction” factor stage of the treatment planning, the radiation dose that is
predicted to be delivered to the tumor and target volumes is linearly and homogeneously
scaled based on a B-10 concentration factor.

This concentration is estimated from

histopathological studies conducted during surgery [9,10].

Based on these studies, it is

estimated that the boron concentration within all individual tumor cells is about 3.5 times
greater than that in the blood. Similarly, it is estimated that the boron concentration within the
normal brain regions is about the same as that in the blood, and the boron concentration in the
scalp is about 1.5 times higher than the blood [13].

Based on the ﬁrst 10 patients that

underwent treatment at BNL, the average blood IOB concentration was 13 i 1.5 ug 10B/g
(range 11.2 to 15.4). Thus, based on the boron blood concentration, the doses to the tumor,

target, brain, and scalp volumes is linearly and homogeneously scaled by 3.5, 3.5, l, and 1.5,
respectively. It is therefore assumed, that every tumor cell within the tumor volume, every
tumor cell within the target volume (tumor volume + 2cm), and every scalp cell within the
scalp region will contain 45.5 ppm, 45.5 ppm, and 19.5 ppm, respectively ( where 1 ppm =
part/million = 1 ug/g of B-10).
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Figure 9: 2D Dose Contour Displays
The reason for deﬁning a target volume that is 2 cm beyond the visible tumor volume in a
MRI image is due to the fact that GBM tends to be proliferative in nature. The central tumor
mass is known to have tumor cells or extensions Of tumor cells which migrate beyond the
main tumor mass. This extended region of tumor cells is generally believed to be about 1-3
cm for the GBM tumor [20]. Because of this proliferative nature Of GBM, medical physicists

tend to deﬁne a 2 cm target region beyond the tumor mass. The 2cm is chosen since it
averages the 1-3 cm regions found in various studies. Also, more studies favor using the 2cm
region when compared with the 3 cm region [20]. This region is also seen as the edema
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region in an MRI image and surrounds the main tumor mass region. Within the BNCT
community there is great debate about the exact distribution of boron and if the in-vivo boron
biodistribution is actually homogeneous.

One recent study concludes that histopathological

determination of the tumor-tO-blood or tumor-tO-brain is highly variable [10].
Another debate while working with GBM tumor is due to the actual extent of the tumor
beyond the tumor mass. What the exact extent of the tumor region beyond what is visible in
an MRI image and the metabolic activity of those tumor cells is not known with any great
certainty. Thus, this extended tumor region known as the target region is never precisely
deﬁned within SERA, and it is only assumed that this region will not extend beyond about 2
cm.
The linear scaling assumption is discussed in the next section and is justiﬁed as long as the
boron concentration in a given region is below about 50 ppm. However, the homogeneous
scaling of the dose within a given volume is not justiﬁed. There are several problems with
assuming that every cell within a tumor volume and the target volume will exhibit similar
metabolic characteristics in terms of taking up the boron (i.e., every cell within the tumor and
target volumes will not have 45 ppm). In addition, the macroscopic dose being delivered to
that volume cannot be homogeneously scaled. Some of the problems associated with this
“homogeneous” scaling include the following:
1. Homogeneous scaling ignores near neighbor effects in which one alpha particle emitted in
one cell may inﬂuence killing of nearby cells. This case was demonstrated in a recent
study [21] that looked at irradiating individual cells and bombarding them with alpha
particles and measuring changes in nearby cells.
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It was concluded that some factors

(perhaps mutated genetic material or other macromolecules) traveled between cells and
promoted killing of nearby cells. This phenomenon is also referred to as the bystander
effect.
. The combined range of the alpha and lithium particles is about 14 microns. Thus, it is
possible for an individual event to occur in one cell while having its impact on a
neighboring cell (i.e,, this more commonly referred to as the “cross-talk” effect in
radiation biology textbooks).
Surgery may reduce availability of boron to peripheral tumor cells within the target region.
. Individual cells commrmicate with one another through the use of gap junctions (and
hence exchange intracellular material).
oxygen radicals

There is also a possibility of having certain

(or other secondary messengers) which result from the irradiation

traveling across cells and causing effects in neighboring cells.
. Cells themselves are heterogeneously distributed throughout a volume. The tumor and
target volumes contain ranging pockets of very densely packed tumor cells to parts where
the tumor cells are loosely packed. Hence, the dose will be a function of this cellular
density (and the boron contained within the cells).
. Cells undergo different cell cycle stages. There is a random distribution of cells in various
stages within the tumor and target volumes. There will be a cluster of cells which maybe
in the S stage, while others will be in the G1 or G2 stages. The stage a particular cell is in
can inﬂuence the B-10 concentration within the cell. Thus, in the tumor/target volume,

not all cells will have equal B-10 uptake.
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Tumor killing is a tissue level response. The killing of tumor is a collective
tissue/macroscopic response rather than an individual cell killing response.
Based on in-vivo 18F-BPA Positron Emission Tomography images, the boron
biodistribution is heterogeneously distributed through out the volume. The heterogeneous
distribution as seen in PET is better related to the cellular density and the metabolic
function of the tumor cells and provides for a better in-vivo biodistribution than point
sampling and averaging of various locations through out the brain tumor volume.
Current methods use point sampling and sample only densely packed and highly
metabolic regions of the tumor to determine the average scaling factor. Point sampling is
highly subjective to error and large variability [10].
10. The homogeneous assumption ignores patient tumor variability and staging of the tumor.
Each patient’s dose is sealed with the same “average” estimate.
11. The homogeneous assumption also ignores the dose “shadowing” effect caused by the
depression of the epitherrnal/thennal ﬂux within the tumor volume. This phenomenon is
described in the next section.
12. Others have also favored use of functional PET images in treatment planning [22-24].
13. Some of the issues listed above are resolved by the use of registered 18F-BPA PET images,
others are not.

1.9 VERIFICATION OF LINEAR SCALING ASSUMPTION
Boron Neutron Capture Therapy Radiation Treatment Planning Environment
(BNCT_RTPE) software and its latest version, Simulated Environment for Radiotherapy
Applications (SERA) are used to determine the dose to the tumor, target, scalp, brain, and
28

other volumes of interest. It is assumed that one can place 1 ppm of boron within a
particular volume to perform a dose calculation. Later, it is assumed that the dose based
on 1 ppm of boron can be linearly scaled as a function of the actual boron concentration
within that particular volume so long as the concentration within the volume is below 50
ppm. This is an assumption that is built into these computer programs and is referred to as
the “linear” assumption.
This linear scaling assumption has been shown to be accurate so long as the boron
concentration within a region is below about 50 ppm. This is generally the case for current
clinical studies using BPA which accumulates in the tumor and target regions on the order
of about 40-50 ppm. Thus, the linear assumption is valid for this type of treatment
planning.

However, this may change in the future with new compounds that may

accumulate in larger amounts within the tumor and target volumes. A separate Monte
Carlo code (MCNP 4b by Los Alarnos National Laboratory) was run to verify this
assumption (Appendix B). Essentially, the boron reaction rate is determined at various
locations around the tumor and for varying boron tumor concentrations. An 8 cm disk
source using the BNL source spectrum used in SERA was placed 20 cm to the left of a
20X20X20 cm3 volume of water representing human tissue.

The 5X5X5 cm3 tumor

volume containing varying concentrations of boron was placed 2 cm inside the left surface
of the larger 20 cm cube water volume. A schematic diagram of the geometry is shown in
Figure 10.
Shown in Figure 11 and 12 are the results for the MCNP calculations which were used
to assess the linear scaling assumption. As can be seen from Figures 11 and 12, the boron-
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neutron reaction rates are linear so long as the concentrations within the tumor (and target)
volumes does not exceed 50 ppm. This allows one to place a few ppm of boron within a
tumor, target, scalp, and brain volumes and post process the results based on the actual
distribution of boron within these volumes.
Using the linear scaling assumption, one can plot the results in Figures 11 and 12
slightly differently. If one plots the reaction rate as a function of depth (while taking out the
homogeneous concentration scaling factor), one will get a plot similar to that shown in Figure
13 where position 0 corresponds to the center of the 5X5X5 cm tumor volume. One can note
from this Figure that there is a depression of the thermal and epithennal ﬂux in deeper parts of
the tumor (as can be seen at detector position 1 which corresponds to being 3.5 cm deep into
the tumor). This results in under predicting the dose to deeper parts of the tumor by about 7.9
% for 50 ppm, regardless of the distribution of the boron within the volume. This percentage
will vary depending on the spatial depthness of the tumor volume and the concentration of
boron within the tumor. Although this study did not explore placing the tumor at various
depths within the larger water volume, these differences could have been as large as 20 %
[25].
One of the effects caused by the linear “homogeneous” scaling assumption is also referred
to as the dose “shadowing” effect that results from the depression of the epithennal/thermal
ﬂux as one penetrates deeper and deeper into the tumor. The current linear homogeneous
scaling assumption that assumes that the dose to the entire tumor volume would be the same is
not valid, even if the tumor concentration throughout the entire volume was the same (as is the
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case in this simple Monte Carlo simulation in which the concentration throughout the entire
tumor volume was kept the same.
If one couples this dose depth shadowing effect along with the fact that the
biodistribution of the pharmaceutical within the tumor and target volumes is not
homogeneous, one would expect greater discrepancies between what is predicted and the
actual dose being delivered to the target and tumor volumes. Thus, ideal treatment planning
for BNCT would couple the actual boron biodistribution as determined from a PET image
along with PET/MRI image registration prior to the Monte Carlo simulation. Currently, SERA
does not allow for incorporation of the boron biodistribution prior to treatment planning. One
is limited to post processing the dose based on the linear assumption. This may be of greater
importance in the ﬁrture if new pharmaceutical accumulate at concentrations well beyond the
50 ppm range or if the administered boron concentration is optimized to allow for greater
accumulation within the tumor regions.

1.10 SIGNIFICANCE OF WORK
Currently, no one has addressed the use of 18F-BPA PET images for the purpose of
improving BNCT radiation treatment plamring for GBM patients. No methodology or
computer codes are available which may allow for such an analysis.

The author has

developed a methodology and a computer algorithm to allow for such detailed incorporation
of the 18F-BPA biodistribution within current BNCT treatment planning using PET images.
The methodology and the computational software are discussed within this work and are well
supported by various references. The current methodology and computational software is
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Shown to greatly improve treatment planning. In addition to improving existing treatment
planning, the author has also developed a technique that allows for better visualization and
reconstruction of PET data using the time integrated PET data.
Besides developing a methodology to improve existing treatment planning using the
heterogeneous boron distribution assumption and for better PET image visualization, the
author has also used the registered 18F-BPA PET images to compare differences between a
metabolic view of the tumor as shown in the PET images with that of an T1 -weighted MRI
images. These differences are analyzed to determine the beam misalignment which can result
between using MRI images or PET images to determine the tumor volume. Finally, the
author also uses the 18F-BPA PET images to determine the peak-tumor-to-normal brain values
and compares that with the homogeneous scaling factor of 3.5. Although this kind of work is
critical to BNCT treatment planning, this work has not been carried out by anyone.
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II. Overview of the Physics and Image Reconstruction Behind MRI and
PET
To better understand the need for Positron Emission Tomography (PET) images within
BNCT treatment planning and the differences between T1 and T2 weighted MRI images in
treatment planning, a basic overview of image reconstruction and the underlying physical
processes governing these imaging modalities is helpful. The 18F-BPA PET images represent
physiological/ﬁrnctional information, whereas Tl

MRI images represent anatomical

information. The reconstructed PET and MRI images are used in treatment planning to set up
the volume and to compute the appropriate dose to these regions. The intensities and the
locations of the Objects within these reconstructed images are also used to register PET and
MRI images and to linearly adjust the dose based on the heterogeneous boron distribution.
Thus, a basic understanding of image reconstruction and the physical processes underlying
these images can provide useful insight to the inherent differences between the two modalities
and how the two modalities can complement one another during treatment planning.
Generally, PET and MRI data retrieved from the University of Tennessee Medical Center
exists either in raw (unreconstructed) format or in reconstructed format.

Sometimes it is

useful to be able to take the raw urrreconstructed data and to create the object that is being
imaged. For example, this may be the case, especially since much of the data at UTMCK is in
proprietary machine speciﬁc format. Generally, the MRI data is in a General Electric Signa
5.0 format while the PET data is in either the CTI ECAT 6.4 or ECAT 7.0 data formats.
These formats are cryptic and make it difﬁcult for individuals to easily work with the data
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(unless appropriate licenses and software are available). Thus, one would like to have separate
algorithms that can use the raw data directly instead of having to obtain various licenses.
Another case, where this maybe appropriate is if one would like to experiment with
reconstructing data to remove artifacts from the image, to reduce noise, ﬁlter data using a
different ﬁlter as opposed to the one used by the manufacture, remove blurring, enlarge
images, change pixel size, etc.

2.1 MRI
Several 2D and 3D image reconstruction algorithms have been developed for PET and
MRI images.

Objects visualized in PET images tend to be quite different from those

visualized in MRI images. MRI images generally rely on the differential decay and recovery
characteristics of the proton NMR signal. Signal processing lies at the heart of MRI and data
acquisition and manipulation occur naturally in the Fourier transform domain of the image.
Hence, the images are easily reconstructed in the Fourier domain.

A Matlabtm code to

reconstruct MRI images using the properties of the Fast Fourier transform is attached as
Appendix C. The original data spectrum (fspec) in the Fourier domain is reconstructed using a
2 dimensional fast Fourier Matlab ﬁrnction (FFT) by taking the FFT of the rows of the image
followed by taking the FFT of the columns. The raw MRI data as acquired by the GE. Signa
5.0 scanner in the frequency domain is shown in Figures 14 and 15. Figure 14 shows a three
dimensional view of the two dimensional image data in the frequency domain. Figure 15
shows a two dimensional view of the frequency data after taking the log of the data. Figure 16
shows the reconstructed MRI data in the space domain using the properties of the Fourier
transform.
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Figure 14: 3-D View of Unreconstructed MRI Data

Figure 15 : 2-D View of Unreconstructed MRI Data
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Figure 16: MRI Image Reconstruction Using Fast Fourier Transform (FFT)
As can be seen from the reconstructed MRI data, there is good discrimination between
hydrogen dense areas (skull, eyes, fat), to less dense areas (brain, etc.). Also, note that several

anatorrrical structures such as the brain, skull, eyes, etc. are readily apparent in MRI images
and the resolution of the MRI data as retrieved from UTMCK is on the order of .8953 mm X
.8953 mm in the X and Y dimensions and 7.5 mm in the Z dimension. The structures that
become visible on an MRI image depend on the decay characteristics of the proton. The local
environment of the protons can greatly inﬂuence the decay properties of the photon. The
differences in the decay properties of the proton can be taken advantage Of by selecting T1 or
T2 weighted image. The physics Of MRI images and the use Of T1 or T2 signals to image
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different anatomical structures is described elsewhere [26]. T1 weighted MRI images have a
short repetition time (TR) and a short echo time (TE) [26]. This makes them ideal for
visualizing the anatomical details needed for treatment planning. It is also ideal for imaging
tumor, muscles, infections, cortical bone, ligaments, tendons, and other anatomic subtleties.

Thus, T1 weighted MRI images are suitable for treatment planning purposes to delineate the
tumor and target regions. T2 weighted MRI images have a long repetition time (TR) and a
long echo time (TE) [26]. Thus, this makes them useful in distinguishing normal from
abnormal soft tissue. T2-weighted MR] images are suitable for studies looking at
inﬂammation and presence of ﬂuids in the brain. The T2-weighted MRI images are not used
in treatment planning or in image registration within this work.

2.2 PET
Others have recently noted considerable beneﬁts in using PET images for revealing
cancer metastases in cervical cancer patients, breast cancer patients, as well as in lung cancer
patients undergoing conventional treatments and therapies [27,28,29]. In these recent studies,
PET was shown to signiﬁcantly alter the conventional treatment protocol and in some cases
even the amount of the dose prescribed and the location at which it was delivered. Several
others have also addressed the importance of using PET images in treatment planning [4,20,
23,24,30]. An understanding of the nature of how PET images are reconstructed is necessary
to understand how they can potentially improve treatment planning. Essentially, a PET image

is an in-vivo look at the biodistribution of a radiolabeled tracer in which the pixel intensity of
the PET image is directly proportional to the concentration of the tracer present within that
pixel.
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For BNCT purposes, a tracer, such as para-Boronphenylalanine (BPA) is radiolabeled
with isotopes like F-18 (most common), C-1 1, N-13, and O-15 that all have unpaired protons
and decay by an emission of a short-lived positron. Once emitted, the positron has a limited
range (on the order of a millimeter or so) before annihilating with an electron to produce two
photons emerging from the point of annihilation at approximately 180 degrees apart, in the
laboratory.

Coincidence detectors along the line of response can then detect the emitted

photons. These lines of response can be rotated about the object to view the resulting photons
from various projection angles. The integral sum of all the lines of responses for a particular
location on the image is directly proportional to the amount of radiotracer present within that
particular point of interest on the image. The resulting images which result from tallying up
the lines of response for various projection angles, 0, and various increments, s, between the
lines of response as the detector gantry rotates about theta results in what is commonly known
as a sinogram image. The sinogram image can be backprojected to represent the actual image
in the x,y coordinate system (as opposed to the (5,0) coordinate system which represents the
sinogram data). Various algorithms have been proposed to reconstruct the images from these
sinogram images. The most common algorithm currently used is the ﬁltered backprojection
(FBP) algorithm [31].

Other algorithms include the ART (Algebraic Reconstruction

Algorithm) and the EM-MLE (Expectation Maximization/Maximum Likelihood Estimate).
The resulting sinogram data in the space domain (as shown in Figure 19) can be reconstructed
using one of the various algorithms like EM-MLE (as shown in Figure 20) or the more
common, like FBP (as shown in Figure 21) in which the data is back-projected to reconstruct
the image.
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Figure 19: PET Sinogram Data

Figure 20: EM/MLE Reconstruction (implemented using Gregor’s
algorithm [ 32].)

Figure 21: Reconstructed PET Image Using FBP
Generally, the PET image reconstruction process involves normalization, back
projection, decay correction, scatter correction, and ﬁltering to produce the standard image.
The ﬁltered back projection method, as derived by Radon in 1917, can be described as:

fbp(x,y)= Im(xcos 6’,ysin6’)dt9

(5)

0

where
fbp is the ﬁltered back-proj ected image in the spatial domain,
x and y are the location of the annihilation event,
6? is the angle at which the detector is located along the line of response,
and m is the mapping function that maps the annihilation event back to the location on
the image.
After reconstructing a PET image, the pixel intensity of the image is proportional to
the distribution of the tracer within the volume. Distribution of 18F-BPA as is Visualized from
a PET image for one of the University of Tennessee Medical Center Knoxville (UTMCK)
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BNCT patients is shown in Figure 22. Others in the ﬁeld have used 18F-BPA to determine
the boron biodistribution within the brain using the FBP reconstructed images [33].

As is evident from the PET pixel intensity plot in Figure 22, the boron distribution within any
volume of interest is not homogeneously distributed, as is assumed in current treatment
planning within SERA. This is especially true within the tumor volume and the target volumes
where the tumor tends to have a larger concentration of boron within the main mass of the
tumor and lesser concentration further out on the peripheral boundaries of the tumor (i.e. the
target region). Thus, erroneous results may be obtained by assuming a homogeneous
distribution within the entire tumor and target volumes during the scaling portion of treatment
planning in SERA.

PEI" Inbrsiy [boron ooncsrriraibn1256X2$

PET Pixel Intensity (i.e. Boron Concentration] 2561258

mm
mm

Figure 22: PET Pixel Intensity for a 18F-BPA Reconstructed PET Image
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Better treatment plamring would allow for registered MRI/PET images to be used to
determine the dose and to incorporate the boron biodistribution within the treatment planning.
This is especially true since the dose is a function of the product of the neutron ﬂuence at a
particular location and the concentration of the boron within that volume. In other words, the
reaction rate of the boron with neutrons is as follows:

RR = ]¢(r, E, O) * R(E)dE
where,

R(E) is the boron absorption response function at some volume element
at is the ﬂux at a particular volume element,
r, E, and Q are quantities described in an earlier section.

Thus, the reaction rate of the boron with the neutrons depends on the spatial
distribution of the boron within a given volume.

Thus if one, is able to get a better

biodistribution of this boron with in—vivo l8F-BPA PET images, one is likely to get a better
estimate of the dose being delivered within the volume.
Even though PET provides metabolic information (and hence the boron
concentration information), it lacks signiﬁcant anatomical information for precise deﬁnition of
certain anatomical structure for volume reconstruction. The boron concentration (# Boron
Atoms/pixel) can be computed as follows:
[x

ECAT

cps] *

[20.5 uCi/ml]

[ECATpixel]

[3.7x104disintegrati0ns/sec0nd] [ls] #ml _

*

[uCi]

[l.053*10‘4]

# Boron Atoms

pixel

where,

x ECAT cps are the ECAT counts per second determined directly from the 16 bit PET
pixel intensity multiplied by the Quantity Scale factor,
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20.5 uCi/ml/ECAT cps/ECAT pixel is the conversion factor that will convert the PET
pixel intensity in ECAT cps into uci/ml,
3.7 X 104 is a factor that will convert uCi into disintegrations/second,

ml is the total tracer volume (10 m1) that is administered to the patient prior to
scanning,
and 1.053*104 is the decay constant of 18F.

Since it is known that 18F—BPA does not associate in-vivo, each annihilation corresponds to 1
atom of boron within 18F-BPA or the soluble form it, l8F-BPA-Fr. One can also take the #B

atoms/pixel as determined in the above equation and convert that directly into a more usable
form ( in ppm/pixel ) as follows:

[#Batomsh [lmole]*10.8g/mole * 1* 106,ug = ppm 10B
[pixel]

6.022 *1023 atoms

g

pixel

where 10.8 g/mole is the molecular weight of boron

Thus, use of PET within treatment planning should be coupled with MRI or CT image
registration for better treatment planning since it can allow for direct measurement of the
boron concentration in-vivo.
A Matlab program has been developed to reconstruct PET images using the
convolution backprojection method (Appendix D).

Shown in Figure 23 is an original

phantom image of the thorax, the radon transform of it and the associated sinogram data, the
ram-shak reconstruction ﬁlter used to remove l/r blurring of the image, and the reconstructed
image using the convolution backprojection algorithm. The phantom is a generic phantom
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built into Matlabtm. A discussion of the phantom can be found in the references [34,35].
Shown in Figure 24 is the same image reconstructed using the radon inverse function within

Matlabtm.
Dynamic PET images consist of several image frames spaced out over about 2 hours.
Each image frame consists of 47 image planes with 128X128 pixels per image for the CTI
ECAT 921 scanner. The image planes are axial planes starting from the top of the head to the
bottom of the head with an axial separation of about 3.5 mm between the planes. Each frame
has a period during which the counters count the number of photons being emitted. This can
range from 10 seconds to 15 minutes as speciﬁed by the user. Since the entire dynamic PET
scan collects counts over a period of 2 hours, the images can be time weighted and integrated
to get a better anatomical view of the brain than is currently available using just a single frame.
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Figure 23: Filtered Backprojection Reconstruction Using Convolution Method
46

Radon Inverse

Figure 24: Filtered Backprojection Reconstruction Using Inverse Radon
A Matlabtm program has been written which time weights the data and integrates each
image to maximize the number of counts corresponding to a given pixel (Appendix E and F).
This can be accomplished as follows:
For k=1:number of frames,

For i = lznumber of planes,
Image(i,k) = Image(i,k)*QS(k)*frametime(k)/sum(frametime) + Image(i,k-l)
End
End
where,

k is the counter over the total number of time frames.
i is the counter over the total number of axial planes.
image is the individual 128X128 axial image, i, and at some time frame, k
OS is the quantity scale factor that converts the 16 bit PET pixel intensities for a given
frame into ECAT counts/second.
Frametime(k) is total count time for a particular image frame.
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This results in PET images that are anatomically and statistically more accurate than
the individual images. Shown in Figure 25 is a side by side comparison of an image in a
particular frame and the time integrated image. Visually, the time integrated PET image is
more descriptive in that the midline ﬁssure of the brain, the scalp, the brain, and other regions
within the PET image are better deﬁned. In addition, streaks and noise are further reduced in
the time integrated PET data. Shown in Figure 26 is a three dimensional view of the PET
pixel intensities along with a comparison of the normalized difference between the two
images. One can note that in regions around the tumor, there is increased uptake in the time
integrated data in some cases. This may indicate better visualization of the tumor regions in
the time integrated data as opposed to the individual frame data.

This can perhaps be

attributed to increased signal-tO-noise ratio by summing up the total accounts in the tumor and
target regions.
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Figure 25: Side by Side Comparison of Individual Frame Image Vs. Time
Integrated Image
48

Single Frame Image

o‘c‘vilhlowiovtvoe

r
140

20

aaaaa

rrrrrr

Time Integrated

40

80

60

It

100

120

140

120

140

40

60

80

100

IIIIIIIIIIIIIIIIII

uuuuuuuuuuuuu

a
.

.

v

a

v

.

.

a

eeeee

20

.
rrrrrrrrrrrr

rrrrrrrrrrrr

zoz

Scaled Difference

....~a~;

Figure 26 3D View of Individual Frame Data, Time Weighted/Integrated Data, and
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III. Simulated Environment for Radiotherapy Applications (SERA)
SERA is a high performance three-dimensional planning system for neutron capture
therapy treatment plans developed jointly by Idaho National Engineering Environment
Laboratory (INEEL) and the Montana State University (MSU) computer science department.
It has been tested and validated at Brookhaven National Laboratory (BNL) [36,37]. SERA
allows for patient geometry to be reconstructed based on highly efﬁcient uniform volume
elements (univels) in which the model resolution is only limited by the image resolution. In
typical use, SERA consists of three main components: manual and semi-automated geometric
modeling of treatment objects derived from PET, MRI, or other medical imaging modalities,
dose computation for these geometries with SeraMC (the INEEL radiation transport code),
and dose contouring that overlays dose contours derived from the dose computation onto the
original image planes to determine healthy tissue limits. A license for SERA was obtained
from INEEL with the help of Dr. George W. Kabalka, Chuck Wirnperly, and David Niggs.
The author has installed a current version of SERA on the nuclear engineering
workstation on Felix.engr.utk.edu under the /ne5/codes/sera directory. To execute SERA, a
path to /ne5/codes/sera/sera1/'I‘arget/bin must be added to the .cshrc ﬁle. In addition, one
must copy the .serarc ﬁle within the main directory and this ﬁle must be sourced in the .cshrc
ﬁle. The author has also kept SERA updated with the latest patches. Latest patches of SERA
can be downloaded from http://www.cs.montana.edu/~bnct/ and following the link under
updates. An appropriate login name and a password Should be obtained from INEEL to keep
SERA updated.
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The ﬁrst part of the task, manual and semi-automated geometric modeling of the

treatment Objects, are implemented using the seraImage and seraModel modules of SERA.
These modules can be launched independently by issuing the seraImage or seraModel
commands at the prompt, or by selecting the appropriate icons from the SERA Graphical User
Interface (GUI). Sera GUI can be launched by issuing the seraMenu command at the prompt.
The solid models generated by seraImage and seraModel are comprised of
volumetric automatons and are referred to as univels. It is the combination of these univels
that deﬁne particular volumes and regions of interest. Because of the uniformity of these
univels, geometric interrogations can be performed using a very efﬁcient integer arithmetic
algorithm and the resolution of the geometry is limited only by the imaging modality. Sera3d
allows for the viewing of the univel geometry as well as particle tracks, beam line orientation,
and dose contours in projected three-dimensional space. It is seraCalc/seraMC modules that
are independently developed at INEEL and are used to calculate the complex radiation ﬁelds
present in BNCT treatment. The SeraDose module can then be used to visualize image space
simultaneously with overlapping dose contours in two-dimensional space.
Other modules in SERA include seraPlan and seraPlot which can be used to develop
a treatment plan or to combine various beam fractionations and to visualize dose volume
histograms and dose depth proﬁle for a given treatment session, respectively. Discussed in this
section are only a brief overview of these modules and the main technical points on how
treatment planning is accomplished using SERA with some end objective in mind. Detailed
information and a user’s manual can be found on line [39] or in an INEEL in-house class
document [38]. Before using SERA, one Should have an endpoint in mind. SERA can be used
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to accomplish a wide variety of tasks such as allowing for the display of dose volume
histograms, dose depth proﬁles, two-dimensional and three dimensional visualization of the
beam setup and various components of the total dose along with patient geometry. It can also
be used to combine multiple fractionations from the same beam or from different beams, and
for generation of various output ﬁles such as .contour or .cdﬂsz which contain individual
contour dose data overlaying particular image planes. For purposes of dose adjustment, the
endpoint Objectives were to demonstrate how current treatment planning is accomplished
using a single beam setup in SERA, to display the various components of the dose, and to
demonstrate how the homogeneous scaling of the dose is incorporated within treatment
planning in SERA. In addition, another objective of using SERA was to obtain certain ﬁles
that could later be utilized within MATLABtm subroutines to post-process the dose and to
improve existing treatment planning by incorportating the PET derived boron bio-distribution.
Thus, with these end objectives in mind, the author only discusses those parts of SERA in the

next few sections that are important to reach these objectives. In a later chapter, there is also a
description of how the MATLAB subroutines use the ﬁles generated by SERA and couple
them with the registered PET and MRI images to better predict the average dose to the tumor
and target volumes.

3.1 CONVERSION OF IMAGES INTO THE APPROPRIATE FORMAT
Before one can begin treatment planning in SERA, MRI or PET images must be
medically acquired and reconstructed. Physicist’s access to these images must be approved by
mutual consent of the patient and the physician. The images must then be converted into an
appropriate format suitable for SERA. MRI images are structurally and anatomically different
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from PET and CT images. There are certain advantages and disadvantages to using MRI, CT,

or PET images within treatment planning.

MRI images are hydrogen density maps and

provide for detailed anatomical description of patient geometry.

Contrast enhanced T1-

weighted MRI images can provide soft tissue contrast in which the edema region and the

tumor region may be readily visible. CT images are tissue density map, and likewise they also
provide detailed anatomical description of patient geometry. However, MRI and CT images
lack the much needed physiological and biodistribution information that can be provided by
PET.
Because MRI, CT, and PET images are generally retrieved and reconstructed using
properitary software, image format conversion is always needed before one can directly use
these images within treatment planning in SERA. Conversion of these images is no trivial
matter given the proprietary nature of the images. SERA only accepts 256X256 8 bit or 16 bit
row major data or QSH format images. The QSH format, developed by Maguire and N02,
provides for a common image format and incorporate data generated by image-processing into
a picture archiving and communication system (PACS) [40-42]. This format is an adaptation
of the American Association of Phycisists in Medicine (AAPM) standard image format and
consists of an ASCII header and a separate image ﬁle. The header may contain any of the
following information: date of image creation, imaging modality, ﬁeld of view, bytes per
pixel, and other parameters needed to convert the N-dimensional array of pixel values to the
visual representation for interpretation. The QSH format will generally include 2 ﬁles. The
.qhd is the header ﬁle and the .qsh ﬁle is a concatenated ﬁle containing the bitmap pixel
intensities of all the image planes.
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MRI and PET images obtained from the University of Tennessee Medical Center,
Knoxville (UTMCK) generally exist in the General Electric (GE) SIGNA 5.0 format or the
CTI ECAT (6.4 or 7.0) formats, respectively.

MRI images from UTMCK are generally

archived as several series under a main study. There may be 4-5 series per MRI study. Each
series of the study will correspond with T1, T2, pulse gated, combined T1+T2, contrast
enhanced, or a combination of these MRI techniques. Which technique is most appropriate
depends on the radiologist’s preference and the object of interest.

Each series generally

consists of about 20 image planes with 150 mm axial ﬁeld of view ana an interspacing of 7.5
mm between each image plane with a resolution of about .8953 mm in the x and y directions.
Most commonly, the MRI image planes tend to be 256X256 16—bit integer format with 7904
bits of header information. There is also a main header associated with a particular study, a
subheader associated with each series, and an imbedded header of 7904 bits of information

within each image plane. The header information can be used to understand the setup of the
scanner used to retrieve the particular image for a particular patient.
The GE SIGNA 5.0 MRI data and the associated header ﬁle must be converted into
raw data or the QSH format. There are at least three Options to convert proprietary MRI data
into SERA suitable raw format.

One is to use an IDL (Interactive Data Language by

CREASO) software, GEVIEW, which is licensed to run only at the medical center. I do not
recommend this option since the license for GEVIEW is expensive and constantly in use by
radiologists at the medical center. GEVIEW allows for visualizing of the data as well as
provides the header information such as pixel size and interplane spacing needed for treatment
planning.
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The second option is to use the MRIZRAW.m program that the author developed in

Matlabtm in tandem with the MRICro shareware developed by Chris Rorden. MRIZRAW.m
is included in the appendix (Appendix G and H) and the MRICro software to visualize MRI
data can be downloaded from the intemet as shareware [43]. Both programs, MRIZRAW.m
and MRIcro must be used in tandem to convert the MRI data into the format needed for
SERA.

MRICro software allows one to visualize MRI image data as Obtained from

UTMCK and to convert the MRI data into the Analyze format. Although, this allows one to
look at the pixel sizes in the x, y, and 2 dimensions and to read the proprietary header
information, the draw back of this program is that it does not allow one to convert the
individual image planes into raw 8 bit 256X256 images suitable for SERA. Thus, one must
resort to alternative means.
To resolve the problem of not having easy access to GEVIEW, and the fact that
MRICro only allows one to convert the data into the Analyze format, I have developed a
subroutine that guesses at the SIGNA image size and the image format and strips out all of the
header information. Knowing that the image size is 138976 bits and with some trial and error,
it was determined that the SIGNA 5.0 MRI images existed in 256X256 16 bit integer format
with 3952 cryptic 16 bit header lines.

The author used this information to remove all

unnecessary header information while keeping only the pixel intensity data.
intensity data is then rewritten into a raw ﬁle.

The pixel

Since the header ﬁle information is in a

proprietary GE SIGNA 5.0 format, the header ﬁle could not be easily parsed. Thus, one can
only get the pixel intensity information from MRIZRAW.m, but no header information
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regarding the x,y, and 2 pixel size is available. Thus, to get the pixel size information, one
should use MRICro in tandem with MRIZRAW.m
To use MRIZRAW.m to convert UTMCK MRI images into raw 8 bit 256X256
format, one must supply an input ﬁle (MRIZRAW.in) which lists the location of the directory
on the seventh line of the input. Directly below this line, the MRIZRAW.m expects a listing
of individual image planes that one would like to convert.

The original MRIZRAW.m

Matlabtm and the MRI2RAW.in input ﬁle is included in appendices G and H. The program
takes a SIGNA 5.0 MRI image, strips out all the header information and takes the 256X256 16
bit pixel intensities and converts them into raw 8 bit 256X256 row major image, which is
suitable for SeraImage. All of the header information is discarded. Thus, one should note the
x,y, and 2 pixel sizes as shown in MRIcro before using MRIZRAW.m to convert the
individual image planes into raw 8 bit 256X256 row major image data. An overview of
MRIZRAW.m is shown in Figure 27. The x, y, and 2 pixel sizes are later used in SERA to
relate the image Obj ects with the patient geometry.
In addition to MRIZRAW.m which converts individual MRI image planes into
256X256 raw 8 bit image format without providing the x,y, and 2, pixel sizes, the author has
also developed another Matlabtm subroutine, Read_registration.m, which reads the MRICro
converted Analyze MRI images and converts them into raw images suitable for SERA.
Read_registration.m also displays registered PET images in the Analyze format as contours
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Figure 27: Overview of MRIZRAW.m Subroutine to Convert MR Images Into
SERA Compatible Format
lying on top of the original MRI image. The program is attached in Appendix 1. Of the three
approaches, the author prefers the later approach of using the Analyze format images from
MRICro

and

using

Read_registration.m

algorithm

to

convert

the

images.

Read_registration.m uses the spm_hread.m function of the Statistical Parametric Program
(discussed in a later section). The only drawback to Read_registration.m is that it must also
be supplied registered PET images in the Analyze format for this to convert MRI images into
SERA compatible format.
PET scans at UTMCK prior to June 1998 were reconstructed using the CTI ECAT 6.4
software. PET scans after June 1998 were reconstructed using the CTI ECAT 7.0 software. As
such, separate programs have been developed to convert these images into appropriate format
since some patients were imaged prior to June 1998 while others were imaged after June
1998. Different methods for converting PET images have been explored by the author over
the course of this work. One method to convert PET images involves the use of zoom_img
software developed by Hedley Bond to strip out one of the frames of a PET study and then
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split the frame out into individual planes [44]. This software only works with ECAT 6.4 data.
This method was commonly used in earlier work with PET data. Use of zoom_img to convert
PET images into raw 8 bit 256X256 format is described elsewhere [45].
Another method is to use the Matlab”m subroutines developed by the author,
ECATZSERA.m (Appendix J). The image data can be in either ECAT 6.4 or ECAT 7.0
format. There are only two inputs needed to convert the images. One must specify the name
of the ﬁle that one wants to convert and if the ﬁle is in ECAT6.4 or ECAT7.0 data format.
The program uses ecatfile.m function (Appendix F) to read the header information and the
data from the ﬁle and converts all the planes from the last frame of the PET. Ecatfile.m is a
program developed by Flemming Herrnansen for the purpose of allowing users to interface
with ECAT6.4 or ECAT7.0 PET image data. Both of the programs, ECATZSERA.m and
ecatfile.m are attached in the appendix section (Appendix J and F, respectively).

For the

purpose of converting PET images for SERA, I recommend ECAT2SERA.m option over the
zoom_img option.

3.1 SERAIMAGE
Basic concepts used by SERA include slices, bodies, and body slices.

Shown in

Figure 28 are slices that correspond to medical imaging data (i.e. reconstructed CT/MRI/or
PET images).

These images contain several anatomical regions of interest over various

planes. These anatomical regions of interest are sometimes referred to as bodies (like skull,
brain, scalp, etc.). The body slices are intersections of these bodies with medical slices. These
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Figure 28: Bodies, Image Slices, and Body Slices

bodies must be deﬁned by picking points, drawing, ﬁlling, or painting a body on the slice.
These body Slices can then be combined to form a three-dimensional volume.
The loading of image slices is accomplished by the use of seraImage. Most treatment
plans in SERA begin with this module. SeraImage is essentially used to convert the Oiginal
image format into the QSH format, which is the standard image format used by SERA.
Currently, seraImage only accepts individual image planes with or without headers and takes
a guess at what the image structure may be, depending on the size of the image. It tries to
guess at the image size, bytes per pixel, and header size. It also allows a user to change these
values. This section of seraImage is not perfect and in many cases, separate programs must be
written so that images can be converted into a suiTable format for seraImage. Some of these
programs have been described in an earlier section.

The image format must be known to

SERA. It is recommended that SERA accept 8 bit or 16 bit, 256X256 row-major image data,

or QSH formatted data. One can expect to get strange results in sera3d (and other parts of
SERA) if the images are not converted into a 256X256 8 or 16 bit format. One strange result
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that I have seen included a misalignment of the image space with that of patient geometry
within sera3d. The author has developed independent Matlabtm programs to convert MRI and
PET data into a 256X256 RAW 8 or 16 bit format needed for seraImage, some of which have
been described earlier.
Invoking seraImage launches a GUI in which one can open a QSH image set or load
raw images. For raw images, one must also edit the header ﬁle to include x,y, and 2 pixel
sizes and deﬁne the locations of each image plane along the z-axis. This is critical, or else
volume rendering will be erroneous and the resulting doses will be inaccurate. Images can
also be reversed, rotated, resliced, or (in limited cases) registered, using the advanced options
of seraImage. After raw images are loaded and the appropriate header information supplied,
the images can then be converted into the .qsh format.

This will result in two ﬁles, an

IMAGE.qsh and a IMAGE.qhd ﬁle, where IMAGE refers to a ﬁle name chosen by the user.
The .qsh ﬁle contains the actual pixel intensity medical data, whereas the .qhd contains all of
the relevant header information supplied by the user. Some of this header information may
include patient name, image data type information (8 bit/16 bit), imaging modality, number of
pixels, the physical sizes of the pixel, automatic 2 separation, 2 values corresponding to each
image plane, and other information used by other modules of the program to relate image
coordinate system with the patient geometry coordinate system.

3.2 SERAMODEL
One of the most time consuming parts of BNCT treatment planning is the patient
modeling (or image editing). After the images are generated using seraImage, the next step in
treatment planning is to deﬁne various anatomical bodies to create the model geometry.
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SeraModel allows for many useful image operations, including manual and semi-automated
(threshold) deﬁnition and generation of univel-based regions of interest, and various image
processing tools to aid in the manual deﬁnition of these regions. Some of these tools include
region copying, scaling, overwriting, painting by ﬁll or borders, threshold segmenting, 3D
region growing, and automatic target deﬁnition. Use of SERA model results in the generation
of .uv and .uvh ﬁles that describe the geometry of the model as well as assigning the physical
properties to the univels.
Invoking the seraModel module via the command prompt or the SERA GUI, yields
the popup menu. To begin deﬁning bodies, one should ﬁrst load the QSH ﬁles (.qhd/.qim)
ﬁles by selecting ﬁle, and open QSH image in the drop down menu. This will allow the user
to load the QSH formatted medical images created using seraImage. The images will be
displayed in columns and rows, as is shown in Figure 29. One can then use the EDIT regions
selection of seraModel to create univel geometry by thresholding, picking points, painting,
ﬁlling a region, copying a body, or by growing a region beyond another deﬁned region. Using
PET or MRI images, one should deﬁne the buffer region (the space beyond the scalp) in
which neutrons will not be tracked. Other regions that can be deﬁned using the various edit
options of SERA include scalp, skull, brain, tumor, target, and others. Within the edit region,
one can select the Edit Body/Materials options to relate material properties with those of
geometric objects drawn on the images.
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Figure 29: SeraModeI GUI Used to Deﬁne Various Volumes of Interest
One can Specify the material properties using the Edit Bodies/Materials selection in
seraModel.

For example, one can deﬁne the brain region to be based on the International

Council on Radiation Units (ICRU) publication number 46 data on adult brain tissue. Other
materials that one can define within SERA include void, buffer, Lucite, polyethylene with
Lithium Hydroxide, water. ICRU skin, ICRU cranium, lung, concrete, MlT_brain, Fairchild
tissue, the ICRU eye lens. and many others. For the brain, target, and tumor regions, the
author recommends choosing the ICRU 46 brain with 10 ppm of boron placed through out the
brain. For the skull region, the author recommends choosing the ICRU 46 skeleton with no
boron, and ICRU 46 Skin for the scalp region. The default material properties such the boron
62

concentration factor for various materials, and the relative biological effectiveness factor
(RBE) associated with gammas, nitrogen-14 reaction, recoil protons, and ultrafast neutrons
can be changed using the view/edit sub option within body materials option in seraModel.
For the born concentration factor (i.e tissue-to-blood), the author chose 3.5, 3.5, and 1.0 for the

tumor, target, and scalp regions, respectively. For the gamma RBE, recoil RBE, nitrogen
RBE, hydrogen RBE, and the ultrafast RBE, the author chose 1.0, 1.0, 3.2, 3.2, and 1.0,

respectively. The maximum constraint dose for the normal brain was set at 12.5 Gyequivalent, and the maximum dose for the scalp and skull regions was set at 20 Gy—equivalent.
After completely deﬁning all of the regions and deﬁning the materials representing the
regions, the save model ﬁle results in the generation of two ﬁles, a .uv and a .uvh ﬁle. The
.uvh is a header ﬁle and the .uv ﬁle are the region deﬁnition ﬁle. Within the .uv ﬁle, one ﬁnds
individual region deﬁnitions which overlay corresponding image planes. These regions are
generally given a number, between 52-60, where each number represents a particular region.
The value corresponding to a particular region on the image is included in the .uvh ﬁle.
Shown in Figure 30 is a 3-D mesh plot of the uniform volume elements (univel)
region deﬁnitions generated by seraModel. These univel regions correspond to the nonuniform rational b-spline interpolation of the points chosen by the user. These univels provide
the link between the medical image space, the geometry space of the calculation, the various
bodies deﬁned by the user, and the material properties associated with the particular univel
volume. These region deﬁnitions can then be used within PET2MRI to relate a particular
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Figure 30: Region Deﬁnition Using Univels

regions with the material properties within that region. The PET2MRI algorithm is described
in a later section.

3.3 SERA3D
Sera3d is used to provide a three-dimensional representation of the geometry and the
dose data generated during treatment planning.

Sera3d also allows for the QSH images

generated by seraImage and the univel data generated by seraModel to be displayed
simultaneously. In addition, it allows for display of particle tracks and beam alignment to be
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displayed superimposed on the univel geometry and a particular image plane.

This

information is critical in visualizing the entire treatment process and helps to facilitate beam
alignment. The beam alignment and the generation of the volume can be coupled with the
dose data for better visualization of the dose in geometry space. An example of having the
univel data and a particular image plane superimposed with particle tracks and beam
alignment is shown in Figure 31. The three-dimensional geometry can be visualized in various
ways. The geometry can be viewed as points, lines, solid volume elements, hollow volume

elements, and image planes. A detail discussion of the various options within SERA3d is
described elsewhere [38, 39].
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3.4 SERACALC
Once the QSH ﬁles ( the .qim and .qsh) and the univel ﬁles (.uvh and .uv) ﬁles have
been successfully created and the materials speciﬁed, one can launch the seraCalc module.
This module couples the patient geometry with Monte Carlo simulation of particle interactions
within the geometry. The user interface to seraCalc is shown in Figure 32. One can use the
user interface, shown in Figure 32, to setup a treatment plan, or supply an input ﬁle, as shown
in the Appendix section (Appendix K). Using the GUI, one must deﬁne an input ﬁle name, a
combinatorial (CG) geometry ﬁle, a patient geometry ﬁle, and a new radiation shielding
transport (RST) ﬁle. The input ﬁle name is the name of the ﬁle to which all of the user
supplied information will be written out to. It is this ﬁle, which serves as the Monte Carlo
input ﬁle. The combinatorial geometry (or CG ) ﬁle is a ﬁle that describes in the analytic
geometry and is associated with the patient geometry ﬁles.
The patient geometry ﬁle is the univel (.uv) ﬁle that contains the model and body
information. Within this ﬁle are also RBE values and material properties which are associated
with a particular body. The new RST ﬁle (.rst) is a ﬁle to which all of the detailed ﬂux and
dose information will be written to. In addition, other ﬁles must be speciﬁed. Some of these
ﬁles include the source ﬁle, the material ﬁle, the cross section ﬁle, and the seraMC run script

(run_seraMC).

The BNL 12 cm aperture source ﬁle (BS.source) is placed in the

/ne1/mkhan/BNCT/Sera/ST/Results/ directory, the material ﬁle (SeraMC.m) is placed in the
$SERA_HOME/Resources/SeraMC/ directory, the cross section library (SeraMC.sigma)
containing the neutron and gamma cross sections is in the $SERA_HOME/Resources/
SeraMC/ directory. The run script used to execute the input ﬁle on the unix workstation is
run_seraMC.
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Figure 32: Sera Calc Graphical User Interface
After supplying the appropriate ﬁle information, seraCalc must be supplied
information regarding the number of histories to simulate, the number of batches to rm, and
various run directives which specify particular particles to be tallied. The nbatch controls the
number of batches, the nhist controls the number of histories to process, where as NFGUPD

or some combination of this represents the run directives. N speciﬁes neutrons with energy 0
to 16.9 MeV, F speciﬁes source-biased neutrons with energy as speciﬁed for the ﬁrst edit bin
which are processed to determine the calculated value for the proton recoil dose, G speciﬁes
that beam and induced gammas, U speciﬁes that neutrons with energies O to 100 MeV are
processed (that is if you are doing fast Neutron Capture Therapy), P speciﬁes that recoil

67

protons generated from neutron scatter with incident neutron energies > 16.9 MeV, and D
speciﬁes that an edit is performed. I recommend the use of NFGD run directives.
The position panel of the seraCalc GUI is used to align the beam. T represents the
target point about which the source is rotated, Zb represents the distance from source to target,
(1) represents the polar angle, and 9 represents the azimuthal angle. The target point, the source
to target separation, (l), and 9 are used collectively to align the beam above the tumor. The
target point is generally chosen to be the center of the tumor point. The target point can be
changed slightly to allow for the dose contours to align up as such that maximum dose is
delivered to the tumor region while sparing the normal surrounding tissue. Alignment of the
beam can take some trial and error to align the beam optimally. Shown in Figure 33 is the
target location (Xp, Yp, Zp), the source center, Xp, Yp, Zp+Zb, and the beam/target point

separation (Zb). Shown in Figure 34 is a 90 polar (4)) rotation of the beam that moves the
beam from the top of the head to the right side of the patient about the target point.
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Figure 33: Target Location
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Figure 34: Polar Angle Beam Rotation From Top of the Head to the Right Side of
Patient

Figure 35: Azimuthal Rotation From Back of the Head to the Right Side of Patient
Shown in Figure 35 is the rotation from the right side of the head to the back of the head. The
azimuthal angle, the polar angle, the target point, and the beam separation (Zb) can be used to
align the beam manually.
The tally panel includes the origin, delw, and the wncut options. The origin option
sets the lower origin of the edit mesh. The wncut option sets the particle weight below which a
binary decision is made to either throw the particle away or to double its weight. The delw
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option controls the width of the edit mesh in centimeters. For example, if one deﬁnes the
origin to be —15, -15, -15, then the mesh size of the geometry will be 30cmX30cmX3O cm.

This is much larger than the geometry of the patient, thus mesh tallying will include all of
patient geometry. A delw of 1 would mean that the mesh tallies should be conducted on
1cmX1cmX1cm voxel size and a wncut of .01 is the Russian roullete weight cut off in which
if a particle weight falls below this value, then a random number is used to decided weather or
not to follow this particle or to discard it. A random number below .5 will discard the particle
and a random number equal to or greater than .5 will cause the weight of the particle to double
and the particle will continue to be tracked. This simulation is continued for all particles.
In addition to the panels described earlier, the IOP panel option numbers 2, 3, and 4
are also useful. They allow for the beam to be automatically placed. IOP of 3 allows (l) and E)
to be determined automatically as such that the Z separation, Zb, between the scalp and the

source is deﬁned by the user. The author used a 2 separation of .5 cm with the automatic beam
alignment option number 3 in most of the treatment plans setup within this work. This was
used because beam orientation was for a single-ﬁeld irradiation, and the author wanted to
ensure a consistent beam scalp separation between all patients.

This was chosen so that

difference in the beam placement above the scalp would not play a signiﬁcant role in the
results from patient to patient.
In addition to the inputs used by seraCalc, one can also specify edit directives that
control the output of the calculation after all of the transport calculations are completed. The
edit directives are critical if one is to post process the dose and to generate dose volume
histograms.

There are four edit directive types. There are passive edit directives that do not
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inﬂuence the seraMC edits, inactive directives that must be placed before active directives,
active directives that must appear before a particular edit directive, and active edit directives.
The passive edit directive may include patient name (#patient), date (#date), and beam
(#beam).

These edit directives are used in seraPlot to label the patient, date, and beam

information when generating dose volume histograms or dose depth proﬁles. Although there
are many edit directives, only a few are discussed within this report. A user’s manual on
SERA should be consulted for further detail pertaining to other edit directives [3 8, 39].
The minimum set of edit directives to allow for the generation of contours needed for
the post processing of the dose and for generation of dose volume histograms and dose depth
proﬁles are shown in Figure 36.
edit_dir

#patient VG UTMCK Tl MRI
#date May_9_l975
#beam BMRR 12_CM
mw_min 1.0
b10_blood 1.0
refvol 1.0 0
ref_reg brain tumor target
ottocon 40 4O scalp tumor target brain
delta 0.25
eps 0.05
#Dose-Volume Histogram for Brain

in_reg brain target
b10_blood 13
rbe 1.3 1.0 3.2 3.2 1.0 1.0
DVbs
#Dose-Volume Histogram for tumor

in_reg tumor target
b10_blood 45.5
rbe 1.3 1.0 3.2 3.2 1.0 1.0
DVbs

#Dose-Volume Histogram for Scalp
in_reg scalp
b10_blood 19
rbe 1.3 1.0 3.2 3.2 1.0 1.0
DVbs

Figure 36: Use of Edit Directives To Generate Dose Volume Histogram and a
Concatenated Dose Contour (.cdf.sz) File
71

The mw_min edit directive speciﬁes the Power level of the reactor. The b10_blood
edit directive speciﬁes the boron blood concentration (in parts per million), the ref vol and the
ref region make the edit directives active within the speciﬁed regions.

The ottocon edit

directives in the most important directive of all since it allows for the generation of a
concatenated dose contour ﬁle (.cdf.sz) which is a zipped ﬁle that contains all of the dose
information that overlays particular image planes containing those regions speciﬁed in the
ottocon directive. For example the “ottocon 40 40 scalp” edit directive results in 40x40 dose
contour grid which overlays any image plane containing the scalp region. In addition to the
ottocon edit directive, the DVbs edit directive allows for dose volume histograms to be
generated for those volumes speciﬁed by the in_reg edit directive. One may also want to
specify the b_10 blood value and the RBE values for those regions. The RBE’s shown in
Figure 36 as 1.3, 1.0, 3.2, 3.2, 1.0, 1.0 are for the boron, gamma, nitrogen, hydrogen, other,

and gamma production. In addition, one can also provide RBEs for proton recoil (E>16.9
MeV) and ultrafast dose components using the rbe edit directive. And example of the dose
volume histogram is shown earlier in Figure 7.

3.5 SERADOSE
Once dose ﬁles have been generated using seraCalc, the dose contours can be viewed
on the images using seraDose. The primary objective of seraDose is to allow for visualization
of the dose contours from the dose contour (.cdf.sz) ﬁles generated by seraCalc. This task can
also be implemented in sera3d. Much of the dose contour displaying presented within this
work has used either sera3d or within Matlabtm using softwares developed by the author.
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3.6 SERAPLOT

Sera plot allows for a different type of visualization of the dose in that it allows for
displaying of dose-depth plots and for dose volume histograms. Within the dose depth proﬁle
option, one can visualize the total dose, b_10 dose, gamma dose, N-14 dose, hydrogen dose,
Gl-ﬂuence, Gp-2 ﬂuence, thermal ﬂuence, gamma production, ultrafast gamma production, ,

and other components of the total dose along the beam centerline. The seraMC output ﬁle
(.rst) is used to visualize these values along the beam centerline. Once can also include the
stride distance along the beam center line, a normalization factor, and a boron concentration
factor to scale the dose depth proﬁle. For example a stride distance of 1 will pick every point
along the beam centerline, a normalization factor of 3.5 is a multiplicative factor which is
applied unifonnly to every data point in the dose, and the boron concentration factor of 13
ppm is a multiplicative factor applied only to the boron dose, and indirectly to the total dose.
SeraPlot is useful in visualizing the dose and the dose rate as a function of depth along the
beam centerline. An example of the dose rate depth proﬁle generated using seraPlot is shown
earlier in Figure 8. SeraPlot can also be used to generate the dose volume histograms for the
various regions (as is shown in Figure 7).

3.7 SERAPLAN
SeraPlan allows for the dose (.rst) ﬁle from seraCalc to be combined into a
treatment plan that couples different beam fractions into one single treatment plan. Generally,
this is useful if the physicist wants to treat the tumor from various angles or at various times.
SeraPlan allows for incorporation of the boron concentration and for exposure data from
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multiple fractions to be incorporated into one treatment plan and for generation of one set of
contour data that represents the collective dose contours that would be administered if several

fractionations were given to the patient with different beam alignments for each fractionation.
Currently, under the Phase I/II FDA approved guidelines, patients were administered a single
fraction, thus the treatment plans within this work only focused on a single beam, single
fraction setup. Thus, this part of SERA is under utilized within this work.
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IV. Image Registration
Generally, image registration can involve resampling of images, smoothing (low pass
ﬁltering), afﬁne transformations (rigid body), some sort of optimization (to minimize the
objective function to align the two images), and in some cases intensity transformations (for
ﬁne tuning of the registration). The images can range from belonging to the same individual
from the same modality to one that is from different patients for different modalities (like
PET/MRI). For inter modality registration such as PET/PET or MRI/MRI, the problem is not
quite as difﬁcult as that for intra-modality registration for a given patient. Intra-modality
registration like PET/MRI is complicated by the fact that the intensities of the two images do
not correlate with one another. Likewise, objects in one image may or may not be readily
apparent in the other.

The primary objective of this work is to focus on intra-modality

registration for a given subject. Intra-modality registration for a given subject involves rigid
body transformations (constrained), image classiﬁcation into grey matter, white matter, and
cerebro spinal ﬂuid (CSF), optimization, and resarnpling of images to get new images that
have been transformed onto a “registered” coordinate system.

4.1 RESAMPLING OF IMAGES
Resampling of images includes determining voxel intensities for the new image once a
mapping of one image into the next is found.

The simplest approach is to take nearest

neighbor (or zeroth order) value for the new intensities. The advantage of this approach is that
it preserves the original intensities but can result in image that is quite degraded. Another
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approach would be to take tri-linear interpolation (ﬁrst-order) to resample the data. An
example of bilinear interpolation (which can be extended to tri-linear) would be as follows:
Let points a through p represent the original regular grids of pixels (x and y represent
the location values for these points, a through p). Point u can be a point whose value is to be
determined using bilinear interpolation.

Points q to t are used as intermediates in the

computation. From this, the following intermediates can be computed before computing the
value for u,

Let v,, vs, represent intermediate pixel intensities for (ﬁrst interpolation)
Vr =

( (xg — x,)vf +(xr — Xf)Vg) / (xg — Xf)

Vs: ((Xk-Xs)vj+(xs - Xj )Vk)/ (Xk—Xj)
From this, the pixel value for u can be determined as follows (i.e. second interpolation):

Vu = (0.. — ys)vr +(yr - yu)vs ) /(yr - ys).
Shown in Figure 37 are the points.
Bilinear interpolation can be extended to three dimensions using 8 nearest points for
interpolation.

Extension to the third dimension is trivial.

Many of these interpolation

subroutines are already built in to MatlabTM as functional routines and can be readily
implemented. Other more common interpolation technique may involve polynomial

Figure 37 : Example of Bilinear Interpolation
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interpolations (like Lagrange polynomials) or sinc interpolation (as is currently used in
Statistical Parametric Mapping software). The sinc interpolation (in time domain) has the
added advantage in that it avoids certain artiﬁcats in images (since ideal interpolation for
images should be done in the Fourier frequency domain).

4.2 SMOOTHING
Generally, smoothing is important for registering images from different patients but is
of not much practical use within this work. Smoothing is used to “spread” out the
different areas of the brain since homologous brains of subjects of different subjects can
never be precisely registered. This is similar to blurring two images from various patients
to try and reduce the discrepancy between the two images. A discrete Gaussian
convolution kernel can be used if needed. Smoothing of images followed by registration
can provide initial guesses for parameters that would register the two images. This initial
guess can then be applied to more rigorous registration using non—smooth images.

4.3 AFFINE TRANSFORMATIONS
Transformation is the mapping of points in one coordinate system (or in one frame of
reference in an image) into another. For each point, (x, y, z) in an image, a mapping can be
deﬁned into the coordinates of another space (x’, y’, 2’) as follows:
v_

'—

'—

This can also be re-written in matrix notation as follows:
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y = Mx, where
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mm, where n and m range from 1 to 4 are the 9 cosine angles of rotation and 3 translations
about the given axis. When n = 1, it represents the rotation and translation of x,y,and 2 about
the x’ axis. When n=2, it represents the rotation and translation about the y’ axis, and when

n=3, it represents the rotation and translation about the z’ axis.

When n=4, it represents

translation only without any rotation. The cosine angles of rotation (n=1 to 3 and m = 1:3), are
also more commonly known as Euler angles of rotation, and can be expressed in spherical
coordinates (with three parameters of rotation and three parameters of translation) for a rigid
body transformation for the same patient is as follows:
Rotation about the X axis:
X axis : (i.e. O or Roll)
1
M _ 0
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Z Axis: (i.e. Q or Yaw)
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The translation matrix can be expressed as follows:

T =

1

0

O

xlrans

0

1

0

O

1

erans

0

0

0

1

ytrans

where ans, ytmns, and 2m, represent the translations in x, y, and z of the original image

coordinate to system to get alignment in the new coordinate system (x’, y’, z’).
Collectively, MxMyMzT, represents the transformation and translation that is needed in

the spherical system to register the two images (that is if the two images have the same pixel
sizes). The order in which the rotations are performed is important. A rotation about X axis
of 1t/2 followed by an equivalent rotation about Y axis would produce different results if the
order of operations was reversed. An algorithm developed by the author to accomplished
optimization and to solve the simple rigid body transformation and translation is included in
the appendix (Appendix L).

The Euler_transform8.m program attached in Appendix L

generates 10 random data points, picks some pitch, yaw, and roll, and adds the known
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coordinate transformations and translation to this synthetic data. It then adds 10% noise to the
synthetic data. Then starting with an initial parameter guess of [0 0 0 0 0 0] for the pitch, yaw,
roll, and the translation parameters, respectively, the code optimizes the solution to determine
the

known

transformations/translations.

The

original

points,

the

known

transformation/translation vector, and constrained optimization results are shown in Appendix
L. The error in each of the points was within half of a percent. This code only implements
rigid body transformation and translation and can be used to align images if one speciﬁes
corresponding points in the two images. However, this code is subject to non-reproducibility
and user dependency. A preferred method (described in a later section) would allow for
automatic image registration.
Because MRI and PET images as retrieved at the UT Medical Center have
different pixel sizes, another transformation matrix must be included to account for the
two different pixel sizes. The pixels for the two images (f and g) will often have
anisotropic pixel sizes. Thus, for an MRI image (f) retrieved at the UT medical center,
the pixel size are generally .8975 mm by .8975 mm (in x,y) and 7.5 mm in depth (2 axis).
In addition, the MRI image is generally a 256 X 256 image for a total of about 19-20
image planes. Thus the afﬁne transformation matrix which maps these pixels into the
normal Euclidean space would be as follows:

M =
’

.8975
0

0
.8975

o
o

o

0

7.5

—19* 7.5/2

0

o

o

1
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—256*.8975/2
— 256 * .8975/2

The Mf transformation will map the original MRI image into the Euclidian space

whose axes are parallel to those of the image and distances will be measure in mm, with the
origin at the center of image. A similar matrix can be deﬁned for the PET image (g) as
acquired at the UT Medical Center. Generally the PET image as acquired at the UT Medical
Center consists of 128X128X47 images with a sampling resolution of 2.1 1X2.1 1X3.75 mm in
the x,y, and 2 dimensions, respectively. Thus, the corresponding matrix that maps this into the
Euclidean space is:

2.11

0

O

—128*2.11/2

M =

0

2.11

O

—128*2.11/2

g

0

0

3.75

0

0

0

—47*3.75/2
1

The objective function of any co-registration is to determine the rigid body
transformations that will map an image (such as f for the MRI) to that of another (such as
g for the PET).

For this to be possible, a rigid body transformation matrix, M,, must be

determined such that Mg'erMf will register images. Various authors have developed
different algorithms to solve such image registration problems [46]. These algorithms
range from being semi-automated to fully automated algorithms. Regardless of the
approach used, most of these algorithms involve some sort of least squares optimization.

4.4 OPTIMIZATION
The objective of optimization in image registration is to determine a set of parameters
for which some function of the parameters is minimized. The simplest method of determining
optimum parameters for a model would be to minimize the sum of the squared differences
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between the model and a set of real world data (X2). In an image registration sense, this is the

equivalent of minimizing the squared difference between the template image and the object
image. Due to the nature of the image registration problem, several parameters need to be
determined. In a Cartesian coordinate system, this can involve 12 unknowns (9 Euler cosine
angles, and 3 translation parameters) or 6 parameters in the spherical coordinate system (3
rotations and 3 translations). The 12 unknowns in the Cartesian coordinate system can be
used to constrain the problem in the spherical coordinate system.
Because the search space is large due to the fact that there are many parameters
involved in optimizing the problem, it is generally not possible to exhaustively iterate through
the entire parameter search space. Thus, the usual approach is to make an initial guess for the
parameter, and begin iteratively searching from there. A judgement is then made about how
the parameter estimate should be modiﬁed, before continuing on to the next iteration. Once
some convergence criteria is reached (like when X2 or the sum of the squared difference stops
decreasing), optimization is terminated.
Image registration is essentially an optimization problem in that one image (the object
image) is spatially transformed so that it matches the other (the template image), by
minimizing X2. The parameters that are optimized are those described in the previous section.
Various algorithms are available for optimization. But the algorithm of choice, and that which
is implemented in Statistical Parametric Mapping Software developed in MatlabTM is similar
to that of Gauss-Newton and is illustrated as follows:
Let di(p) be a function that describes the difference between the object and template
images at voxel, i, where the vector of the model parameters has value p. Thus, for each
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voxel, i, a ﬁrst order approximation of Taylor’s Theorem can be used to estimate the value that
this difference will take if the parameters p are increased by some step size, t, where t is also a
vector representing the step size for individual parameters, p.

Using Taylor Series

approximation, the next value for di(p+t) would be as follows:

di(p+t) =di(p)+tl

ad.(p) + t2 6611(1))” 3 5di(P)+...
p1

6P2

0193

where the series is truncated after the ﬁrst derivative terms.
From this, one can get simultaneous equations (of the form Ax = b) to estimate the
values that t should have to minimize 2i d i (p + t)2 :
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where, k represents the total number of parameters and j represents the total number of voxels,
i.
From this, one can derive an iteration scheme for improving the parameter estimates.
For iteration n the parameters p are updated as follows:
p("”) = p" + (A’A)’l A'b
where,

83

(_ a6111(10)
apl

_ 5612(1))
apI

A = _5d_3(l_’l
0p]

_ 6d,-(p)
E

5p]

_ 5611(1))

_ adl(p)

_ ad1(p)

apz

6173

617/.

_ 661120))

_ 6612(1))

_ 5d2(p)

apz

_ 5013(1))

6173

_ 661,02)

d2 (.0)

. b = 613(1))

_ 061300)

ap3

apk

_ 5611(1))

6[)2

(d1 (p) \

5p].

_ a611309)

apz

\

_ 661,-(19)

6173

K d. (12))

apk

/

This process is repeated until X2 no longer decreases or for a ﬁxed number of
iterations. One of the problems with the previous approach is that there is no guarantee that a
global solution will be reached since the algorithm can get trapped in a local minimum. To
reduce this problem, the starting point, p should be as close as possible to the optimum
solution. The number of potential local minima can be decreased by working with smooth
images (smoothing of images has the effect of making the ﬁrst order Taylor approximation
more accurate for larger displacements).

Once registration is close to the true solution,

registration can continue with less smooth images.
In addition to spatial transformations, (p5), one can also incorporate intensity
information into the context of the optimization problem. The optimization problem can be
assumed to minimize two sets of parameters, those that describe spatial transformation (p3) (as
described previously and implemented in the algorithm that I developed) and those that
describe intensity transformations (pt).

Thus, one can modify the objective function as

follows:

611(1)) = f(s(x.-,p.. )) -t(x.-,p,) .
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where f represent the intesity transformation function and t represents the spatial

transformation function as described previously. The intensity transformation can be linear or
non-linear. However, the objective function (di(p)) is more appropriate for inter-modality
registration in which the intensities in the two modalities are directly related to the objects that
they represent and have similar representations across images (for example MRI/MRI
intensities or PET/PET intensities). However, this is not appropriate for PET/MRI registration
unless the intensities in one are scaled accordingly to the other. Thus, an appropriate intensity
function must be sought before using an objective function that accounts for intensity
differences along with spatial transformation differences in the optimization process. The
intensity transformation function must also account for various differences in the modality

(PET, SPECT, '8F-DOPA, 'gF-BPA, '8F-FDG, Tl-MRI, T2 MRI, etc..) or different
anatomical regions (cortical gray matter, sub-cortical gray matter, cerebellum, etc.), or some
combination of the above.

4.5 INTRA-MODALITY REGISTRATION THEORY ( SPM APPROACH)
Automatic co-registration of brain images of the same subject from different
modalities has proven itself to be challenging since there is nothing obvious about what to
minimize in the two modalities. Intensity values that represent a particular object in one
modality may represent a completely different object in the other.

Thus, intra-modality

registration is not a trivial task. At least two algorithms have been developed to carry out
intra-modality registration. Woods has developed the Automated Image Registration (AIR)
algorithm to co-register MRI and PET images [47]. However it is complicated by the fact that
laborious manual scalp editing must be carried out to remove any tissue that is not part of the
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brain. AIR 3.08 has been setup on the engineering workstation (felix.engr.utk.edu) under
/ne 1 /mkhan/registration/AIR/AIR3 .08 directory.
A more recent algorithm (SPM99) involves the matching of images by maximizing
mutual information developed by Ashbumer and Friston [ 48-52, 54]. An alternative example
would involve the manual identiﬁcation of homologous objects in both images (for example
matching Gray Matter, White Matter, and Cerebrospinal Fluid regions). These landmarks
could then be used to align the images together. The two approaches, one using mutual
coregistration, and the other using certain landmarks, are currently implemented in the
Statistical Parameteric Mapping algorithm (SPM99) developed by researchers and
collaborators of the Wellcome Department of Cognitive Neurology in United Kingdom and is
the choice of software for the registration work which implements fully automated image
registration. The SPM algorithm has the added advantage in that it is reproducible. Earlier
algorithms which involved visual registration (2D and 3D visual registration) developed by
the author and the semi-automated algorithms (which involved picking corresponding points
in two images and implementing rigid body transformation and translation) failed in
reproducibility and required manual interaction to register the two images.
The SPM algorithm is described as follows:
1. Determine the afﬁne transformation that maps between images (f, g) and the template (tf,
g.) by minimizing the sum of squares difference between f and tf, and g and tg (where tf and tg
are template images). These transformations are constrained such that only the parameters
that describe rigid body transformation are allowed to differ.
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2.

Segment or partition the images using the probability images and the modiﬁed mixture

model algorithm. Then, map between the probability images to images f and g having been
determined in step 1.
3. Co-register the partitions using the rigid body transformations computed from step 1 as
starting estimates.
Step 1 is described above in an earlier section regarding transformation of images.
Steps 2 and 3 are ﬁrrther discussed in SPM related papers [48-52].
Let Mf, Mg, and M. be matrices which map from the voxel coordinates of images f, g,

and the templates into their Euclidian space. For the UTMCK MRI images, Mf is as follows:

M =
’

.8975
0
0
0

0
.8975
o
0

0
0
7.5
o

— 256*.8975/2
—256* .8975/2
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For the UTMCK PET images, Mg is as follows:
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g

0

O

3.75

O

O

0

—47*3.75/2
l

and Mt depends on the template image that is used to align the PET or MRI image to.
Generally it is possible (and easier) to obtain matching of images of most normal brains to a
template image of the same modality using a twelve (or even nine) parameter transformation,
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as described earlier. On can easily register image g to a template tg from the same modality,
and similarly register f to a template image, tr, from the same modality. Let the transformation
matrices which carry out these mappings of image f to the template tf and g to tg be Mﬁ and
Mg, respectively. Thus, a mapping from f to g, now becomes Mg'lMgtMﬁ'le,
where Mg1Mﬂ is the trasforrnation matrix (M,) which maps f to g. However, it is important to
note that this afﬁne transformation has not been constrained to be rigid. For this to be a rigid
body transformation, Mg. must be decomposed into a matrix that performs a rigid body
transformation (Mg), and one that performs scaling (Mgr) and shearing (M...) In other words,
Mg. = Mngta.

Similarly, Mﬁ can be decomposed into a scaling (Mﬁ) and shearing (Mta)

components. In other words, Mﬁ = Mﬁ-Mta. Also, note that Mm is same for both f and g. The
earlier mapping from f to g, now becomes Mg-lMgr(MtaMta-I)Mﬁ-|Mf. This represents the rigid

body transformation that describes the mapping of f to g via the use of templates. This rigid
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body transformation and translation can be expressed as follows:

Where, parameters, q1, q2, q3, represent translation of g which will align with the template
using rigid body translation, q4, q5, and q6, represent the R011, Pitch, and Yaw, respectively,

which will transform g into the template coordinate system using rigid body transformations.
Similarly, q7, qg, q9, represent the rigid body translation of f which will align with the template,
and qlo, q] 1, and qlz, represent Roll, Pitch, and Yaw, respectively, which transform g into the

template coordinate system using rigid body transformations.
When aligning the images to templates, one results in a set of parameters, q = (q1, q2,
...), which must be optimized in order to determine the transformations (and translations) that
will minimize the sum of squares difference between the images and the templates. The
Gauss-Newton method of iteratively optimizing the objective function was described in a
previous section (Section 4.4). It essentially involves the use of generating a matrix AtA and a
vector Atb for each iteration, solving the equations, and incrementing the parameter estimates:
p(n+l) : p" +(AIA)—lAlb

For the purpose of this optimisation of matching two images to templates, one can
deﬁne two matrices, M. = (Mt'lMﬁMf)l and M2=(M{1MgtMg'l). Thus, A can be described as
follows:
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Where, f(x) represent the intensity of the image f at the position x, g(x) is the intensity
at position x, tf(X) is the intensity of the template image at position x, and tg(x) is the intensity
of the template image at position x. Mx represent the mapping from one coordinate system to
another (i.e., f(M1x1) represents the mapping of pixel, X] at this position, into the new position
which corresponds with the template coordinate system.

The vector b, is computed as

follows:

(f(M1x1)—q19tf(x1)\
f(M2x2)_ql9tf(x2)

g(M1x1)—q20tf(x1)
f(M2x2)—q20tf(x2)

K

5

2

The parameters, ql3 to q13 describe the non-rigid transformations (shearing of images)
could also be derived from either f or g, but instead these parameters are estimated from using
both images. The results in SPM are biased so that the image that ﬁts the template better has a
greater inﬂuence over parameter estimates. This is achieved by weighting rows A and b that
corresponds to the different images. The weights are derived from the sum of squares
difference between the template and object images, obtained from the previous solution of q.
The weights are for f and g, respectively:

I

and

I

erMxo—qwtxmr

llama—error

Once optimisation converges to a ﬁnal solution, one can obtain the rigid body
trasforrnation that approximately maps between f and g. This also gives the afﬁne
transformation matrices that map between the images and the templates, which can be used in
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the partitioning of images into various segments (i.e, Gray Matter, White Matter, and
Cerebrospinal Fluid, etc.).
Healthy brain can generally be classiﬁed into three broad tissue categories (Gray
Matter (GM), White Matter (WM), and Cerebro-Spinal Fluid (CSF), on the basis of an MR]
image. This classiﬁcation can be performed on manually on a good quality T1 weighted MRI
image by simply selecting suitable image intensity ranges that encompass most of the voxel
intensities of a particular tissue type. (This is possible because of the varying tissue T1
relaxation properties). However, this manual selection can be highly subjective. Several
groups have used clustering algorithms to partition MR images into different tissue types by
either using images acquired from a single MRI image or by combining information from two
or more registered images acquired using different scanning sequences (proton-density and
T2-weighted). SPM uses the modiﬁed version of one of the clustering algorithms. The
clustering algorithm used within SPM is the maximum likelihood “mixture-model” algorithm
[53]. Essentially, SPM assumes that the MR image consists of a number of distinct tissue
types (clusters) from which every voxel has been drawn. The intensities of the voxel
belonging to each of these clusters conform to a multivariate normal approximation, which
can be described by a “mean” vector, a covariance vector, and the number of voxels belonging
to the distribution. In addition, SPM uses approximate knowledge of the spatial distribution of
these clusters, in the form of probability images provided by Montreal Neurological Institute
that were derived from MR images of a large number of subjects. The original images were
segmented into binary images of GM, WM, and CSF, and all normalized to the same space

using a 9 parameter (3 translations, 3 rotations, and 3 orthogonal zooms) afﬁne transformation.
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The probability images are the means of these binary images, so that they contain values in the
range of 0 to 1. These images represent the prior probability of a voxel being either GM,
WM, or CSF after an image has been normalized to the same space using a 9 parameter afﬁne
transformation. The difference between the approach used in SPM and the Mixture Model
described elsewhere [ 53] is in the update of the belonging probabilities. The assignment of a
probability for a voxel is based upon determining the probability of it belonging to cluster, ci,
given that it has the intensity, v. This is based upon simple Bayesian statistics:

[90’ | 0,- )p(C.-)
p(ci IV) = K

Z [’0’ l Ck )P(ck)

p(v / c, ) represents the probability density for the cluster ci at a value v, and p(ci) is the prior
probability of the voxel belonging to cluster ci (where p(ci) is based on apriori probability
images) where p(ci) can be calculated as follows
p(ci) = nibi /Zbi

where bi represent the value at the corresponding position of the ith probability image, ni
represents the number of voxels known to belong to a cluster, and 2 b, is the integral over
the image. Step by step implementation of using probability images to map MRI or PET
images in SPM onto templates are described in SPM related papers.

V. Statistical Uncertainty with SPM
The SPM algorithm [48-52, 54] developed by the Wellcome Department of Cognitive
Neurology, University College, London, is written in Matlabtm and provides for a method of
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detecting regional, task-related changes in brain activity from neuroimaging data along with
image registration, smoothing of data, and resampling of data.
Keibel has cross-validated MRI and PET coregistration using Friston’s SPM99
algorithm with another more commonly used algorithm developed by Woods from the
University of California, Los Angeles (UCLA) using 32 simulated PET images with known
rigid body transformations [54].

It was shown that using SPM without scalp editing and

applying random transformation and translations, the mean error in the x, y, and z translation
was .670 i .236 mm, -1.150 i .172 mm, and 2.071 i .295 mm,

respectively.

In the

transformation matrices, it was shown that pitch, roll, and yaw had errors of -1.131 i .082

degree, -.145 i .151 degree, and -.260 i .078 degree, respectively [54]. Thus, the translation
uncertainty was at most about 2 mm while angular uncertainty was at most about one degree
[54].

Scalp editing PET images prior to registering can further reduce the uncertainty in

PET/MRI image registration.
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VI. Dose Adjustment
Once registered PET/MRI images are obtained then one can adjust the boron
component of the total dose. The PET adjusted dose can than be compared with standard
methodology. The boron dose contours shown in Figure 9 are for a standard 1 ppm boron
distribution within the entire brain, scalp, target, and tumor regions. The unit of dose shown in

Figure 9 is cGy/MW-min/ppm. The contours are homogeneous and well centered due to the
fact that the scaling of the boron component of the dose has not been taken into account. The
total dose is usually scaled by three factors under the standard protocols. One factor accounts
for the treatment time (40-50 minutes) as well as the power of the reactor (2 MW). Another
factor accounts for relative biological effectiveness (RBE) of killing cells with neutrons,
photons, as well as the chemical nature of the process within tumor and brain cells. A third
and ﬁnal factor accounts for the boron distribution differences between the normal cells within
the brain volume and tumor cells in the tumor and target volumes. The dose which takes into
account for all three of these factors is generally referred to Gray-Equivalent because it
represents the “boron equivalent” dose that would be delivered if X-rays or photons were
being used to deliver the dose as opposed to using BNCT.
Although IOB has the highest neutron capture cross section in a BNCT therapy situation,
the concentration of nitrogen and hydrogen in the body is high and can also contribute
signiﬁcantly to the total dose delivered to the tumor.

The total dose is the sum of the

individual components contributing to the dose adjusted by a weighting factor, as shown in the
following equation:
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Di = Ai*D 3-10+Bi*14N+Ci*y+Di*ln
where, A, B, C, and D are the respective weighting factors, i is at a given location, and 10B, ”N,

y, and fast neutron, 1n, are the principal components of the dose that contribute to the total dose
during therapy.
The total dose that is scaled appropriately for various factors are shown in Figures 7 and
8. Figure 7 accounts for RBE differences, treatment time using the BNL 2MW reactor and 50
minute exposure time, and the homogeneous scaling of the boron dose with 15 ppm of boron
within the scalp and normal brain regions and with 52.5 (or 3.5 times as much) in the target and
tumor volumes. Thus, the total BNCT “equivalent” dose in Gray-Equivalents (Gy-Eq)
administered during a treatment protocol is shown in Figure 7 as a dose depth proﬁle. Shown in
Figure 8 is a dose rate depth proﬁle along the beam centerline and is presented as a BNCT “dose
equivalent” rate in (cGy/MW-min). This also takes into account the various scaling factors
(RBE/power/treatment time) along with homogeneous scaling of the boron dose within the
tumor and target volumes. The tumor and target volumes lay approximately 1 cm — 9 cm along
the beam centerline (for this patient). Thus, there is a clear discontinuity in the predicted dose to
the tumor and target cells at the target/normal brain border points.

This is the case with

assuming an equal boron concentration throughout all tumor cells and scaling the dose
homogeneously with the 3.5 scaling factor.
However, this scaling of the dose can be better approached with using registered PET

pixel intensity information as shown earlier in Figure 22. The heterogeneous distribution of the
boron with the tumor and surrounding volumes is clearly evident within Figure 22. Thus, an
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appropriate linear peak to average scaling of the dose could be accomplished as follows with
registered 18F-BPA PET images:
(DB—10(x9y9 2)) * (11’15'1' (x: y, 2))
Dadjuslea’ (x9 ya Z) =

< (10.1.12)) >

where, (Dadjugredhy,Z is the "corrected" boron dose, (Dblo)x,y,z is the calculated boron dose based

on homogeneous B-10 distribution, (11%)”,Z is the PET 2D pixel intensity for a given image
plane at an axial location, and z <Iawe (z)> is the average pixel intensity for the brain and tumor
regions for a given image plane at axial location, 2 and can be computed as follows:
n

2
Ibrain (x, y, Zr)
.=1
Iave(’x.3.)/9Zi):l

N
The uncertainty with the adjusted dose would be a function of the uncertainty with SPM
image registration, SERA dose results, and with the reconstructed PET pixel intensities. The
uncertainty with SPM registration is described in an earlier section. The next two sections
describe the uncertainty with SERA dose results and with the reconstructed PET pixel
intensities.
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VII. Statistical Uncertainty with SERA
Executing SeraCalc results in the generation of an output ﬁle with an .rst extension.
This output ﬁle contains the volume-integrated region edits at the body level deﬁned. Each
body level consists of many uniform volume elements. Some of the output contained within
this ﬁle includes total current in, total current out, total absorption, gamma production, energy
deposition, and the ﬁrst three groups ﬂux information for the various bodies (or regions). The
standard deviations associated with these values at the body level for the various patients
examined within this work all have ranges much less than 5 % when the Monte Carlo
simulations are executed with the 2 million maximum allowable particles.
Although SERA does not explicitly compute statistics associated within each univel in a
particular volume, the statistics at the univel level are adequate so long as the body level
statistics are sufﬁcient [55]. This is especially true since the statistics at the univel level and the
doses at the univel level are interpolated from the tally grid that deﬁnes the particular volumes
and computes the dose within those volumes [55].
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VIII. Statistical Uncertainty with PET Pixel Intensity
To obtain statistical uncertainty with the reconstructed PET image data, one must ﬁrst
determined the number of counts that corresponds with a particular pixel intensity. Based on
discussions with personnel at CTI, there are at least two methods available [56]. The ﬁrst is the
Heusmann method, and the other is the ﬁrst order approximation to the number of counts. The
Huesmann method is described elsewhere [57]. The second method, which is a reasonable ﬁrst
order approach according to Casey [56], involves the use of a scaling factor which scales the
data in the image space such that the fractional contribution of the pixel intensity, Pm, to the total
sum of the pixel intensity is the same in the unreconstructed domain and the reconstructed

domain.

In other words, the ratio of PiJ to the total sum of the pixel intensities in the

reconstructed image space can be directly related to total number of counts measured in the
sinogram space. The use of a scaling ratio in the two different image domains is also conﬁrmed
by Gregor in the Computer Science department at the University of Tennessee, Knoxville [58].
Thus, with this methodology, one can determine the number of counts corresponding to a given
pixel in the image as follows:

p _
CL}

I60 192

= —”— *22
128 128
EXP/J

Shm

I=l m=l

i=1 j=l

where Cir represents the number of counts associated with a pixel, Phi» in the 128X128 pet
image, and SLm represent the number of counts measured for a particular ray integral, 1, at a
particular angle, m.
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Determining counts for each pixel in an image plane involves the use of the sinogram
data associated with that particular plane. However, it would be much more useful to be able to
arrive at a universal constant which scales the ECAT count data (i.e. the pixel intensity) in an
image directly to the number of counts without the need for sinogram data. In other words, it is
desired to arrive at a ratio of ECAT counts per second in a pixel as output in the reconstructed
image data to the number of counts measured at that particular pixel. The pixel intensity, PU,
can be used to determine the ECAT counts by multiplying the pixel intensity by the Quantity
Scale (QS) factor as follows:

ECATcps = QS * P131
The quantity scale factor is a factor contained in the image header ﬁles and allows one to relate
the pixel intensity into ECAT counts per second. The ECAT counts per second can later be
converted into a known unit of uCi/ml.
If one takes the ratio of ECAT cps to the number of counts, one will note that the
individual pixel intensity, PiJ, drops out. This leads to what is referred to as a universal scaling
factor using the ﬁrst order approximation to the number of counts as follows:
ECA T cps _

QS
160 192

Counts

This universal value using the ﬁrst order approximation was determined for several studies
using different planes and different time sequences for a given patient whose sinogram data was
available. This value was determined to be 2.06E—5. Little variation in this value was noted if
one picked an earlier PET study or a later PET study for the same patient. This value was also
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found to be constant as one picked different planes in the same study or if one used different
frame times in the dynamic PET data. Thus, this allows one to take the PET ECAT cps and
convert it directly to the number of counts by multiplying the PET pixel intensity by the
quantity scale factor and scaling it with this value as follows:

Cu; = P1,} * QS * (2.06E — 5)’1
This has been implemented on several patients to determine the number of counts in a
given pixel. For most of the studies, it was determined that the number of counts was on the
order of about 1000 counts for the data analyzed within this work. This corresponds to about
300-400 counts within the normal brain data, in the worst case. Thus, the uncertainty with 300

counts is about 5.7%. This represents the worst-case scenario for the PET data analyzed within
this work since much of the data analyzed here involves the use of later frames to adjust the
dose.

Later time frames allowed for larger collection time and more concentration of the

pharmaceutical in the tumor and target regions. Thus, the higher counts, on the order of a 1000
or so, corresponds to the tumor and target regions whereas the counts on the order of 300-400
represent the number of counts in the normal brain.

Shown in Figure 38 is a plot of the

statistical uncertainty with a single frame image data plane taken along at the center of the
tumor. Also shown in Figure 38 is a plot of the statistical uncertainty with time integrated PET
data. It can be noted that the statistical uncertainty with time integrated PET data is signiﬁcantly
reduced when compared with a single frame image.
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Statistical Uncertainty With PET Data Using First Order Approximation/One Frame Data
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IX. PET2MRI Algorithm
The PET2MRI.m algorithm is the main software that couples the results of the
Statistical Parametric Mapping along with the SERA treatment planning program to generate
new isodose contours based on '8F-BPA determined boron biodistribution. Shown in Figure 39
is a schematic overview of the main program, its functions, the input/output ﬁles used by the
program and the program ﬁrnctions, and the type of graphical output of results by the program.
The program and the associated functions are included in the appendix (Appendices M, N, O, P,
Q, R, and S). PET2MRI.m uses several ﬁles that are generated by the statistical parametric
mapping algorithm and SERA. These ﬁles include the .qhd/.qsh MRI image ﬁles, the .uvh/.uv
ﬁles containing volumetric deﬁnition of the regions of interest, the .cdf/.chd dose contour ﬁle
generated by the Monte Carlo portion of SERA, and the registered PET .hdr/.img ﬁles which
are generated by SPM. These ﬁles are combined within the main program and its functions to
write out the new dose contours. The output ﬁles created by the PET2MRI.m program include
an adjusted.cdf ﬁle, a BNL.cdf ﬁle, Table1.mat, Table2.mat, and several graphical ﬁgures. The
adj usted.cdf is a PET adjusted dose ﬁle written in the same format as the original .cdf ﬁle
created by SERA. The BNL.cdf ﬁle provides dose contours created by sealing the boron
component of the dose within the tumor and target volumes by a factor of 3.5. Table l.mat and
Table 2.mat contain several columns of output data that repeats the total area (in mmz) for a
particular dose contour line. For example for a particular image plane, the total area falling
within the 90% contour line, the 70% contour line, 50% contour line, and the 10% contour line
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could be found within these ﬁles. Table 2.mat lists this data for the homogeneously adjusted
dose. Tablel .mat lists this data for the PET adjusted dose.
Part of the graphical display output on the screen includes a plane by plane view of the
original boron dose contours superimposed on top of the image, the homogeneously scaled
boron component of the dose superimposed on top of the image, and the PET adjusted boron
component of the dose superimposed on top of the image. These are shown for each of the
image planes for which SERA outputs the dose contour data. In addition, another ﬁgure (Figure
100) is also generated by the program. Within this ﬁgure, the output includes the original MRI
images with superimposed registered PET image contours, and the tumor volume deﬁned by
using an MRI image superimposed over the PET tumor. This output allows for a quick check
of the volume deﬁnition of the tumor regions if one were to use PET or MRI to deﬁne the tumor
volume.
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X. Results and Discussion
Shown in Table 3 are the results from the use of the SPM algorithm to register the 18FBPA PET images with Tl-weighted MRI images. M“ -— M33 represent the cosines of the Euler
angles of transformation, which align the PET images to the T1 MRI images. In most cases,
pre-surgery PET images were selected for registration with presurgery Tl MRI images. No
presurgery PET data was available for patient MD, thus post surgery MRI and post surgery PET
images are registered for this patient. In addition, patient CR was a melanoma patient while all
others were GBM patients. This did not affect the registration results in any manner since the
tumor type was not a factor in the registration process.
Visual inspection of the registered PET/MRI images has been implemented for all the
patients. Based on visual inspection, all patient data were successfully registered using brain
segmentation and template matching within SPM. Shown in Figures 40 and 41 are the brain
segmentations of T1 -MRI and 18F-BPA PET images, respectively, into gray and white matter.
Shown in Figure 42 are MRI images with the contours of the MRI images plotted on top, in the
left column. Shown in the right column of Figure 42 are the MRI contours plotted on top of
18F-BPA PET images. Based on visual inspection of the MRI image contours plotted on top of
the PET images, one is led to believe in the validity of the SPM registration algorithm. The
ﬁndings in Figures 40-42 are shown only for VG patient. Similar ﬁndings are noted for other
patients.
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Table 3: Transformation/Translation Parameters Which Register PET Images
with MRI Images
Patient

M11

M12

M13

M21

M22

M23

M31

M32

T2

T3

VG

.407

-.007

-.231

.011

.403

.554

.016

—.040 2.19

13.02

2.442

7.196

EG

2.337

-.221

.0282

.222

2.337

.091

.002

-.010

.675

-.326

-46.88 -8.07

CR

2.986

.087

.255

-.1 14

2.959

.569

-.021

-.051

.444

-58.27 -55.67 4.789

LB

2.940

-. 179

.0672

.170

2.91 1

.551

.013

.070

-.6682 47.19 -73.66 24.86

BP

-2394 -.531

.193

-.543

2.370

-.547

.007

.062

.669

317.75 28.96

-12.16

MD

2.455

-.022

-.054

.022

-2.455 -.043

.006

.005

.676

-2793 -69

—5.77

MB

4.737

.405

.978

-.213

4.842

-.218

.120

.645

-230.8 -1999 5.207

106

-.622
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Figure 41: SPM Brain Segmentation of Tl-Weighted MRI Images for VG

107

Segmentation
Image:

..an]registration]SPHgSQ/Gaddia/gad1110jldgfzél.im

means:

0.10961

0.10598

0.10103

Std devs:
R vox:

0.29323
0.17306

0.29438
0.10464

0.2917
0.038731

I. '1

153993751Of???-

Figure 41: SPM Brain Segmentation for 18F-BPA PET Images for Patient VG
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Figure 42: Veriﬁcation of Image Registeration for VG: Registered PET Image
Contours Plotted on Top of MRI Images
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Shown in Figure 43 is a MR] image, a registered PET Image, and a superposition of
the PET tumor volume on top of the MRI image for patient VG. As can be seen, the MRI
provides anatomical detail, but lack signiﬁcant metabolic detail provided by the PET. One
can also note from Figure 43, that what is visualized in an MRI image may not be in the same
location as that seen in the 18F-BPA PET image. In addition, what may be seen as the more
dense part of the tumor (the white contrasted portion of the tumor) may not correspond with
the most metabolically active parts of the tumor.
Shown in Figure 44 are MRI and registered PET image planes taken along the
boundary of the tumor along the z axis (i.e. the deeper portion of the tumor along the axial
axis).

Note that the tumor region in the MRI image is relatively small compared with

registered PET image for patient VG. The tumor volume is axially located deeper in a
registered PET image than that visualized in an MRI image. In addition, the size of the tumor
area is larger and shifted in the registered PET image when compared to the MRI image.
The Tl-MRI images are incorporated into seraModel.

Tumor axial length is

measured by visually looking for contrast enhanced regions of the MRI image along the zaxis. The ﬁrst and the last planes along the z-axis are noted. Using the inter-plane separation
of 7.5mm for the MRI images, one is able to determine the axial length of the tumor. A
similar approach is applied with the registered 18F-BPA PET images. The results are shown in
Table 4. The differences range from 20—150% for the GBM patients, and no difference is seen
for the Multiple Melanoma (MM) patient (i.e. CR). The resolution of the PET in the Z-axis is
7.5 mm and the uncertainty due to SPM registration is about 2 mm.
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Figure 43: Side by Side Comparison of Registered PET/MRI Tumor Volumes (top
images) and a Superimposing of the PET Tumor Volume On Top of MRI Image
(bottom image)
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Figure 44: Registered Tumor Volume Differences Along the Z-Axis. A Side by Side
Comparison of PET/MRI (top images) and a Superimposing of The PET Tumor
Volume on Top of MRI (bottom image)
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The differences in the tumor axial extent range from 0.75 cm to 4.5 cm for the GBM
patients analyzed in this work.

Therefore, tumor axial extent differences larger than a

centimeter are greater than the resolution of the PET and the uncertainty due to registration. In
all GBM cases, the tumor axial extent is larger in the registered PET images when compared
with MRI images. These differences can perhaps be due to the fact that GBM tumors are
known to have tumor extensions which are not visible on an MRI image. Generally the tumor
volume and the extensions of the tumor fall about 1-3 cm outside the main MRI tumor volume
[20]. Some of these tumor extensions may be picked up by the PET imaging resolution if the
tumor cells readily uptake 18F-BPA and the density of the tumor cells are such that the PET
pixel intensity exceeds the background noise level.
The MRI images are loaded into seraModel as described earlier. Within seraModel, one
can deﬁne the tumor volume by painting or picking points around the contrast enhanced
regions of the tumor on each plane. These tumor bodies deﬁned on individual planes can then
be volume rendered and the total tumor volume can be determined within seraModel. A
similar approach can be applied with registered 18F-BPA PET images.

Table 4: Comparison of Tumor Axial Extent (in cm) Using Registered 18F-BPA
PET and Tl-Weigted MRI images

Patient
VG
EG
LB
MB
BP
Mean
"

MRI
3.75
2.5
1.5
3
3.75
2.9

PEI'
4.5
3.75
3
7.5
5.25
4.8

0.95

1.73
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% Difference
20.00
50.00
100.00
150.00
40.00
65.52

The results of determining the tumor volume based on MRI images and registered l8FBPA PET images for the same patient is shown in Table 5. The differences range from 14
cm3- 93 cm3 for the GBM patients. The relative percent differences range from 34.04 to
136.36%. These differences are greater than the .31 cm3 (6.5mmX6.5mmX7.5mm) resolution
of the PET image and the .08 cm3 (2mmX2mmX2mm) resolution of the SPM registration
algorithm. In all GBM cases, the tumor volume as deﬁned with seraModel using registered
PET images is larger than using the Tl-MRI images to deﬁne the tumor volume.

This

correlates with the increased tumor axial extent visualized in Figures 44 and 45 when using
PET images instead of using T1 MRI images. This ﬁnding also correlates with tumor axial
extent differences noted in Table 4.
Generally, the target location is deﬁned as the tumor center to ensure that dose contours is
centered about the tumor. This centering of the tumor allows for beam placement to ensure
adequate coverage of the tumor region while sparing the normal surrounding regions. Shown
in Table 6 are the target regions deﬁned using MRI images and registered PET images. The
absolute three-dimensional differences in beam placement range from 1.33 cm to 4.29 cm for
the GBM patients. Little difference is noted for the Melanoma patient (CR).

Table 5: Comparison of Tumor Volumes (in cm3 ) Using Registered 18F-BPA
PET and Tl-Weigted MRI images
Patient
VG
EG
LB
MB

BP
Mean

MRI
47
11
20
70

64
‘~
42.4
26.16

114

PET
63
26
34
163

127
82.6
59.97

% Differenc
34.04
136.36
70.00
132.86

98.44
94.81

Table 6: Comparison of (x,y,z)Target Location (in cm) Using Registered 18FBPA PET and Tl-Weigted MRI images

Patient
VG
EG
LB
MB
BP

MRI
_
(3.72, -2.56, 8.25)
(2.75, 2.31, 12)
(1.40, -4.88, 6)
(2.57, 2.22, 9.75)
£07, 4.68, 7.5)

' (598329975

PET
Difference (cm)
(4.98, -394, 9.00)
2.01
(1.76, 2.78, 11.25)
1.33
(-195, -6.02, 6)
1.27
(3.38, 1.23, 9.0)
1.48
(4.81, 3.51, 5.25)
4.29
2.08 +/- 1.27
_
039

The differences greater than approximately one centimeter are larger than the resolution of the
PET image and the uncertainties associated with the SPM registration algorithm.
Besides using 18F-BPA PET images to deﬁne the tumor volumes, one can also use the
boron biodistribution contained in the PET images to determine the peak-to-normal brain
values. The PET pixel intensity along the tumor axial center was shown earlier in Figures 22
and 26.

From such plots, one can determine the relative uptake in the tumor volume

compared with the normal brain. The results of such an analysis are shown in Table 7. The
peak-to-normal brain values range from 2.05 to 3.4 for the last frame data for these patients.
The peak-to-nonnal brain values using the time integrated data ranges from 1.71 to 4 for these
patients. These are signiﬁcantly different than the 3.5 homogeneous scaling factor used in
current treatment plans. The post-surgery peak-to-normal brain values for the residual parts of
the tumor are 1.5 to 1.7.
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Table 7: Tumor Peak-To-Normal Brain (PNB) Value (@ Tumor Axial Center)

Using '8F-BPA PET
Patient

VG
EG
LB
MB
BP
Mean

PNB
3.4
2.6
2.05
2.43
2.2
2.53 +/- .83

PNB

Time I

4
2.5
2.2
2.66
1.71
2.61+/- .86

Time I
1.70

PNB

1.50

1.6 +/- .14

Shown in Table 8 are the doses that would be predicted for the tumor, target, scalp, and
normal brain volumes using current treatment planning with Tl-MRI images and using a
homogeneous scaling factor of 3.5 within the tumor and target volumes. Table 8 presents a
summary of the dose volume histograms generated using seraPlot. An example of the dose
volume histogram was presented earlier in Figure 7. The treatment plans assumed a 50 min
irradiation with 2 MW reactor power and a boron concentration of 13 ppm in the blood. As
such, the scaling factor of 3.5 is applied within the tumor and target volumes to determine the
dose.

Table 8: Gray-Equivalent Mean Dose Administered to Patients with 50 min
Irradiation at @ 2MW, assuming 13 ppm blood boron concentration, a
Tumor-to-Blood uptake of 3.5, Tumor-to-Scalp uptake of 1.5 using MRI
deﬁned Volumes
Patient
VG
EG
LB
MD
CR
MB
BP
Mean

Scalp (Range)
0.9 (0.1, 8.9)
1.2 (0, 10.3)
1.9 (0.2, 10.9)
1.1g 10.17)
1.2 (0.1, 10.1)
1.8 (0.3, 8.9)
1.4 (0.1, 10.4)
1.36

Nonnal Brain (Range)
1.9 (0.2, 8.2)
2.4 (0, 9.7)
2.0 (0.3, 10.4)
1.7 (0, 8.6)
2.0 (0.2, 9.4)
1.2 (0.1, 10.37)
1.5 (0.2, 8.8)
2.12
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Tumor (Range)
38.8 (24.0, 48.4)
42.4 (29.6, 51.4)
44.5 (29.1, 54.0)
42.8 (24.2, 56.0)
46.6 (40.1, 53.0)
34.4 (16.1, 52.5)
33.5 (14.9, 52.7)
40.57

Target (Range)
28.6 (12.5, 48.0)
36.2 (15.8, 52.7)
34.0 (14.0, 53.9)
31.2 (11.5, 53.5)
39.0 (25.3, 53.0)
26.9 (8.6, 53.3)
23.5 (7.0, 53.1)
31.44

One can take the doses presented in Table 8 and linearly scale them based on the PET
determined peak—to-normal brain value instead of the 3.5 scaling factor. The resulting doses
are shown in Table 9. The doses to the tumor and target volumes are signiﬁcantly different in
the two approaches. Table 8 and Table 9 both use the scaling factor and the peak-to—normal
brain factor, respectively, in a homogeneous manner to scale the dose. No consideration is
given to the shape of the boron biodistribution as visualized in a PET image, as shown in
Figures 22 and 26.
Shown in Figure 45 are the boron dose rate contours as determined from normal
treatment planning using SERA in which the tumor volumes are deﬁned using MRI images.
No scaling of the boron dose within the tumor and target regions is implemented in the dose
rate contours shown in Figure 45. A three-dimensional view of the boron dose rate contours
shown in Figure 45 is shown in Figure 46. The boron contours in Figures 45 and 46 are
uniform in shape and correspond to the assumption of a uniform boron biodistribution
throughout all the volumes. The units of the dose rate in Figure 46 are cGy/Mw-min/ppm
since no considerations regarding the total irradiation time and the boron scaling factor have
been made. Also, note that the maximum beam ﬂux is expected to be about 2.5 cm into the
brain. Thus the 90 % contours are generally located closer to the surface of the brain as
opposed to being further in the brain.

117

Table 9: Gray-Equivalent Mean Dose Administered to Patients with 50 min
Irradiation at @ 2MW, assuming 13 ppm blood boron concentration, a PET

based Tumor-to-Normal Brain, Tumor-to-Scalp uptake of 1.5 using MRI
defined Volumes

0.87 097 8.7
.89 7.
1.11 11
1.14
9.
1.25
6.1
.88

.

.94

1

38.66
31.49
26.5 17.04
44.3
1
23.88 11.1
21.05

38.1
31
50.
36.
33.1
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Figure 45 : Original Boron Dose Contours
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Figure 46: A Three Dimensional View of The Original Boron Dose Rate As
Calculated by SERA
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If a linear homogeneous scaling factor of 3.5 is applied within the tumor and target
volumes to scale the boron component of the dose, then the resulting dose contours are shown
in Figure 47. Figure 47 assumes that the boron concentration within the tumor and target
volumes is 45.5 ppm and is 13 ppm in the normal brain regions, as deﬁned within SERA. As
such the dose rate in Figure 46 is scaled homogeneously using a step input scaling of 3.5
within the tumor and target volumes to account for the boron concentration scaling factor.
This results in the 90% and 70% contours staying in essentially the same location. However,
the 50% and 30% contours tend to overlap one another along the tumor/normal brain
boundaries as a result of applying a constant input function of 3.5 to scale the dose. A three
dimensional view of this type of homogeneous scaling is shown in Figure 48.
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Figure 47: Boron Dose (or Dose Rate) Contours After Applying the Homogeneous
Scaling Assumption
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Figure 48: Three Dimensional View of Homogeneously Scaled Boron Dose Rate
121

However if one uses the registered l8F—BPA PET images within treatment planning
the boron dose rate contours would be as those shown in Figure 49. Note that the 90%, 70%,
50%, 30%, and the 10% dose contours have all shifted towards the metabolically active parts
of the tumor, as is visualized in a registered 18F—BPA PET image. The contours are narrower

and more focused on the metabolically active parts of the tumor, unlike the homogeneously
scaled contours shown in Figure 47. The differences in the two contours is attributed to the invivo boron biodistribution as determined from a registered 18F-BPA PET image. A three
dimensional view of the boron dose rate which is PET adjusted is shown in Figure 50.
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Figure 49: Registered 18F-BPA PET Adjusted Boron Dose ( or Dose Rate) Contours
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Figure 50: A Three Dimensional View of the Adjusted Boron Dose Rate (or Dose)

Based on Registered 18F-BPA PET Images
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Note from Figure 48 that the scaling of the boron dose at the boundaries of the tumor
and the target volumes leads to a sharp cutoff of the contours along the boundaries. This is
evident in Figure 47 and 48 for the 30% and the 50% dose contour lines.

This line

corresponds with the 2 cm target/normal brain boundary that surrounds the tumor volume.
Within this boundary, the dose is homogeneously scaled by a factor of 3.5.

This sharp

discontinuity along the target/normal brain boundary was also demonstrated earlier in Figure 8
with the beam centerline dose depth proﬁle. The results presented in Figures 46 and 47 are for
patient VG whose peak-to-normal brain value was 3.4 as shown in Table 7. The 3.4 peak-tonorrnal brain value is close to the 3.5 scaling value.

However, note that the PET pixel

intensity for this patient, as shown earlier in Figures 22 and 26 is not homogeneous in the
tumor and target regions.

For this patient data, the PET biodistribution demonstrated an

increased uptake in the center/metabolic regions of the tumor and a tapering off of the boron
biodistribution in nearby regions. Thus, if one takes the registered PET biodistribution data
for this patient and integrates this biodistribution information together with the original boron
dose contours as shown in Figure 46, contours shapes similar to those presented in Figures 49
and 50 result. The boron contours in Figure 49 are representative of the metabolic activity of
the tumor and the biodistribution of boron within the tumor regions, unlike the contours

shown in Figure 46.
The signiﬁcant changing of the dose contours when using the PET boron
biodistribution within treatment planning are also noted for other patients.

The 3D dose

images and the dose contours for all patients are included in the Appendix (Appendix T).
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XI. Conclusions
Use of registered 18F-BPA PET images can signiﬁcantly improve treatment planning
for BNCT. These images can provide much needed boron biodistribution information along
with better visualization of the metabolically active regions of the tumor. This information
provided by the PET image is not used in current treatment planning for BNCT, which uses
MRI images to reconstruct the tumor volume and to predict the dose using the homogeneous
assumption. The heterogeneous boron biodistribution information obtained from PET images
better predicts the average boron component of the dose to the tumor volume than the value
obtained based on the homogeneous assumption. Computational software and the
methodology to implement such a task have been discussed in this work. Results show
remarkable difference between current treatment planning and improved treatment planning
using the registered lgF-BPA PET images.
Better visualization of the metabolically active regions of the tumor, notable
differences in the tumor axial extent, and differences in tumor volume deﬁnitions between the

T1 -MRI images and the registered PET images can lead to reorientation of the beam. In
addition to reorienting of the beam based on anatomical and metabolic differences in the two
imaging modalities, the 18F-BPA PET boron biodistribution can also lead to signiﬁcant
changes in the dose contours relative to those obtained based on the homogeneous
assumption. Better beam alignment and better dose contours, which result from using the
PET boron biodistribution data, can signiﬁcantly improve future BNCT treatment planning.
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XII. Future Work

Future work should address several aspects of using l8F-BPA PET images within
treatment planning: (1) additional patients and PET studies should be utilized in treatment
planning and a comparison of the tumor volume differences and the peak-to-normal brain
differences should be further assessed across many patients; (2) the peak-to-normal brain
value and the tapering of the boron concentration as visualized in PET should be correlated
with histopathological sampling of those regions. The uncertainties in the histopathological
sampling used to derive the 3.5 scaling ratio should be correlated with the PET determined
boron biodistribution of those regions; (3) compartment modeling should be coupled with
with treatment planning using 18F-BPA PET images.

The comparatmental information

provided by PET can perhaps lead to optimization of the boron concentration within the tumor
cells and this can be coupled with treatment planning to better predict the actual dose
delievered to the tumor cells post-surgically.
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A: EXAMPLE OF SERA MONTE CARLO INPUT
G 1_PET_Presurgery
1000
2000
1.000000E-02
-4.1700000E+00
-3.8500000E+00
5.0600000E+00
1 .8500000E+01
-l . 1000000E+02
1.4500000E+02
/home/mokhan/ST/Results/cg.geom
/home/mokhanNG/G 1_PET_Presurgery.uv
30
3
32
72
94
-1 .50000000E+01 -l .50000000E+01 -1 .50000000E+01
1.00000000E+00
0
none
/home/mokhan/VG/G 1_PET_sera.rst
/home/mokhan/ST/Results/BS.source
1
0
NFGD
05_Apr_2001
$SERA_HOME/Resources/SeraMC/seraMC.mat
$SERA_HOME/Resources/SeraMC/seraMC.sigma
521 508 513 512 505
0
0 6.0143E—08 6.3150E-02 7.9110E-04 7.2700E-03 2.6800E-02 0.0000E+00
0.0000E+00
run_seraMC

10p
3 APERTURE BUFFER
0.50
edit_dir
#patient John Doe
#date Jan_07_2001

#beam BMRR_12_CM
mw_min 1.0

b10_blood 1.0
refvol 1.0 0
ref_reg brain tumor target
ottocon 40 40 scalp

delta 0.25
eps 0.05
#dose-volume histogram for brain
in_reg brain target

b10_blood l3
rbe1.31.03.23.21.01.0
DVbs
#dose-volume histogram for tumor
in_reg tumor target

b10_blood 13
rbe1.31.03.23.21.01.0
DVbs
#dose-volume histogram for scalp
in_reg scalp

b10_blood 19
rbe1.31.0 3.2 321010
DVbs
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B : MCNP 4B CODE TO VERIFY LINEAR ASSUMPTION
c
c
c

Cells
Cells

1 = water and BoronlO in the cube 20x20x20
2 = tumor cell(water &Boron 10) 5x5x5 cell located in the

middle of the big cube but 2cm from the edge
c

3 = rest of the world

c

4 = void cell inside the cylinder

c cell# - material# -density (if its 1 write-1)
above plane,—below plane)
1 l -l 6 -9 l -4 10 ~13
(-7:8:-2:3:-1l:12)
2 2 -1 7 -8 2 —3 11 —12
3 O
-6:9:-1:4:-10:13

-position of the cell(+

4 O -14
c Surfaces
1—5 = the y slices
c
6-9 = the x slices
c
10-13 = the vertical slices
c
l4=cylinder
1 py -4.5
2 py -2.5
3 py 2.5

4 py 15.5
5 py -24.5
6 px -1O
7 px -2.5

8 px 2.5
9 px 10
10 pz —10
11 pz -2.5
12 pz 2.5
13 pz 10
14

cy 4

mode n
m1 8016.50c
1001.50c
5010.50c
m2 8016.50c
1001.50c
5010.50c
m3 5010.50c
c

FMn

—33.333333 &
-66.666666 &
-.OOOOOl
—33.33332667 &
-66.66665333 &
-.00002
—100.00

c m R

c c=N is the number of densities,

for

water=(1g/cm3)*(.6023*E24/18g.mole)*(E—24 cm2/bn)=.0334 atoms/bn/cm
c c-B10=.O334*E—6
c FMn, FM4 FM calculate the reaction rate see mcnp manual

n=4(flux averaged over a cell)

c 2=material#,

section
F5:N O 1 O .9
F15:N O —1 O .9
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3-74

and

-2 absrption cross

F25:N 0 -3.5 0 .9
F35:N O 3.5 O .9
SDEF SUR=5 ccc =4
DIR=l ARA=50.2655 ERG=D9
819 H
1.0000E-l5 1.0000E-07
4.1400E-07

OJOOOOOOOOOOO

l—‘le—‘CDUJONNCOl—‘H

8.7642E—07&
.8553E-06 5.0435E-06 1.0670E-05 3.7267E-05&
.0130E-04
2.1445E-04 4.5400E-04 1.5846E-03 &
.3456E-03 7.1017E-03 1.5034E-02 2.1800E-02 &
.4176E-02 2.6058E-02 3.1828E-02 4.0868E-02 &
.7379E-02 1.1109E-01 1.8316E-01
2.9720E-01&
.6880E-01 4.9787E-01 6.0810E-01 7.4274E-01&
.2085E-01 1.0026E00
1.3534E00
1.6531E00 &
.9205E00 2.2313E00
2.3457E00 2.3653E00 &
.4660E00
2.7250E00
3.0119E00
3.6788E00 &
.9659E00
6.0653E00 7.4682E00
8.6070E00 &
.0000E01
1.2220E01
1.4190E01
1.7330E01
SP9
0
0.0037824
0.0076709
0.031638 &
.079111
0.16621
0.13363
0.094952&
.038046
0.04379
0.036715
0.011644&
.002897
0.00082789
0.0035116
0.0034636&
.0011275
0.0016118
0.0015223
0.001346&
.0018339
0.0011668
0.00074724
0.00076219&
.0002533
0.00017918
0.00011774
0.000097977&
.0000418 27
0.0000064622 0.0000036135
0.0000010106&
.037475
0.074
0.086655
0.096206&
.0023802
0.0013448
0.0027085
0.0031173&
.0005693 7
0.00090662
0.00035775
0.000065409&
.0001342 3
0.000085045 0.000000156
0.000000022654
FMS
.34E—08 3 -2
FM15 3.34E-08 3 -2
FM25 3.34E-08 3 -2
FM35 3.34E-08 3 -2
impzn 1 1 0 0
nps 100000
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(3:thﬂ_IhdAd3FHKEKS(NYSTHRLKSTTI)FLDG
clear all;

close all;

%program to reconstruct MRI images using 2D Fast Fourier Transform
%

*****************************Part

path(path,

a

************************

'E\Moe\codes\project1\Prolc.m');

load fspec;

figure(l)
mesh(abs(M));
Ms=fftshift(M);
mesh(abs(Ms) ;

figure(2)
imagesc(log(l+abs(Ms)));

%

%shows the logarithmic weighted image

***********~k*****************Part

Mc=conj(Ms);

b

*******~k******~k*******~k*****

%take complex conjugate of signal

r=size(Ms,1);
c=size(Ms,2);

for i = lzc;
%Step through all of the columns and take FFT of the
complex signal
X(:,i)=l/128*fft(Mc(:,i));
end
for j=1:r;

%Step through all of the rows and take FFT of the

intermediate

X(j.=)=l/128*fft(X(j.=));
end

figure(3)
imshow(abs(X));

%********************Double

Check

on

work

****************************

%Double Check on the FFT using the fft2 function
M82 = ifft2(Ms);

%the 2d Inverse Fourier Transform built into matlab

figure(4);
imshow(abs(MsZ));
max(max( (abs(M52)-abs(X))./abs(M32)

)

with matlab
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)

%Comparison of my results

o\0 H

o\° o\0

D: FILTER_BACKPROJECTION.M
fbp.m Code to reconstruct CT/PET images using parallel-beam filtered
back projection algorithm by using means of convolution and Radon
nverse;
Developed by Mohammad K.

clear all;
theta =

Khan

(C.S.

594 Class).

close all;

[0:1:179];

Ns = 100;
f = phantom(128);

%Sequence of angles

%Number of rayintegrals computed per View angle;

p = radon(f,theta, Ns);
path(path, 'E:\Moe\codes');
figure(l);
subplot(2,2,l);

imshow(f);

subplot(2,2,2);

imshow(p); title('Sinogram');

[f2,

h]

= fbp_recon(lOO,

title('Original Image');

p',

'Shepp',

10);

%filtered backprojection

function using convolution method
subplot(2,2,3); plot(h); title('Filter');
subplot(2,2,4);

imshow(f2);

title('Reconstructed');

figure(2);
p2=iradon(p,

theta,

'nearest',

'Shepp-Logan');

imshow(p2); title('Radon Inverse');

function

[f,

%n=100; p=p';
[nt,

h]

= fbp_recon(n,

p,

filter,

nh);

filter='ramp'; nh=10;

ns]=size(p);

ds = ( 2*ceil(128/sqrt(2))+2)/(ns-1);
%distance between ray integrals
assuming original image size to be 128X128
if strcmp(filter, 'ramp');
h = ramp_filter(nh, ds);
elseif strcmp(filter, 'Shepp')

= shepp_logan_filter(nh,

ds);

else
error('unkown filter.');
end

%hh = zeros(1,nt);
%hh(l, (nt/2—nh):(nt/2+nh) )=h;
g=zeros(nt, ns+2*nh);
for i = lznt,
g(i, :)=conv(p(i,:),h);
end

%convolution of p and h
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x=l:100;
y=1:100;

%x=repmat([1:n]-ceil(n/2), n,l); y = rot90(x);
%coordinate matrices
[X,Y]=meshgrid(x,y);

xpr = X—n/2;

Ypr= flipud((Y-n/2));
%transformation coefficients

theta = [0:1:179]*(pi/180);
costheta = cos(theta);

sintheta=sin(theta);

%projection zero padding
max_s = 2*ceil(n/(ds*sqrt(2)))+2;

lrz =

[1; rrz =

[1;

if ns < max_s
rz = max_s-ns;
lrz=zeros(1,ceil(rz/2));
rrz=zeros(1,floor(rz/2));
end

%projection center index
sctr = ceil(ns/2)+length(lrz);
f=zeros(n);

for k = 1:nt,

%loop over each angle,

theta

q=CODV(p(k,:),h);
q=[lrz q(nh+l:nh+ns)

rrz];

s = xpr*costheta(k)+ypr*sintheta(k);
as=floor(s./ds);
f=f+q(as+sctr)+((s-as*ds)./ds).*(q(as+1+sctr)-q(as+sctr));
end

f = f*pi/(nt-1);
return;

function [h] = ramp_filter(nh, ds);
n = 2*nh+1;
h=zeros(1,n);
k=0;
for i = -nh:nh;
k=k+l;
h(1,k) = 1/(4*(ds)“2)*(2*sinc(i)-sinc(i/2)“2);
end
return;

function

[ h]=shepp_logan_filter(nh,ds)
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n = 2*nh+1;
h=zeros(1,n);
k=0;
for i = -nh:nh;
k=k+1;

h(1,k) = 2/< pi“2*ds“2*(1-4*i“2) );
end

return;
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E: TIME_INTEGRATED.M
%program to read ECAT 6.4 DATA and to see the header information (works with Gaddis data)
%by Mohammad Khurram Khan (c) copyright 2002
%this shows the PET images (statistically better visulatization of PET data.
clear all; close all; fclose('all'); clear; pack;fclose('all');
ﬁlename= 'E:/BNCT_RAW_DATA/Godwin/Pet/Nov97/god1 124j 1d.img';
%ﬁle_system= 'ecat7';
fpname = ﬁlename;
%[ﬁd, message] = ecatﬁle('open', ﬁlename, ");

%[ ﬁd, message]
= ecatﬁle( 'open', ﬁlename, 'ecat7' );
[ﬁd, message ]
= ecatﬁle( 'open', ﬁlename, 'ecat6.4' );
[mh, message ]
= ecatﬁle( 'mh', ﬁd );
selmatrix= [1 l 1 0 0]; %frame number num_planes
[ vol, hd, message] = ecatﬁle( 'read', ﬁd, selmatrix );
°/o [ vol, hd, message] = ecatﬁle( 'read', ﬁd, selmatrix, segment); % 3D si$
% [ descr, hd, message ] = ecatﬁle( 'read_offset', ﬁd, selmatrix );
% [ descr, hd, message] = ecatﬁle( 'read_offset', ﬁd, selmatrix, segment); $
% [ hd, message ]
= ecatﬁle( 'hd', ﬁd, selmatrix );
% message
= ecatﬁle( 'writemh', ﬁd, mh );
% message
= ecatﬁle( 'write', ﬁd, vol, hd, selmatrix );
% message
= ecatﬁle( 'write', ﬁd, vol, hd, selmatrix, segment $
% message
= ecatﬁle( 'close', ﬁd );
% message
= ecatﬁle( 'close', 'all' );
[matranges, message ] = ecatﬁle( 'matranges', ﬁd );
% fclose('all');
hd.mh.num_ﬁames=matranges(2, l );
l=zeros(hd.mh.num_ﬁames, hd.mh.num_planes, 128, 128);
ﬁametime=zeros( 1 ,hd.mh.num_ﬁames);
quantscale=zeros( 1 ,hd.mh.num_ﬁames);
for k=l :matranges(2,1),
for i = 1:47,

selmatrix: [k i 1 0 0] %ﬁame number & plane number
[vol, hd, message]=ecatﬁle('read',ﬁd,selmatrix);
frametime(l ,k) = hd.sh.ﬁame_duration;
quantscale( 1 ,k)= hd.sh.quant_scale;
1(k, i,1:128, 1:128) = vol(l:128, 1:128);
end
end

limage15 = squeeze(l(1:matranges(2,1), 15, :,:));
imng = 0;
imgtl 5 = 0;

for i = l :matranges(2,1),

%shows a particular image plane over all ﬂames
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imgl 5=squeeze(limage15(i, 1:128, 1 : 128));
imgt15=squeeze(limage15(i, l : 128, l : l28))*quantscale(i)*frametime(i)/sum(frametime)+imgtl 5;
end

ﬁgure(l);
subplot(],2,1);

imagesc(imgl 5');title('Particular Frame lmage');colonnap('gray');
subplot(] ,2,2);
imagesc(imgtl 5'); title('Time lntegrated'); colormap('gray');
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F: ECATFILE.M FUNCTION TO READ ECAT6.4/7.0 DATA

function [res], r852, res3 ] = ecatﬁle( action, p1, p2, p3, p4, p5 )
% USAGE:
% [ ﬁd, message ]
= ecatﬁle( 'open', ﬁlename, ﬁle_system );
% [ ﬁd, message ]
= ecatﬁle( 'open', ﬁlename, 'ecat7' );
% [ ﬁd, message ]
= ecatﬁle( 'open', ﬁlename, 'ecat6.4' );
% [ ﬁd, message ]
= ecatﬁle( 'open', ﬁlename, " );
% [ ﬁd, message ]
= ecatﬁle( 'create', ﬁlename, mh );
% [ mh, message ]
= ecatﬁle( 'mh', ﬁd );
% [ vol, hd, message ] = ecatﬁle( 'read', ﬁd, selmatrix );
% [ vol, hd, message ] = ecatﬁle( 'read', ﬁd, selmatrix, segment); % 3D sinogram
% [ descr, hd, message ] = ecatﬁle( 'read_offset', frd, selmatrix );
% [ descr, hd, message ] = ecatﬁle( 'read_offset', fid, selmatrix, segment); % 3D sinogram
% [ hd, message ]
= ecatﬁle( 'hd', ﬁd, selmatrix );
% message
= ecatﬁle( 'writemh', ﬁd, mh );
% message
= ecatﬁle( 'write', ﬁd, vol, hd, selmatrix );
% message
= ecatﬁle( 'write', ﬁd, vol, hd, selmatrix, segment); % 3D sinogram
% message
= ecatﬁle( 'close', ﬁd );
% message
= ecatﬁle( 'close', 'all' );
% [ matranges, message ] = ecatﬁle( 'matranges', ﬁd );
% [ matlist, matstatus, message ] = ecatﬁle( 'matlist', ﬁd );
% [ hd, hds, message ] = ecatﬁle( 'blankhd', ﬁle_system );
% [ mh, hds, message ] = ecatﬁle( 'blankhd', 'ecat7' );
% [ mh, hds, message ] = ecatﬁle( 'blankhd', 'ecat6.4' );
% [ sh, hds, message ] = ecatﬁle( 'blankhd', 'ecat7', ﬁle_type );
% [ sh, hds, message ] = ecatﬁle( 'blankhd', 'ecat6.4', ﬁle__type );
%
% The user has the responsibility that the written headers are compatible
% with the ﬁle and data structure
% Revision: April 24, 2001.
% ecatﬁle has been tested under MATLABS.3. It has not been tested thoroughly under MATLAB6.
% Copyright (C) 1999, 2000, 2001 by Flemming Hermansen.
% Disclaimer, copyright & licencing
% ecatﬁle is free but copyright software, distributed under the
% terms of the GNU General Public Licence as published by the Free
% Software Foundation (either version 2, or
% at your option, any later version). Further details on "copyleft" can
% be found at http://www.gnu.org/copyleft/. In particular, ecatﬁle is
% supplied as is. No formal support or maintenance is provided or
% implied. The author will have no responsibility of the use and possible errors.

% Known problem with opened ﬁles:
% The ecatﬁle.m reads all headers and all the index blocks when the ECAT ﬁle is opened.

% Further calls to open will not reread the headers and index blocks if the ﬁle is
% already open. Each call to open or create will generate different ﬁd values for the

% same ﬁle. The headers and the index blocks will only be discarded, when all ﬁd's have
% been closed (or when 'close all' is issued). This will give problems if the ﬁle is
% modiﬁed outside the Matlab process, because the headers and index blocks in the Maltab
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% process then don't correspond to those in the physical ﬁle. This may also happen, if a
% ﬁle is renamed or copied. In this situation the user may call
% message = ecatﬁle( 'close', 'all' )
% to make sure that ecatﬁle.m will reread the headers and index blocks. Usually, each
% program should close a ﬁle after using it. Still, ﬁles may be left opened, if a
% program crashes before closing the ﬁle. A subroutine that is used to read portions of a
% ﬁle will thus open and close the ﬁle many times. This will impose a high overhead
% because the headers and index blocks will be read repeatedly. This overhead may be

% prevented if the calling program, itself, opens the ﬁle before calling the
% subroutine, and closes the ﬁle when it has performed the last call to the subroutine.
%
%
%
%
%
%
%

UNRESOLVED PROBLEM: I have not seen a deﬁnite report from CT] stating all possible
formats. There may, therefore, be errors due to misunderstandings and ignorance of
certain formats.
Especially, 1 do not know the machine format of the ﬁle. 1 have assumed that 6.4
ﬁles can be read by using machinefonnat 'vaxg' in the fopen routine. Likewise, l
assume that ecat7 ﬁles can be opened using 'ieee-be'. I assume that the entire ﬁle
be read by the same machineformat.

%
%
%
%
%
%
%
%
%
%
%
%
%
%

The routines have been tested, and they can read and write the
following ecat6.4 ﬁles types: l:*.scn, 22*.img, 3:*.atn, 4:*.nrm
and the following ecat7 ﬁles types: 3:*.a, 7:*.v, 112*.S, l4:*.S
It can read the header from the following ﬁle type: 132*.N
It should also be able to read other headers (see the tables below), but they have not been tested.
The written ﬁles have been tested binarily, and there are some differences:
The CT] generated ﬁles do not contain a truly doubly linked list of index blocks, as index block 2
points back to block 0.
Floating point numbers are not reproduced binarily exact, but the read value is the same,
except for values very close to zero. (assumedly a problem with the representation of
underﬂow, or illegal values)
The last block in CT] generated ecat7 3D sinograms are ﬁlled with non-zeros.
The last block in CTl generated ecat7 3D attenuation is truncated.

%NOT IMPLEMENTED and known errors:
% Problem not yet solved (requires a call to the c-routine stat in stat.h):
% A ﬁle may be opened twice or more times at the same time. The ﬁlename must,
% however, be spelled exactly the same way. Otherwise, the ecatﬁle-system
% can not keep the headers and directoryblocks updated for all ﬁds.
%
% check that seek succeeds.
% seek during write should write zeros in ﬁont of the matrix, if the ﬁle is too short.
%
% The system updates the index blocks after the data have been written, so that

% the ﬁle always will contain valid data. The only exception is when 3D ﬁles are written.
% Then the index block is updated after the ﬁrst 3D-segment has been written. The ﬁle
% will thus be too short, until the last 3D-segment has been written.
%
% pers.handlelist
% pers.ﬁlelist
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% pers.ﬁlelist{ } .ﬁlename
% pers.ﬁlelist{ } .mainheader
% pers.ﬁlelist{}.dirblocks.data( 1:n )
% pers.ﬁlelist{}.dirblocks.ﬁlepos( 1:n )
% pers.ﬁlelist{} .pos
% pers.ﬁlelist{ } .pos.dirblock()
% pers.ﬁlelist{ } .pos.fpgdb()
% pers.ﬁlelist{ } .pos.blockstart()
% pers.ﬁlelist{ } .pos.blockend()
% pers.ﬁlelist{ } .pos.status()
% pers.ﬁlelist{ } .pos.header{ } % may be empty
global pers
% persistent pers

if isempty( perS )

pers = [1;
pers.handlelist = H;
pers.ﬁlelist = H;
end
switch action

case 'blankhd'
% [ hd, hds, message ] = ecatﬁle( 'blankhd', ﬁle_system );
% [ mh, hds, message ] = ecatﬁle( 'blankhd', 'ecat7' );
% [ mh, hds, message ] = ecatﬁle( 'blankhd', 'ecat6.4' );
ﬁle_system = p];
if nargin == 2
[hds , message ] = getmhs( ﬁle_system );
if isempty( message )
[ hd , message ] = blankhd( hds );
end
res] = hd;
res2 = hds;
res3 = message;
return
end
ﬁle_type = p2;
[hds , message ] = getshs( ﬁle_system, ﬁle_type );
if isempty( message )
[ hd , message ] = blankhd( hds );
end

res] = hd;
resZ = hds;

res3 = message;
case 'matlist'
% [ matlist, matstatus, message ] = ecatﬁle( 'matlist', ﬁd );
res] = H;
res2 = H;
ﬁd = pl;
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res3 = 'lllegal handle';
if ﬁd > length( pers.handlelist ) | ﬁd < 1
res3 = 'lllegal handle';
return;

elseif pers.handlelist( ﬁd ) ==
res3 = 'lllegal handle';

return;
end
ﬁle = pers.ﬁlelist{ pers.handlelist( ﬁd ) };
res] = ﬁle.pos.fpgdb;
res2 = ﬁle.pos.status;
res3 = ";
return
case 'matranges’

% [ matranges, message ] = ecatﬁle( 'matranges', ﬁd );
resl = U;
res2 = ";
ﬁd = p1;
if ﬁd > length( pers.handlelist) | ﬁd < 1
re52 = 'lllegal handle';
return;
elseif pers.handlelist( ﬁd ) ==
res2 = 'lllegal handle';
return;
end
ﬁle = pers.ﬁlelist{ pers.handlelist( ﬁd ) };
[ ranges, message ] = getranges( ﬁle);
res] = ranges;
resZ = message;

return

case 'close'
% message
% message

= ecatﬁle( 'close', ﬁd );
= ecatﬁle( 'close', 'all' );

resl = ";
ﬁd = pl;
if strcmp( ﬁd,'all' )

pers = [1;
pers.handlelist = H;
pers.ﬁlelist = H;
res] = ";
return
end
if ﬁd > length( pers.handlelist) | ﬁd < l
resl = 'lllegal handle';

return;
elseif pers.handlelist( ﬁd ) == 0
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res] = 'lllegal handle';
return;
end
ﬁleno = pers.handlelist( ﬁd );
pers.handlelist( ﬁd ) = 0;

if any( pers.handlelist == ﬁleno ) | ﬁd < 1
return
end
pers.ﬁlelist{ ﬁleno } = U;

return
case 'write’
% message = ecatﬁle( 'write', ﬁd, vol, hd, selmatrix );
% message = ecatﬁle( 'write', ﬁd, vol, hd, selmatrix, segment); % 3D sinogram
ﬁd = p1;
vol = p2;
hd = p3;
selmatrix = p4;
% 3D sinogram segment:
if nargin < 6
selsegment = 1;
else
selsegment = p5;
end
resl = ";

postponeindexupdate = 0;
xyz_dimension = size( vol );
while length( xyz_dimension ) < 3
xyz_dimension = [ xyz_dimension, 1 ];
end
if prod( xyz_dimension ) ~= prod( xyz_dimension( 1 :3 ) )
error( 'dimension of vol is higher than 3' )
return

end
if ﬁd > length( pers.handlelist)
resl = 'lllegal handle';
return;
elseif pers.handlelist( ﬁd ) ==
res] = 'lllegal handle';
return;
end

ﬁle = pers.ﬁlelist{ pers.handlelist( ﬁd ) };
[ datadescr, message ] = getdatadescr( ﬁle.mainheader.ﬁle_system,
ﬁle.mainheader.ﬁle_type, hd.sh.data_type );
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if isempty( message )
[ hd, offsetfromheader, writeﬁll, numdatablocks, message ] =
set_xyz_dimension( hd, datadescr, xyz_dimension, selsegment );
end
if isempty( message )
[ hds, message ] = getshs( ﬁle.mainheader.ﬁle_system, ﬁle.mainheader.ﬁle_type );

end
if ~isempty( message )

return
end
% total number of blocks == numdatablocks + hds.header_size / 512
ﬁdphys = fopen( ﬁle.ﬁlename, 'r+', ﬁle.mhmachineformat );
if isempty( ﬁle.pos.fpgdb)
matpos = 0;
else
matpos = ﬁrstno(
ﬁle.pos.fpgdb( 1, : )==
ﬁle.pos.fpgdb( 2, : ==
ﬁle.pos.fpgdb( 3, : )==
ﬁle.pos.fpgdb( 4, : )==
ﬁle.pos.fpgdb( 5, : )==
end
%
%
%
%

selmatrix(
selmatrix(
selmatrix(
selmatrix(
selmatrix(

1
2
3
4
5

)&
)&
)&
)&
) );

calculate number of blocks
data_type.ftype = 'intl6';
data_type.size = 2;
data_type.fopentype = 'ieee-be';

if matpos == 0
% entry does not exist, create entry
% allocate space in the index block,
% do not write the updated index block yet
% function matnum = fpgdb2matnum( fpgdb )
% ﬁnd an index block that is not full
indexblockno = ﬁrstno( ﬁle.dirblocks.data( 1, : )~= 0 );
if indexblockno == 0
% all index blocks are full, create a new index block
newindexblock = max( max( ﬁle.dirblocks.data( l, : )),
max( ﬁle.pos.blockend ) ) + l;
lastindexblock = ﬁle.dirblocks.ﬁlepos( end );
ﬁle.dirblocks.data( 2, end ) = newindexblock;
ﬁle.dirblocks.data( 3, 1 )= newindexblock;
ﬁle.dirblocks.ﬁlepos = [ ﬁle.dirblocks.ﬁlepos, newindexblock ];
ﬁle.dirblocks.data( :, end + 1 ) =
[ 31, 2, lastindexblock, 0, zeros( 1, 124 ) ];
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% the following writing sequence ensures, that next will be consistent in
% the links, even in case of interruption during writing
% write new index block;
status = fseek( ﬁdphys, ( newindexblock - 1 ) * 512, -l );
if status ~= 0
fclose( ﬁdphys );
resl = 'Error writing the index block';
return
end
count = fwrite( ﬁdphys, ﬁle.dirblocks.data( :, end ), 'uint32' );
if count ~= 128
fclose( ﬁdphys );
res] = 'Error writing the index block';
return
end
% write ﬁrst index block
status = fseek( ﬁdphys, ( 2 - 1 ) * 512, -l );
if status ~= 0
fclose( ﬁdphys );
resl = 'Error writing the index block';
return
end
count = fwrite( ﬁdphys, ﬁle.dirblocks.data( :, 1 ), 'uint32' );
if count ~= 128
resl = 'Error writing the index block';
return
end
% write last index block
if length( ﬁle.dirblocks.ﬁlepos ) > 2
status = fseek( ﬁdphys, ( ﬁle.dirblocks.ﬁlepos( end - 1 )- 1 ) * 512, -l );
if status ~= 0
fclose( ﬁdphys );
resl = 'Error writing the index block';
return
end
count = fwrite( ﬁdphys, ﬁle.dirblocks.data( :, end - 1 ),
'uint32' );
if count ~= 128
fclose( ﬁdphys );
resl = 'Error writing the index block';
return
end
end
pers.ﬁlelist{ pers.handlelist( ﬁd) } = ﬁle;
indexblockno = length( ﬁle.dirblocks.ﬁlepos );
end % create a new index block
%
%
%
%

add item into indexblock
0: matnum
1: ﬁrst data block (subheader)
2: last data block
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% 3: status: lzexists; 0: allocated, no data yet written, -1: matrix deleted
startblock = max( max( ﬁle.dirblocks.data( 2, : ) ),
max( [ ﬁle.pos.blockend, 0 ] ))+ 1;
p = ﬁle.dirblocks.data( 4, indexblockno ) * 4 + 4;
ﬁle.dirblocks.data( p+1:p+4, indexblockno ) = [

fpgdb2matnum( selmatrix ),
startblock,

startblock + numdatablocks + hds.header_size / 512 - 1,

1 1;
ﬁle.dirblocks.data( l, indexblockno ) = ﬁle.dirblocks.data( 1, indexblockno ) - 1;
ﬁle.dirblocks.data( 4, indexblockno ) = ﬁle.dirblocks.data( 4, indexblockno ) + 1;
matpos = length( ﬁle.pos.dirblock ) + 1;

ﬁle.pos.dirblock( matpos ) = indexblockno;
ﬁle.pos.fpgdb( :, matpos ) = selmatrix( : );
ﬁle.pos.blockstart( matpos ) = startblock;

ﬁle.pos.blockend( matpos ) =
startblock + numdatablocks + hds.header_size / 512 - 1;
ﬁle.pos.status( matpos ) = 1;
ﬁle.pos.header{ matpos } = hd.sh;
ﬁle.pos.relpos( matpos ) = p / 4;
postponeindexupdate = 1;
% postpone the updating of ﬁle and writing the above changes to the hard disk
% until the matrix has been succesfully written
else
% entry exists, check size of existing entry
if ﬁle.pos.blockend( matpos ) - ﬁle.pos.blockstart( matpos ) + 1 ~=
numdatablocks + hds.header_size / 512
error( 'Trying to change the size of a matrix' )
return
end
ﬁle.pos.header{ matpos } = hd.sh;
if ﬁle.pos.status ~= 1
% change status to l
p = ﬁle.pos.relpos( matpos );
ﬁle.pos.status( matpos ) = l;
ﬁle.dirblocks.data( p * 4 + 4, indexblockno ) = 1;
postponeindexupdate = 1;
end
end
% pers.ﬁlelist{ } .pos.dirblock()
% pers.ﬁlelist{ } .pos.fpgdb()
% pers.ﬁlelist{ } .pos.blockstart()
% pers.ﬁlelist { } .pos.blockend()
% pers.ﬁlelist{ } .pos.status()
% pers.ﬁlelist{}.pos.header{} % may be empty
status = fseek( ﬁdphys, ( ﬁle.pos.blockstart( matpos ) - 1 ) * 512, -1 );
if status ~= 0
fclose( ﬁdphys );
resl = 'Error writing matrix';
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return
end

message = writehd( ﬁdphys, hd.sh, hds );
if ~isempty( message )
fclose( ﬁdphys );
resl = message;

return
end
% 'a', ﬁell( ﬁdphys )
% skip to the right 3D segment
if offsetfromheader ~= 0
fseek( ﬁdphys, offsetfromheader, 0 );
end
for pl = 1:xyz_dimension( 3 )
count = fwrite( ﬁdphys, double( vol( :, :, p1 ) ), datadescrﬁype );
if count ~= prod( xyz_dimension( 1:2 ) )
fclose( ﬁdphys );
resl = 'Error writing matrix';
return
end
end
% ﬁll last block with zeros
count = fwrite( ﬁdphys, zeros( 1, writeﬁll / datadescrsize ), datadescrﬁype );
if count ~= writeﬁll / datadescrsize
fclose( ﬁdphys );
resl = 'Error writing matrix';
return
end
if hds.header_size +
( ﬁle.pos.blockstart( matpos ) - 1 + numdatablocks ) * 512
~= ftell( ﬁdphys )
% waming( 'The length of the written matrix is wrong.’ );
end
% write the updated indexblock
if postponeindexupdate
status = fseek( ﬁdphys, ( ﬁle.dirblocks.ﬁlepos( indexblockno ) - 1 ) * 512, -1 );
if status ~= 0
fclose( ﬁdphys );
resl = 'Error writing the index block';
return
end
count = fwrite( ﬁdphys, ﬁle.dirblocks.data( :, indexblockno ), 'uint32' );
if count ~= 128
fclose( ﬁdphys );
resl = 'Error writing the index block';
return
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end
end

pers.ﬁlelist{ pers.handlelist( ﬁd) } = ﬁle;
fclose( ﬁdphys );
return
case { 'read', 'hd', 'read_offset' }
% [ vol, hd, message ] = ecatﬁle( 'read', ﬁd, selmatrix );
% [ vol, hd, message ] = ecatﬁle( 'read', ﬁd, selmatrix, segment); % 3D sinogram
% [ descr, hd, message ] = ecatﬁle( 'read_offset', ﬁd, selmatrix );
% [ descr, hd, message ] = ecatﬁle( 'read_offset', ﬁd, selmatrix, segment); % 3D sinogram
% [ hd, message ]
= ecatﬁle( 'hd', ﬁd, selmatrix );
ﬁd = p1;
selmatrix = p2;
% 3D sinogram segment:
if nargin < 4
selsegment = 1;
else
selsegment = p3;
end

vol = [ ];
hd = [ ];
descr = U;
message = ";
if ﬁd > length( pers.handlelist) | ﬁd <= 0
message = 'lllegal handle';
elseif pers.handlelist( ﬁd ) ==
message = 'lllegal handle';
else
ﬁle = pers.ﬁlelist{ pers.handlelist( ﬁd )
if isempty( ﬁle.pos.fpgdb )
message = 'Matrix does not exist';
else
matpos = ﬁrstno(
ﬁle.pos.fpgdb( 1, : )== selmatrix( l
ﬁle.pos.fpgdb( 2, : )== selmatrix( 2
ﬁle.pos.fpgdb( 3, : )== selmatrix( 3
ﬁle.pos.fpgdb( 4, : ) == selmatrix( 4
ﬁle.pos.fpgdb( 5, : )== selmatrix( 5
if matpos ==
message = 'Matrix does not exist';
end
end
end

};

)&
)&
)&
)&
));

% pers.ﬁlelist { } .pos.dirblock()
% pers.ﬁlelist{ } .pos.fpgdb()
% pers.ﬁlelist{ } .pos.blockstart()
% pers.ﬁlelist{ } .pos.blockend()
% pers.ﬁlelist{ } .pos.status()
% pers.ﬁ1elist{}.pos.beader{} % may be empty
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if isempty( message )
ﬁdphys = fopen( ﬁle.ﬁlename, 'r', ﬁle.mhmachineformat );
fseek( ﬁdphys, ( ﬁle.pos.blockstart( matpos ) - 1 ) * 512, -1 );

[hds, message ] = getshs( ﬁle.mainheader.ﬁle_system, ﬁle.mainheader.ﬁle_type );
else
ﬁdphys = -1;

end
if isempty( message )
[ sh, message ] = readhd( ﬁdphys, hds );
hd.sh =sh;
hd.mh = ﬁle.mainheader;
end
if strcmp( action, 'hd' )
res] = hd;
re52 = message;
if ﬁdphys > 0
fclose( ﬁdphys );
end
return
end
% 'a', ftell( ﬁdphys )
if isempty( message )
[ descr, message ] = getdatadescr( ﬁ1e.mainheader.ﬁle_system, ﬁle.mainheader.ﬁle_type, sh.data_type

);
end

if isempty( message )
[ xyz_dimension, offsetfromheader ] = get_xyz_dimension( hd, descr, selsegment );
descr.xyz_dimension = xyz_dimension;
descr.headeroffset = ( ﬁle.pos.blockstart( matpos ) - 1 ) * 512;
descr.header_size = hds.header_size;
descr.dataoffset = descr.headeroffset + hds.header_size + offsetfromheader;
end
if strcmp( action, 'read' ) & isempty( message)
% skip to the right 3D segment
if offsetfromheader ~= 0
fseek( ﬁdphys, offsetfromheader, 0 );
end
% preallocate vol:
switch descrftype
case 'ﬂoat32'
voll = zeros( xyz_dimension( 1 ), xyz_dimension( 2 ) );
case { 'int8', 'int16' }
voll = int16( zeros( xyz_dimension( l ), xyz_dimension( 2 ) ) );
end
vol = voll( :, :, ones( xyz_dimension( 3 ), 1 ) );
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for pl = 1:xyz_dimension( 3 )
[ voll, count] = fread( ﬁdphys, prod( xyz_dimension( 1:2 ) ),
descrftype );
if count ~= prod( xyz_dimension( 1:2 ))
message = 'ﬁle too short';
break
end
switch descr.ftype
case 'ﬂoat32'
vol( :, :, pl ) =
reshape( voll, xyz_dimension( 1:2 ) );
case { 'int8', 'intl6' }
vol( :, :, pl ) =
reshape( int16( voll ), xyz_dimension( 1:2 ) );
end
end
end
if strcmp( action, 'read' )
if ~isempty( message )

vol = [1;
end
resl = vol;
else
res] = descr;
end
res2 = hd;
res3 = message;
if ﬁdphys > 0
fclose( ﬁdphys );
end
return
case 'writemh'

% message = ecatﬁle( 'writemh', ﬁdphys, mh );
ﬁd=pl;
mh=p2;
res] =";

if ﬁd > length( pers.handlelist ) | ﬁd <= 0
resl = 'lllegal handle';
elseif pers.handlelist( ﬁd ) ==
resl = 'lllegal handle';
end
ﬁle = pers.ﬁlelist{ pers.handlelist( ﬁd ) };

ﬁdphys = fopen( ﬁle.ﬁlename,
'r+', ﬁle.mhmachineformat );
if ﬁdphys <= 0
resl = [ 'Can"t open ﬁle: ', ﬁleﬁlename ];

return
end
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[hds, message ] = getmhs( mh.ﬁle_system );
if isempty( message )
message = writehd( ﬁdphys, mh, hds )
end
fclose( ﬁdphys );
if ~isempty( message )
resl = message;
return

end
pers.ﬁlelist{ pers.handlelist( ﬁd) }.mainheader = mh;

return
case 'mh'
% [ mh, message ] = ecatﬁle( 'mh', ﬁd );
resl = H;
resZ = ";
ﬁd = p1;
if ﬁd <= 0 | ﬁd > length( pers.handlelist ) | ﬁd <= 0
res2 = 'lllegal handle';
return;
elseif pers.handlelist( ﬁd ) ==
resZ = 'lllegal handle';
return;
end
resl = pers.ﬁlelist{ pers.handlelist( ﬁd ) }.mainheader;
return
case { 'open', 'create'
% [ ﬁd, message ]
% [ ﬁd, message ]
% [ ﬁd, message ]
% [ ﬁd, message ]
% [ ﬁd, message ]
ﬁlename = pl;

}
=
=
=
=
=

ecatﬁle(
ecatﬁle(
ecatﬁle(
ecatﬁle(
ecatﬁle(

'open', ﬁlename, ﬁle_system );
'open', ﬁlename, 'ecat7' );
'open', ﬁlename, 'ecat6.4' );
'open', ﬁlename, " );
'create', ﬁlename, mh );

if strcmp( ﬁlename, " )
ﬁd = -1;

message = 'lllegal ﬁlename';
resl = ﬁd;
res2 = message;
return
end
if nargin < 3
p2 ___ '1;

end
for i = 1:length( pers.ﬁlelist )
if ~isempty( pers.ﬁlelist{ i } )
if strcmp( pers.ﬁlelist{ i }.ﬁlename, ﬁlename)
if strcmp( action, 'create' )
% ﬁle already open. Truncate the ﬁle.
[ ﬁle, message ] = openecat( ﬁlename, 'create', p2 );
if ~isempty( message )
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ﬁd = -1;
resl = ﬁd;
resZ = message;

return
end

pers.ﬁlelist{ i } = ﬁle;
end
% ﬁle already open, return a duplicate ﬁd
ﬁd = ﬁrstno( [ pers.handlelist, 0 ] == 0 );
pers.handlelist( ﬁd ) = i;
message = ";
resl = ﬁd;
re52 = message;

return
end
end
end

[ ﬁle, message ] = openecat( ﬁlename, action, p2 );
if ~isempty( message )
ﬁd = -1;
resl = ﬁd;
resZ = message;
return
end
pos = length( pers.ﬁlelist ) + 1;
for i = 1:length( pers.ﬁlelist )
if isempty( pers.ﬁlelist{ i } )
pos = i;
break
end
end
pers.ﬁlelist{ pos } = ﬁle;
ﬁd = ﬁrstno( [ pers.handlelist, O ] == 0 );
pers.handlelist( ﬁd ) = pos;
message = ";
resl = ﬁd;
resZ = message;

return
otherwise
error( 'lllegal action' )
end % switch action

%
function matnum = fpgdb2matnum( fpgdb)
frame = fpgdb( 1 );
plane = fpgdb( 2 );

gate = fpgdb( 3 );
data = fpgdb( 4 );
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bed = fpgdb( 5 );
matnum = bitand( frame, 511 ) +
bitshift( bitand( plane, 3 * 256 ), 9 - 8 ) +
bitshift( bitand( data, 4 ), 11 - 2 ) +
bitshiﬁ( bitand( bed, 15 ), 12 ) +
bitshift( bitand( plane, 255 ), l6 ) +
bitshift( bitand( gate, 63 ), 24 ) +
bitshift( bitand( data, 3 ), 30);

%
function [ ﬁle, message ] = openecat( ﬁlename, create, ﬁle_system );
% function [ ﬁle, message ] = openecat( ﬁlename, 'open', ﬁle_system );
% function [ ﬁle, message ] = openecat( ﬁlename, 'create', mh );
if nargin < 2
create = 'open';
end
message = ";

fﬂe==lh
% read mh, matdir, fpgdb
if strcmp( create, 'create' )
% truncate or create
mh = ﬁle_system;
frle_system = mh.ﬁle_system;
switch mh.ﬁle_system
case 'ecat7'
ﬁdphys = fopen( ﬁlename, 'w', 'ieee-be' );
case 'ecat6.4'
ﬁdphys = fopen( ﬁlename, 'w', ' vaxg');
otherwise
error( 'Wrong header’ )
end
if ﬁdphys == -1
message = [ 'Can"t open ﬁle: ', ﬁlename ];
return
end
[hds, message ] = getmhs( mh.ﬁle_system );
if isempty( message )
message = writehd( ﬁdphys, mh, hds );
end
if ~isempty( message )
fclose( ﬁdphys );
return
end
fwrite( ﬁdphys, 31, 'uint32' ); % 31 unused entries

fwrite( ﬁdphys, 2, 'uint32' ); % 1: next index block
fwrite( ﬁdphys, 2, 'uint32' ); % 2: previous index block ? 0
fwrite( ﬁdphys, 0, 'uint32' ); % 3: number of used entries in the block?
fwrite( ﬁdphys, zeros( 4 * 31, 1 ), 'uint32' );
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if ftell( ﬁdphys ) ~= 1024
message = 'File write error';
end
fclose( ﬁdphys );
end % create or truncate
[ ﬁle, message ] = readmh( ﬁlename, ﬁle_system );

if ~isempty( message )

ﬁle = [1;
return
end
if strcmp( create, 'create' )
ﬁdphys = fopen( ﬁlename, 'r+', ﬁle.mhmachineformat ); % 'w+' ?
else
ﬁdphys = fopen( ﬁlename, 'r', ﬁle.mhmachineformat ); % 'w+' ?
end
if ﬁdphys == -1

ﬁle = [1;
message = [ 'Can"t open ﬁle: ', ﬁlename ];

return
end
% read indexblocks

%
%
%
%
%

ﬁrst entry of an index block:
0: number of unused entries?
1: next index block
2: previous index block
3: number of used entries in the block?

%
%
%
%
%

succeeding entries in an index block:
0: matnum
1: ﬁrst data block (subheader)
2: last data block
3: status: lzexists; 0: allocated, no data yet written, -1: matrix deleted

fseek( ﬁdphys, 512, '1 );
blockno = 2;
matdir = [ ];
ok = 1;
ﬁle.dirblocks.data = [ ];

ﬁle.dirblocks.ﬁlepos = [ ];
while 0k
fseek( ﬁdphys, 512 * ( blockno - 1), -1 );
[ al, count]= fread( ﬁdphys, 128, 'uint32');
if count < 128

ﬁle = [1;
157

message = [ 'Can"t read index block: ', ﬁlename ];
return
end
ﬁle.dirblocks.data = [ ﬁle.dirblocks.data, a1 ];

ﬁle.dirblocks.ﬁlepos = [ ﬁle.dirblocks.ﬁlepos, blockno ];
if 81(2) ==
ok = 0;
elseif any( a1(2) == ﬁle.dirblocks.ﬁlepos( 2:end ) ) | al( 2 ) <= 0
% error if the directory block numbers are circular or not positive
message = 'lllegal index block numbers';

ﬁle = [1;
return;
end

blockno = a1(2);
end
% matdir(l :8, z)
% fclose(ﬁdphys);
52 = size( ﬁle.dirblocks.data );
direntries = [ ];

ﬁle.pos.dirblock = [ ];
ﬁle.pos.relpos = [ ];
for i = l:sz( 2)

jj = ﬁle.dirblocks.data( 4, i );
ifjj<0|jj>3l
message = 'Wrong index block';

ﬁle = [1;
return
end
direntries = [ direntries, reshape( ﬁle.dirblocks.data( 5:4 + jj * 4. i ), 4, .11 )1;
ﬁle.pos.dirblock = [ ﬁle.pos.dirblock, i + zeros( l, jj ) ];
ﬁle.pos.relpos = [ ﬁle.pos.relpos, lzjj ];
end
fpgdb = ﬁle.dirblocks.data( 5:128, : );
fpgdb = [ zeros(7, sz(2)*31); reshape( fpgdb, 4, sz(2)*3] ) ];

m = direntries( 1, : );
frame = rem( m, 512 ); m = floor( m / 512 );
hiplane = rem( m, 4 ); m = ﬂoor( m / 4 );
hidata = rem( m, 2 ); m = ﬂoor( m / 2 );
bed = rem(m, 16); m = ﬂoor(m/ 16);
plane = rem( m, 256 ) + hiplane * 256; m = floor( m / 256 );
gate = rem( m, 64 ); m = ﬂoor( m / 64 );
data = rem( m, 4 ) + hidata * 4; m = ﬂoor( in / 4 );
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ﬁle.pos.fpgdb = [ frame; plane; gate; data; bed];

ﬁle.pos.blockstart = direntries( 2, : );
ﬁle.pos.blockend = direntries( 3, : );
ﬁle.pos.status = direntries( 4, : );
fclose( ﬁdphys );
%
function [ ranges, message ] = getranges( ﬁle)
ranges = [ ];
message = ";
% check homogeneity
if length( ﬁle.pos.fpgdb( 1, : ) ) ==
m1 = ﬁle.pos.fpgdb;
m2 = ml;

else
m1 = min( ﬁle.pos.fpgdb' )';
m2 = max( ﬁle.pos.fpgdb' )';
end
tot=m2-m1 +1;
f=1;
fori=1:5
f(i, l )=f(end)*tot(i);
end
if f(5) ~= length( ﬁle.pos.status )
message = 'Inhomogeneous fpgdb\n';
return

end
testexists = zeros( f(5), 1 );
p=1+[1, f(l:4 )'] *
( ﬁle.pos.fpgdb - m]( :, ones( 1, size( ﬁle.pos.fpgdb, 2 ) ) ) );
testexists( p ) = 1;
if sum(testexists) ~= length( ﬁle.pos.status )
message = 'Inhomogeneous fpgdb\n';

return
end
ranges = [ m1, m2 ]';
if any( ﬁle.pos.status ~= 1 )
message = 'Matrices with wrong status\n';
end
return

%
function [ hd, message ] = blankhd( hds )
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message = ";

M = [1;
n = 0;

P08 = [1;
for i =1 :length( hds.s )
pos( end +1 )= n;
switch hds.s(i).type
case 'intl6'
n = n + 2 * hds.s(i).noelements;
hd = setﬁeld( hd, hds.s(i).ﬁeldname, zeros( 1, hds.s(i).noelements ) );
case { 'ﬂoat32', 'matlst', 'mat2nd', 'int32' }
n = n + 4 * hds.s(i).noelements;
hd = setﬁeld( hd, hds.s(i).ﬁeldname, zeros( 1, hds.s(i).noelements ) );
case 'char'
n = n + 1 * hds.s(i).noelements;
hd = setﬁeld( hd, hds.s(i).ﬁeldname, " );
end % switch hds.s(i).type
end
if n ~= hds.header_size
error( 'Blank header, wrong internal description')
end
% make sure that ecat 7 mh contains a non-zero magic number
if strcmp( hds.ﬁle_system, 'ecat7' )
hd.magic_number = 'MATRIX7';
end
%
function message = writehd( ﬁdphys, hd, hds )
message = ";

initialpos = ﬁell( ﬁdphys );
% make sure that ecat 7 mh contains a non-zero magic number
if strcmp( hd.ﬁle_system, 'ecat7' )
if isempty( hd.magic_number)
hd.magic_number = 'MATRIX7';
elseif a11( hd.magic_number == 0 )
hd.magic_number = 'MATRIX7';
end
end
0k = l;
for i =1 :length( hds.s )
val = getﬁeld( hd, hds.s(i).ﬁeldname );
if strcmp( hds.s(i).type, 'char' )
if length( val(:) ) < hds.s(i).noelements
val = [ val(:); char(
zeros( hds.s(i).noelements - length( val(:) ), 1 ) ) ];
end
end
if strcmp( hds.s(i).type, 'matlst' )
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if length( val(:) ) ~= 12
error( 'illegal header length\n')
end
elseif strcmp( hds.s(i).type, 'mat2nd' )
% the size has already been tested
elseif length( val(:) ) ~= hds.s(i).noelements
error( 'illegal header length\n')
end
switch hds.s(i).type
case 'intl6'
ok = 0k & length( val(:) ) == fwrite(
case 'int32'
ok = 0k & length( val(:) ) == fwrite(
case 'ﬂoat32'
ok = 0k & length( val(:) == fwrite(
case 'mat 1 st'
val = val( 1:3, 1:3 )';
ok = 0k & length( val(:) ) == fwrite(
case 'mat2nd'
val = val(:,4);
ok = 0k & length( val(:) ) == fwrite(
case 'char'
ok = 0k & length( val(:) == fwrite(
end % switch hds.s(i).type
end
if ~ok
message = 'Can"t write header';
return
end

ﬁdphys, val, 'intl 6' );
ﬁdphys, val, 'int32' );
ﬁdphys, val, 'ﬂoat32' );

ﬁdphys, val(:), 'ﬂoat32' );

ﬁdphys, val, 'ﬂoat32' );
ﬁdphys, val, 'uchar' );

if ﬁell( ﬁdphys ) - initialpos ~= hds.header_size
error( 'Writing header, wrong internal description' )
end

%
function [ ﬁle, message ] = readmh( ﬁlename, ﬁle_system )
% this function determines the header type and the machineforrnat
% that is used for reading the main header and the index blocks.
% if the ﬁle is too short, it returns ﬁle = [], otherwise, it returns
% ﬁle.mainheader = mh;
% ﬁle.mhmachineformat = mhmachineformat;
% ﬁle.ﬁlename = ﬁlename;
% the routine uses ad hoc testing to determine the format. This testing may

% need to be changed if the routine can not determine the format correctly
message = ";

ﬁle = [1;
mhmachineformat = 'ieee-be‘;

mh = [1;
ﬁdphys = fopen( ﬁlename, 'r', mhmachineforrnat );

if ﬁdphys == -1
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message = [ 'Can"t open ﬁle: ', ﬁlename ];
return
end
magic_number = fread( ﬁdphys, 14, 'char' );
% check length of main header
[mh, count ]= fread( ﬁdphys, 256-7, 'uint16');
if count < 256-7
message = 'Header read error';

return
end
if ( all( magic_number == 0 ) & strcmp( ﬁle_system, " ) ) |
strcmp( ﬁle_system, 'ecat6.4')
fclose( ﬁdphys );
% ecat 6.4
mhmachineformat = 'vaxg';
ﬁdphys = fopen( ﬁlename, 'r', mhmachineformat );
if ﬁdphys == -1
return
end
hds = getmhs( 'ecat6.4' );
elseif strcmp( ﬁle_system, " ) | strcmp( ﬁle__system, 'ecat7')
% ecat7
fseek( ﬁdphys, 0, -1 );
hds = getmhs( 'ecat7' );
else

message = 'lllegal ﬁle system';
fclose( ﬁdphys );
return
end
[ mh, message ] = readhd( ﬁdphys, hds );
if ~isempty( mh )
ﬁle.mainheader = mh;
ﬁle.mhmachineformat = mhmachineformat;
ﬁle.ﬁlename = ﬁlename;
end

fclose( ﬁdphyS );
%
function [ hd, message ] = readhd( ﬁdphys, hds )
message = ";
0k = 1;

hd = [1;
initialpos = ﬁell( ﬁdphys );
hd.ﬁle_system = hds.ﬁle_system;
for i =1 :length( hds.s )
switch hds.s(i).type
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case 'intl6'
[ val, count] = fread( ﬁdphys, hds.s(i).noelements,
hd = setﬁeld( hd, hds.s(i).ﬁeldname, val' );
case 'int32'
[ val, count ] = fread( ﬁdphys, hds.s(i).noelements,
hd = setﬁeld( hd, hds.s(i).ﬁeldname, val' );
case { 'float32', 'matlst' }
[ val, count] = fread( ﬁdphys, hds.s(i).noelements,
hd = setﬁeld( hd, hds.s(i).ﬁeldname, val' );
case 'mat2nd'
[ val, count] = fread( ﬁdphys, hds.s(i).noelements,
mt = getﬁeld( hd, hds.s(i).ﬁeldname );
mt = [ reshape( mt, 3, 3 )', val ];
hd = setﬁeld( hd, hds.s(i).ﬁeldname, mt);
case 'char'
[ val, count ] = fread( ﬁdphys, hds.s(i).noelements,
val = char( val( val ~= 0 ) );
hd = setﬁeld( hd, hds.s(i).ﬁeldname, val' );
otherwise
count = hds.s(i).noelements;
end % switch hds.s(i).type
ok = 0k & count == hds.s(i).noelements;

'intl6' );

'int32' );

'ﬂoat32' );

'ﬂoat32' );

'uchar' );

end
if ~ok
message = 'Header read error';
end
if ﬁell( ﬁdphys ) - initialpos ~= hds.header_size
error( 'Reading header, wrong internal description' )

end
function [ hds, message ] = getmhs( ﬁle_system )
message = ";
switch ﬁle_system
case 'ecat7'
a = { 'magic_number',
'original_ﬁle_name',
'sw_version',
'system_type',
'ﬁle_type',
'serial_number',

'scan_start_time',
'isotope_name',
'isotope_halﬂife',
'radiopharmaceutical',
'gantry_tilt',

14, 'char'
32, 'char'
1 , 'int 1 6'
l , 'int 1 6'
1, 'int 1 6'
10, 'char'

l, 'int32'
8, 'char'
1, 'ﬂoat32'
32, 'char'
1, 'ﬂoat32'

'gantry_rotation',

1, 'ﬂoat32'

'bed_elevation',

1, 'ﬂoat32'

'intrinsic_tilt',
'wobble_speed',
'transm_source_type',

1, 'ﬂoat32'
l , 'int 1 6'
1 , 'int 1 6'
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1, 'ﬂoat32'
1, 'ﬂoat32'
'angular_compression',
1, 'int 1 6'
1, 'int 1 6'
'coin_samp_mode',
1, 'int] 6'
'axial_samp_mode',
1, 'ﬂoat32'
'ecat_calibration_factor',
1, 'int] 6'
'calibration_units',
1, 'int 1 6'
'calibration_units_label',
1, 'int] 6'
'compressi0n_code',
12, 'char'
'study_type',
16, 'char'
'patient_id',
32, 'char'
'patient_name',
1, 'char'
'patient_sex',
1, 'char'
'patient_dexterity',
1, 'ﬂoat32'
'patient_age',
1, 'ﬂoat32'
'patient_height',
'patient_weight',
1, 'ﬂoat32'
1, 'int32'
'patient_birth_date',
32, 'char'
'physician_name',
'operator_name',
32, 'char'
32, 'char'
'study_description',
'acquisition_type',
1, 'int] 6'
1, 'int 1 6'
'patient_orientation',
'facility_name',
20, 'char'
'num_planes',
1, 'int 1 6'
1, 'int] 6'
'num_frames',
'num_gates',
1, 'int 1 6'
1, 'int 1 6'
'num_bed_pos',
16, 'ﬂoat32'
'bed_position',
l, 'ﬂoat32'
'plane_separation',
1, 'int 1 6'
'lwr_sctr_thres',
1, 'int] 6'
'lwr_true_thres',
1, 'int 1 6'
'upr_true_thres',
10, 'char'
'user_process_code',
1, 'int 1 6'
'acquisition_mode',
1, 'ﬂoat32'
'bin_size',
'branching_fraction',
1, 'ﬂoat32'
1, 'int32'
'dose_start_time',
1, 'ﬂoat32'
'dosage',
1, 'ﬂoat32'
'well_counter_corr_factor',
32, 'char'
'data_units',
1, 'int 1 6'
'septa_state',
'ﬁll',
6, 'intl6' };

'distance_scanned',

'transaxial_fov',

hds.s = struct( 'ﬁeldname', a(:,1), 'noelements', a(:,2),

'type', a(:,3) );
hds.header_size = 512;
hds.ﬁle_system = 'ecat7';
case 'ecat6.4'

a = { 'ﬁlll',
'original_ﬁle_name',
'sw_version',

14, 'intl6' % changed type
20, 'char' % changed length

1, 'intl6'
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'data_type',
'system_type',
'ﬁle_type',

1, 'intl6' % ecat6.4
1 , 'int] 6'
1, 'int 1 6'

'node_id',

10, 'char' % serial_number

%'scan_start_time', 1, 'int32'

'scan_start_day',
'scan_start_month',

1, 'intl6' % ecat6.4
1, 'intl6' % ecat6.4

'scan_start_year',
1, 'intl6' % ecat6.4
'scan_start_hour',
1, 'intl6' % ecat6.4
'scan_start_minute',
l, 'intl6' % ecat6.4
'scan_start_second',
1, 'intl6' % ecat6.4
'isotope_code',
8, 'char' % isotope_name
'isotope_halﬂife',
1, 'ﬂoat32'
'radiopharmaceutical',
32, 'char'
'gantry_tilt',
1, 'ﬂoat32'
'gantry_rotation',
1, 'ﬂoat32'
'bed_elevation',
1, 'float32'
%'intrinsic_tilt', 1, 'ﬂoat32'
'rot_source_speed',
1, 'intl6' % ecat6.4
'wobble_speed',
1 , 'int 1 6'
'transm_source_type',
1 , 'int] 6'
%'distance_scanned', l, 'ﬂoat32'
'axial_fov',
1, 'ﬂoat32'
'transaxial_fov',
l, 'ﬂoat32'
'transaxial_samp_mode',
1, 'intl6' % ecat6.4
%'angular_compression', 1, 'intl6'
'coin_samp_mode',
1 , 'int] 6'
'axial_samp_mode',
1, 'intl6' % subtracted l in ecat7
'calibration_factor',
1, 'ﬂoat32' % ecat_calibration_factor
'calibration_units',
1 , 'int 1 6'
%'calibration_units_label', 1, 'intl6'
'compression_code',
1, 'int 1 6'
'study_name',
12, 'char' % study_type
'patient_id',
16, 'char'
'patient_name',
32, 'char' % changed length
'patient_sex',
1, 'char'
'patient_age',
10, 'char' % changed type
'patient_height',
10, 'char' % changed type
'patient_weight',
10, 'char' % changed type
'patient_dexterity',
1, 'char' % changed position
%'patient_birth_date', 1, 'int32'
'physician_name',
32, 'char'
'operator_name',
32, 'char'
'study_description',
32, 'char'

'acquisition_type',

1, 'int 1 6'

'bed_type',

1, 'intl6' % ecat6.4

'septa_type',

1 , 'int 1 6'

%'patient_orientation', l, 'intl6'
'facility_name',
20, 'char'
'num_planes',
l, 'intl6'
'num_frames',
1 , 'int 1 6'
'num_gates',
1 , 'int] 6'

'num_bed_pos',

1, 'int] 6'
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'bed_position',
'plane_separation',

'lwr_sctr_thres',

16, 'ﬂoat32'
1, 'ﬂoat32'

1 , 'int 1 6'

'lwr_true_thres',
l, 'intl6'
'upr_true_thres',
1 , 'int] 6'
'collimator',
l, 'ﬂoat32' % ecat6.4
'user_process_code',
10, 'char'
%'acquisition_mode', 1, 'intl6'
'ﬁ112',
20, 'intl6' };
%'bin_size', 1, 'float32'
%'branching_fraction', 1, 'ﬂoat32'
%'dose_start_time', 1, 'int32'
%'dosage', 1, 'ﬂoat32'
%'well_counter_corr_factor', l, 'ﬂoat32'
%'data_units', 32, 'char'
%'septa_state', 1, 'int] 6'

%'ﬁll', 6, 'intl6' };
hds.s = struct( 'ﬁeldname', a(:,1), 'noelements', a(:,2),

'type'. a(:,3) );
hds.header_size = 512;
hds.ﬁle_system = 'ecat6.4';
otherwise
message = 'lllegal ﬁle system';

hds = [1;
end % switch ﬁle_system
function [ hds, message ] = getshs( ﬁ1e_system, ﬁle_type );
message = ";

hds = [1;
switch ﬁle_system
case 'ecat7'

switch ﬁle_type
% implemented:
% 01=Sinogram, 03=Attenuation Correction, 04=Nonnalization,
% 05=Polar Map, 07=Volume 16, 11=3D Sinogram 16, 13=3D Normalization
% not implemented:
% 00=unknown, 02=Image-16, 06=Volume 8, 08=Projection 8,
% 09=Projection 16, 10=Image 8, l2=3D Sinogram 8, 14=3D Sinogram Fit
case 1
% sinogram
a= {
'data_type',
'num_dimensions',
'num_r_elements',
'num_angles',
'corrections_applied',

1 , 'int 1 6'
1, 'int 1 6'
1 , 'int] 6'
1, 'int] 6'
1, 'int 1 6'
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'num_z_elements',

1, 'intl6'
1, 'int 1 6'
'xyz_resolution',
3, 'ﬂoat32'
'w_resolution',
l, 'ﬂoat32'
6, 'int] 6'
'ﬁll 1 ',
'gate_duration',
1, 'int32'
'r_wave_offset',
l, 'int32'
'num_accepted_beats',
1, 'int32'
'scale_factor',
1, 'ﬂoat32'
1, 'int] 6'
'scan_min',
'scan_max',
1, 'int 1 6'
'prompts',
1, 'int32'
'delayed',
1, 'int32'
'multiples',
1, 'int32'
'net_trues',
1, 'int32'
'cor_singles',
16, 'ﬂoat32'
'uncor_singles',
16, 'ﬂoat32'
'tot_avg_cor',
l, 'ﬂoat32'
'tot_avg_uncor',
1, 'ﬂoat32'
'total_coin_rate',
1, 'int32'
'frame_start_time',
1, 'int32'
'frame_duration',
1, 'int32'
'deadtime_correction_factor',
l, 'ﬂoat32'
'physical_planes',
8, 'intl6'
'ﬁ112',
83, 'int 1 6'
'ﬁll3',
50, 'int] 6' };

'ring_difference',

hds.s = struct( 'ﬁeldname', a(:,1), 'noelements', a(:,2),

'WPC', 30.3) );
hds.header_size = 512;
case 3
% attenuation
a= {
'data_type',
'num_dimensions',
'attenuation_type',
'num_r_elements',
'num_angles',
'num_z_elements',

ring_difference',
x_resolution',
y_resolution',
z_resolution',
w_resolution',
'scale_factor',
'x_offset',
'y_offset',
'x_radius',
'y_radius',
'ti1t_angle',
'attenuation_coeff,
'attenuation_min',

1, 'int 1 6'
1, 'int 1 6'
1, 'int 1 6'
1, 'int 1 6'
1, 'int 1 6'
1, 'int 1 6'
1, 'int 1 6'
1, 'ﬂoat32'
1, 'ﬂoat32'
1, 'ﬂoat32'
1, 'ﬂoat32'
1, 'ﬂoat32'
1, 'ﬂoat32’
1, 'ﬂoat32'
1, 'ﬂoat32'
l, 'ﬂoat32'
1, 'ﬂoat32'
1, 'ﬂoat32'
1, 'ﬂoat32'
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'attenuation_max',
1, 'ﬂoat32'
'skull_thickness',
1, 'ﬂoat32'
'num_additional_atten_coeff',
1 , 'int 1 6'
'additional_atten_coeff‘,
8, 'ﬂoat32'
'edge_ﬁnding_threshold',
1, 'ﬂoat32'
'storage_order',
1 , 'int 1 6'
'span',
1, 'int 1 6'
'z_elements',
64, 'int 1 6'

'ﬁlll',
'ﬁ112',

86, 'intl6'
50, 'intl6' };

hds.s = struct( 'ﬁeldname', a(:,1), 'noelements', a(:,2),

'type', a(1.3));
hds.header_size = 512;
case 4
% 6.5 normalization
a= {
'data_type',
1 , 'int 1 6'
'num_dimensions',
1, 'int 1 6'
'num_r_elements',
1, 'int 1 6'
'num_angles',
1, 'int 1 6'
'num_z_elements',
1, 'int] 6'
'ring_difference',
1 , 'int 1 6'
'scale_factor',
l, 'ﬂoat32'
'nonn_min',
1, 'ﬂoat32'
'nonn_max',
l, 'ﬂoat32'
'fov_source_width',
l, 'ﬂoat32'
'nonn_quality_factor',
1, 'ﬂoat32'
'nonn_quality_factor_code',
1 , 'int 1 6'
'storage_order',
1 , 'intl 6'
'span',
1, 'int 1 6'
'z_elements',
64, 'int] 6'

'ﬁlll',
'ﬁ112',

123, 'intl6'
50, 'intl6' };

hds.s = struct( 'ﬁeldname', a(:,1), 'noelements', a(:,2),

'type', a(:,3) );
hds.header_size = 512;
% polar map
case 5
a= {
'data_type',
'polar_map_type',
'num_rings',
'sectors_per_ring',
'ring_position',
'ring_angle',
'start_angle',
'long_axis_leﬁ',
'long_axis_right',
'position_data',

l , 'int] 6'
1, 'int] 6'
1, 'int 1 6'
32,'int16'
32, 'ﬂoat32'
32, 'int 1 6'
1, 'int 1 6'
3, 'int] 6'
3 , 'int 1 6'
1 , 'int 1 6'
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'image_min',
'image_max',
'scale_factor',
'pixel_size',
'frame_duration',

1, 'int] 6'
1, 'int] 6'
1, 'ﬂoat32'
1, 'ﬂoat32'
1, 'int32'
'frame_start_time',
1, 'int32'
'processing_code',
1, 'int 1 6'
1, 'int 1 6'
'quant_units',
40, 'char'
'annotation',
'gate_duration',
1, 'int32'
'r_wave_offset',
l, 'int32'
'num_accepted_beats',
1, 'int32'
'polar_map_protocol',
20, 'char'
30, 'char'
'database_name',
'ﬁll 1',
27, 'intl6'
'ﬁ112',
27, 'intl6' };

hds.s = struct( 'ﬁeldname', a(:,1), 'noelements', a(:,2),

'type'. a(:,3) );
hds.header_size = 512;
case 7
% image
a= {
'data_type',
'num_dimensions',
'xyz_dimension',
'xyz_offset',

1, 'int] 6'
1, 'int] 6'
3, 'int] 6'
3, 'ﬂoat32'
'recon_zoom',
1, 'ﬂoat32'
'scale_factor',
1, 'ﬂoat32'
'image_min',
1, 'int] 6'
'image_max',
1, 'int 1 6'
'xyz_pixel_size',
3, 'ﬂoat32'
'frame_duration',
1, 'int32'
1, 'int32'
'frame_start_time',
'ﬁlter_code',
1, 'int 1 6'
'xyz_resolution',
3, 'ﬂoat32'
'num_r_elements',
1, 'ﬂoat32'
'num_angles',
1, 'ﬂoat32'
'z_rotation_angle',
l, 'ﬂoat32'
l, 'ﬂoat32'
'decay_corr_fctr',
'processing_code',
1, 'int32'
'gate_duration',
1, 'int32'
'r_wave_offset',
1, 'int32'
1, 'int32'
'num_accepted_beats',
l, 'ﬂoat32'
'ﬁlter_cutoff_frequency',
1, 'ﬂoat32'
'ﬁlter_resolution',
l, 'ﬂoat32'
'ﬁlter_ramp_slope',
'ﬁlter_order',
1, 'int] 6'
1, 'ﬂoat32'
'ﬁlter_scatter_fraction',
1, 'ﬂoat32'
'ﬁlter_scatter_slope',
'annotation',
imt',

40, 'char'

9, 'matl st'
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'rﬁlter_cutoff‘,
'rﬁlter_resolution',
'rﬁlter_code',
'rﬁlter_order',

1, 'ﬂoat32'
1, 'ﬂoat32'
1 , 'int 1 6'
1 , 'int 1 6'

'zﬁlter_cutoff,
'zﬁlter_resolution',

1, 'ﬂoat32'
l, 'ﬂoat32'

'zﬁlter_code',
'zﬁlter_order',
'mt',
'scatter_type',
'recon_type',
'recon_views',
'ﬁll',

1 , 'int] 6'
1 , 'int] 6'
3, 'mat2nd'
1, 'intl 6'
l , 'int] 6'
l , 'int] 6'
136, 'intl 6' };

hds.s = struct( 'ﬁeldname', a(:,1), 'noelements', a(:,2),

'type', a(:,3) );
hds.header_size = 512;
case { 11, 14 }
% 3D sinogram
a= {
'data_type',
'num_dimensions',
'num_r_elements',
'num_angles',
'corrections_applied',

'num_z_elements',
'ring_difference',
'storage_order',
'axial_compression',
'x_resolution',
'v_resolution',
'z_resolution',
'w_resolution',

'ﬁlll',

l , 'int] 6'
1, 'int 1 6'
1, 'int] 6'
1, 'int 1 6'
1, 'int 1 6'

64, 'intl 6'
1, 'int] 6'
1 , 'int] 6'
1, 'int 1 6'
1, 'ﬂoat32'
l, 'ﬂoat32'
1, 'float32'
1, 'float32'

6, 'intl6'

'gate_duration',
1, 'int32'
'r_wave_offset',
1, 'int32'
'num_accepted_beats',
1, 'int32'
'scale_factor',
1, 'ﬂoat32'
'scan_min',
1, 'int] 6'
'scan_max',
1, 'int 1 6'
'prompts',
1, 'int32'
'delayed',
1, 'int32'
'multiples',
l, 'int32'
'net_trues',
1, 'int32'
'tot_avg_cor',
1, 'ﬂoat32'
'tot_avg_uncor',
1, 'ﬂoat32'
'total_coin_rate',
1, 'int32'
'frame_start_time',
1, 'int32'
'frame_duration',
1, 'int32'
'deadtime_correction_factor',
1, 'ﬂoat32'

'ﬁ112',
'ﬁll3',

90, 'int] 6'
50, 'intl6'
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'uncor_singles',

128, 'ﬂoat32' 1;

hds.s = struct( 'ﬁeldname', a(:,1), 'noelements', a(:,2),

'WPC', a(1,3));
hds.header_size = 1024;
case 13
% 3D normalization
a= {
'data_type',
1 , 'int 1 6'
'num_r_elements',
1 , 'int 1 6'
'num_transaxial_crystals',
1 , 'int 1 6'
'num_crystal_rings',
1 , 'int] 6'
'crystals_per_ring',
1, 'intl6'
'num_geo_corr_planes',
1, 'intl6'
'uld',
1, 'int 1 6'
'lld',
1, 'intl6'
'scatter_energy',
1 , 'int 1 6'
'nonn_quality_factor',
1, 'ﬂoat32'
'nonn_quality_factor_code',
1 , 'int 1 6'
'ring_dtcorl ',
32, 'ﬂoat32'
'ring_dtcor2',
32, 'float32'
'crystal_dtcor',
8, 'ﬂoat32'
'span',
1, 'int 1 6'
'max_ring_diff,
1 , 'int 1 6'
'ﬁlll',
48, 'intl6'
'ﬁ112',
50, 'intl6' };
hds.s = struct( 'ﬁeldname', a(:,1), 'noelements', a(:,2),

'type', a(=.3) );
hds.header_size = 512;
otherwise

message = 'lllegal ﬁle type';
end % switch ﬁle_type

hds.ﬁle_system = 'ecat7sh';
case 'ecat6.4'
switch ﬁle_type
% implemented:
% Ol=.scn, 02=.img, O3=.atn, 04=.nrm
case 1 % .scn

a= {

'ﬁlll',
'data_type',

'ﬁ112',
'dimension_l ',
'dimension_2',
'smoothing',

63, 'intl6'
1 , 'int] 6'

2, 'intl6'
1, 'int 1 6'
1, 'int] 6'
1, 'int 1 6'
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'processing_code',

1, 'int] 6'
3, 'intl6'
'sample_distance',
1, 'ﬂoat32'
'ﬁll4',
8, 'int] 6'
'isotope_halflife',
1, 'ﬂoat32'
'frame_duration_sec',
1, 'int] 6'
'gate_duration',
1, 'int32'
'r_wave_offset',
l, 'int32'
1, 'int] 6'
'ﬁllS',
1, 'ﬂoat32'
'scale_factor',
'ﬁll6',
3, 'int] 6'
'scan_min',
1, 'int] 6'
1, 'int] 6'
'scan_max',
'prompts',
l, 'int32'
'delayed',
1, 'int32'
'multiples',
1, 'int32'
'net_trues',
1, 'int32'
'ﬁll7',
52, 'intl6'
'cor_singles',
16, 'ﬂoat32'
16, 'ﬂoat32'
'uncor_singles',
'tot_avg_cor',
1, 'ﬂoat32'
'tot_avg_uncor',
1, 'ﬂoat32'
'total_coin_rate',
1, 'int32'
'frame_start_time',
1, 'int32'
'frame_duration',
1, 'int32'
'loss_correction_fctr'
1, 'ﬂoat32'

'ﬁ113',

'ﬁ118',

22,'int16' };

hds.s = struct( 'ﬁeldname', a(:,1), 'noelements', a(:,2),

'type', a(1.3));
hds.header_size = 512;
case 2 % .img
8= {

'ﬁlll',
'data_type',
'num_dimensions',

'ﬁ112',
'dimension_l ',
'dimension_2',

'ﬁll3',
'x_origin',
'y_origin',
recon_scale',
quant_scale',
image_min',
image_max',

'ﬁll4',
'pixel_size',
'slice_width',
'frame_duration',
'frame_start_time',

63, 'intl6'
1, 'int] 6'
1, 'intl 6'
l, 'intl6'
1, 'intl6'
1, 'int 1 6'
12, 'intl6'
1, 'ﬂoat32'
1, 'float32'
1, 'ﬂoat32'
1, 'ﬂoat32'
1, 'int 1 6'
1, 'int] 6'
2, 'intl6'
1, 'ﬂoat32'
1, 'ﬂoat32'
1, 'int32'
l, 'int32'
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'slice_location',

1, 'int 1 6'
1, 'int 1 6'
1, 'int 1 6'
1, 'int 1 6'
1, 'int32'
12, 'intl6'
'ﬁ115',
1, 'int] 6'
'ﬁlter_code',
1, 'int32'
'scan_matrix_num',
l, 'int32'
'norm_matrix_num',
1, 'int32'
'atten_cor_mat_num',
23, 'intl6'
'ﬁll6',
1, 'ﬂoat32'
'image_rotation',
1, 'ﬂoat32'
'plane_eff_corr_fctr',
1, 'ﬂoat32'
'decay_corr_fctr',
'loss_corr_fctr',
1, 'ﬂoat32'
32, 'intl6'
'ﬁll7',
'processing_code',
1, 'int 1 6'
1, 'int 1 6'
'ﬁll8',
'quant_units',
1, 'int 1 6'
'recon_start_day',
1, 'int 1 6'
'recon_start_month',
1, 'int 1 6'
'recon_start_year',
1, 'int] 6'
1, 'ﬂoat32'
'ecat_calibration_fctr',
'we11_counter_cal_fctr',
l, 'ﬂoat32'
'ﬁlter_params',
6, 'ﬂoat32'
40, 'char'
'annotation',
'ﬁll9',
26, 'intl6' };

'recon_start_hour',
'recon_start_min',
'recon_start_sec',
'recon_duration',

hds.s = struct( 'ﬁeldname', a(:,1), 'noelements', a(:,2),

'type', a(:,3) );
hds.header_size = 512;
case 3 % .atn

a= {

'ﬁlll',
'data_type',
'attenuation_type',

'ﬁ112',
'dimension_l ',
'dimension_2',

'ﬁll3',
'scale_factor',
'x_origin',
'y_origin',
'x_radius',
'y_radius',
'tilt__angle',

'attenuation_coeff',
'sample_distance',

'ﬁll4',

63, 'int] 6'
1, 'int 1 6'
1, 'int 1 6'
1, 'int] 6'
1, 'int] 6'
1, 'int 1 6'
23, 'intl6'
1, 'ﬂoat32'
1, 'ﬂoat32'
1, 'ﬂoat32'
1, 'ﬂoat32'
1, 'ﬂoat32'
1, 'ﬂoat32'
1, 'ﬂoat32'
1, 'ﬂoat32'
149, 'intl6' };

hds.s = struct( 'ﬁeldname', a(:,1), 'noelements', a(:,2),
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'type', a(:,3) );
hds.header_size = 512;
case 4 % .nrm

a= {

'ﬁlll',

63, 'intl6'

'data_type',

'ﬁ112',

l , 'int 1 6'

2, 'intl6'

'dimension_l ',
'dimension_2',

1, 'int 1 6'
1, 'int 1 6'

'ﬁll3',

23, 'intl6'

'scale_factor',
'norm_hour',
'norm_minute',
'norm_second',
'norm_day',
'norm_month',
'norm_year',
'fov_source_width',
'ﬁll4',

l, 'ﬂoat32'
l , 'int 1 6'
1, 'int 1 6'
1 , 'int 1 6'
1 , 'int 1 6'
1 , 'int 1 6'
1, 'intl6'
1, 'ﬂoat32'
155, 'intl6' };

hds.s = struct( 'ﬁeldname', a(:,1), 'noelements', a(:,2),

'Wpe'. a(=.3) );
hds.header_size = 512;
otherwise

message = 'lllegal ﬁle type';
end % switch ﬁle_type

hds.ﬁle_system = 'ecat6.4sh';
otherwise
message = 'lllegal ﬁle system';
end % switch ﬁle_system
function [ datadescr, message ] = getdatadescr( ﬁle_system, ﬁle_type, data_type );
datadescr = ﬂ;
message = ";
switch ﬁle_system
case 'ecat6.4'

switch ﬁle_type
case { 1, 2, 3,4}
% 1 = .scn, 2 = .img, 3 = .atn, 4 = .nrm
switch data_type
case 2 % VAX_Ix2
datadescrftype = 'intl6';
datadescrsize = 2;
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case 4 % vax ﬂoat
datadescrftype = 'ﬂoat32';
datadescrsize = 4;
case 5 % ieee ﬂoat
datadescrftype = 'ﬂoat32';
datadescrsize = 4;
otherwise
message = 'Data type not implemented';
end
otherwise
message = 'File type not implemented';
end %switch ﬁ1e_type
case 'ecat7'

% implemented:
% 01=Sinogram, 03=Attenuation Correction, 04=Nonnalization,
% 05=Polar Map, 07=Volume 16, 11=3D Sinogram l6, 13=3D Normalization
% not implemented:
% 00=unknown, 02=Image-16, 06=Volume 8, 08=Projection 8,
% 09=Projection 16, 10=lmage 8, l2=3D Sinogram 8, 14=3D Sinogram Fit

switch ﬁle_type

.

case { 11, 14 }
switch data_type
case 1 % byte
datadescrﬁype = 'int8';
datadescrsize = 1;
case { 2, 6 } % Sun short, sun_in
datadescrftype = 'intl6';
datadescrsize = 2;
case 5 % ieee ﬂoat
datadescrﬁype = 'ﬂoat32';
datadescrsize = 4;
otherwise
message = 'Data type not implemented';
end
case 13
switch data_type
case 1 % ieee-ﬂoat
datadescrﬁype = 'ﬂoat32';
datadescrsize = 4;
case 5 % sun-ﬂoat
datadescrﬁype = 'ﬂoat32';
datadescrsize = 4;
otherwise
message = 'Data type not implemented';
end
case { 1, 3,4, 5, 7}
% (0=Unkonwn Matrix Data Type, 1=Byte Data, 2=VAX_Ix2, 3=VAX_Ix4,
% 4=VAX_Rx4, 5=lEEE Float, 6=Sun short, 7=Sun long)
% DTYPE_BYTES, _I2, _14, _VAXR4, _SUNFL, _SUNIN

switch data_type
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case 1 % byte
datadescrftype = 'int8';
datadescrsize = 1;
case 6 % Sun short
datadescrﬁype = 'int 1 6';
datadescrsize = 2;
case 5 % ieee ﬂoat
datadescrftype = 'ﬂoat32';
datadescrsize = 4;
otherwise
message = 'Data type not implemented';
end
otherwise
error( 'File type not implemented' );
end %switch ﬁle_type

otherwise
message = 'File system not implemented';
end % switch ﬁle_system
%
function [ hd, offsetfromheader, writeﬁll, numdatablocks, message ] =
set_xyz_dimension( hd, datadescr, xyz_dimension, selsegment );
% implemented:
% 01=Sinogram, 03=Attenuation Correction, 04=Nonnalization,
% 05=Polar Map, 07=Volume 16, 11=3D Sinogram l6, 13=3D Normalization
message = ";
offsetfromheader = 0;
writeﬁll = 0;
numdatablocks = 0;
switch hd.mh.ﬁle_system
case 'ecat6.4'
switch hd.mh.ﬁle_type
case { 01, 02, 03, 04 } % .scn, .img, .atn, .nrm
hd.sh.dimension_l = xyz_dimension( 1 );
hd.sh.dimension_2 = xyz_dimension( 2 );
numdatablocks = ﬂoor(
( prod( xyz_dimension ) * datadescrsize + 511 )/ 512 );
writeﬁll = ( 511 - rem( prod( xyz_dimension ) * datadescrsize + 511, 512 ) );

otherwise
message = 'Writing of the ﬁle type not implemented';

hd = [1;
end
case 'ecat7'
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switch hd.mh.ﬁle_type
case 07 % Volume 16
hd.sh.xyz_dimension = xyz_dimension;
numdatablocks = ﬂoor(
( prod( xyz_dimension ) * datadescrsize + 511 )/ 512 );
writeﬁll = ( 511 - rem( prod( xyz_dimension ) * datadescrsize + 511, 512 ) );
case { 11, 14 } % 3D Sinogram 16, FORE sinogram ﬂoat
if hd.sh.storage_order ==
hd.sh.num_r_elements = xyz_dimension( l );
hd.sh.num_z_elements( selsegment ) = xyz_dimension( 2 );
hd.sh.num_angles = xyz_dimension( 3 );
else
hd.sh.num_r_elements = xyz_dimension( 1 );
hd.sh.num_angles = xyz_dimension( 2 );
hd.sh.num_z_elements( selsegment ) = xyz_dimension( 3 );
end
nobytes = hd.sh.num_r_elements * hd.sh.num_angles * datadescrsize *
hd.sh.num_z_elements;
% numdatablocksarr = ﬂoor( ( nobytes + 511 )/ 512 );
% offsetfromheader = sum( numdatablocksarr( l:selsegment-l )) * 512;
offsetfromheader = sum( nobytes( l:selsegment-l ) );
% numdatablocks = sum( numdatablocksarr );
numdatablocks = ﬂoor( ( sum( nobytes ) + 511 )/ 512 );

if sum( hd.sh.num_z_elements( selsegment + 1 : end ) ) ==
writeﬁll = ( 51 1 - rem( prod( xyz_dimension ) * datadescr.size + offsetfromheader + 511, 512 ) );
else
writeﬁll = 0;
end
case 3 % Attenuation
if hd.sh.storage_order ==
hd.sh.num_r_elements = xyz_dimension( 1 );
hd.sh.z_elements( selsegment ) = xyz_dimension( 2 );
hd.sh.num_angles = xyz_dimension( 3 );
else
hd.sh.num_r_elements = xyz_dimension( 1 );
hd.sh.num_angles = xyz_dimension( 2 );
hd.sh.z_elements( selsegment ) = xyz_dimension( 3 );

end
if selsegment == 1
hd.sh.num_z_elements = hd.sh.z_elements( 1 );
end
nobytes = hd.sh.num_r_elements * hd.sh.num_angles * datadescrsize *
hd.sh.z_elements;
% numdatablocksarr = ﬂoor( ( nobytes + 51 1 )/ 512 );
% offsetfromheader = sum( numdatablocksarr( l:selsegment-l ) ) * 512;
offsetfromheader = sum( nobytes( l:selsegment-l ) );
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% numdatablocks = sum( numdatablocksarr );
numdatablocks = ﬂoor( ( sum( nobytes ) + 511 )/ 512 );
if sum( hd.sh.num_z_elements( selsegment + 1 : end ) ==
writeﬁll = ( 511 - rem( prod( xyz_dimension ) * datadescrsize + offsetfromheader + 511, 512 ) );
else
writeﬁll = 0;
end

otherwise
message = 'Writing of the ﬁle type not implemented';

hd = [1;
end

otherwise
message = 'File system not implemented';

hd = [1;
end % switch hd.mh.ﬁle_system
%
function [ xyz_dimension, offsetfromheader, message ] = get_xyz_dimension( hd, datadescr, selsegment)
% implemented:
% 01=Sinogram, 03=Attenuation Correction, 04=Nonnalization,
% 05=Polar Map, 07=Volume l6, 1 1=3D Sinogram l6, 13=3D Normalization
message = ";
xyz_dimension = U;
offsetfromheader = 0;
switch hd.mh.ﬁle_system
case 'ecat7'

switch hd.mh.ﬁle_type
case 07 % Volume 16
xyz_dimension = hd.sh.xyz_dimension;
case { 11, 14 } % 3D Sinogram 16, FORE sinogram ﬂoat
if hd.sh.storage_order ==
xyz_dimension = [ hd.sh.num_r_elements,
hd.sh.num_z_elements( selsegment ), hd.sh.num_angles ];
else
xyz_dimension = [ hd.sh.num_r_elements, hd.sh.num_angles,
hd.sh.num_z_elements( selsegment ) ];
end
nobytes = hd.sh.num_r_elements * hd.sh.num_angles * datadescrsize *
hd.sh.num_z_elements;
% numdatablocksarr = ﬂoor( ( nobytes + 511 )/ 512 );
% offsetfromheader = sum( numdatablocksarr( l:selsegment-l )) * 512;
offsetfromheader = sum( nobytes( l:selsegment-l ) );
case 3 % Attenuation
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if hd.sh.storage_order ==
xyz_dimension = [ hd.sh.num_r_elements,
hd.sh.z_elements( selsegment ), hd.sh.num_angles ];
else
xyz_dimension = [ hd.sh.num_r_elements, hd.sh.num_angles,
hd.sh.z_elements( selsegment ) ];

end
nobytes = hd.sh.num_r_elements * hd.sh.num_angles * datadescrsize *
hd.sh.z_elements;
% numdatablocksarr = ﬂoor( ( nobytes + 511 )/ 512 );
% offsetfromheader = sum( numdatablocksarr( l:selsegment-l ) ) * 512;
offsetfromheader = sum( nobytes( l:selsegment-l ) );

otherwise
message = 'Reading of the ﬁle type not implemented';
end
case 'ecat6.4'
switch hd.mh.ﬁle_type
case { 01, 02, 03, 04 } % .scn, .img, .atn, .nrm

xyz_dimension = [ hd.sh.dimension_l, hd.sh.dimension_2, 1 ];
otherwise
message = 'Reading of the ﬁle type not implemented';
end

otherwise
message = 'File system not implemented';
end % switch hd.mh.ﬁle_system
%
function n = ﬁrstno( sel )
n = [ ﬁnd( sel(:) ); 0 ];

n = n( 1 );
%
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G: MR12RAW.M : CONVERTS MRI IMAGES INTO RAW FORMAT SUITABLE
FOR SERA

close all; clear all;

%

MR12RAW.m

%

Code to Read MRI image & Convert to 8 bit RAW format image for BNCT

sprintf('%s', '********************************')

sprintf('%s', 'This is written by Mohammad K. Khan')
sprintf('%s', '
Copyright February, 1999 ')
sprintf('%s', "1‘******************************')

clear all
nn='MRl2RAW.in';
nn=input('Please enter the name of input ﬁle(MR12RAW.in) ?', 's' ;
inputﬁd = fopen(nn, 'r');
%CHECK for the existence of ﬁle in the current directory
while (inputﬁd = -l)
sprintf('Attempt to ﬁnd MR12RAW.in in the current directory failed... Please try
again')
nn=input(' \n Enter the path to input (MR12RAW.in) ﬁle ? \n', 's');
inputﬁd = fopen(nn, 'r');
end
hh = 0; %this is a counter that will count how many image ﬁles to read
% and get pixel size
% Read the contour ﬁle names from the input ﬁle
global pixelsize plotsize FigureSelect lNELfactor
n=fgetl(inputﬁd);
nt=fgetl(inputﬁd);
nt=fgetl(inputﬁd);
nt =fgetl(inputﬁd);
nt =fgetl(inputﬁd);
nt = fgetl(inputﬁd);
D = pwd;
nt=deblank(nt);
cd(nt);

while(feof(inputﬁd) ~= l)
hh= hh+1;
n1=fgetl(inputﬁd);
if n1 = -1,
break;
end
nt=deblank(nl); % Gets the image ﬁle names from the input ﬁle
imageﬁles(hh) = {nt}; %narnes of all the mri/pet image ﬁles
imageﬁd=fopen(nt, 'r');
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%sprintf('Working on %s ﬁle... Please be patient! ..', nt)
while (imageﬁd = -1)
sprintf('Attempt to ﬁnd %s failed... Please try again', nt)
nt=input(' \n please enter the path to that ﬁle ? \n', 's');
irnageﬁd = fopen(nt, 'r');
end

say = fread(imageﬁd, 'int] 6');
k=0;
for i = 1:256,
for j = 1:256,
k=k+l;
A(i,j) = say(3952+k); % Header Lines NOT NEEDED
end
end
imagematrix(:,l+(hh-l)*256:256*hh)=A;
fclose(irnageﬁd);
end

cd(D);
grayimages= ind2gray(imagematrix, gray(256));
if min(min(imagematrix)') <0;
grayimages = ind2gray(imagematrix/2, gray(256));
end
ﬁgure(l)
montage(grayimages, [256 256 hh]);
sprintf('lmage planes are number l..2..3..4 .. etc right to left and into next row')
number = input('please select an image plane to convert from MRI to EMF 8 BIT ? ');
IM = grayimages(:, 1+(number-l)*256:256*number);
1M = ﬂipud(IM);
nt = imageﬁles(nLunber);
nt2 = strcat(nt, '.img');
nt = strcat(nt, '.bmp');
output = fopen(char(nt2), 'wb');
imwrite(lM*255, gray(255), char(nt), 'bmp');
fwrite(output, 1M'*255, 'int8'); % Convert to Raw 8 bit image

ﬁgure(2);
imshow(lM);

cd(D);
multiple= input('Would you like to convert other images Planes (n/y)?','s');
while(multiple = 'y' | 'Y')
number = input('\n please select an image plane to convert from RAW to Bitmap ? ');
[M = grayimages(:, l+(number-1)*256:256*number);
1M = ﬂipud(IM);
nt = imageﬁles(number);
nt2 = strcat(nt, '.img');

nt = strcat(nt, '.bmp');
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output = fopen(char(nt2), 'wb');
imwrite(lM*255, gray(255), char(nt), 'bmp');
fwrite(output, 1M'*255, 'int8'); % Convert to Raw 8 bit image
ﬁgure(2);
imshow(IM);

cd(D);
multiple= input('\n Would you like to continue converting other images Planes (n/y)?','s')
if ((multiple = 'n') | (multiple = rN'))
break;
end
end
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H: INPUT FILE FOR MRI2RAW.M

MRICONVERT.in (R_in.m)
THIS IS AN INPUT FILE TO MR12RAW.m: A code to read raw 8 bit
raw MRI/PET images
and convert a selected image into a raw format.
HERE IS A LIST OF PET/MRI IMAGES THAT I WOULD TO SEE:

/ne5/bnct/Godwin/MRI/10_15_97/
E5039S3Il.MR
E503983I2.MR

E5039SBI3.MR
E5039S3I4.MR

E5039S315.MR
E503983I6.MR
E503983I7.MR
E5039S318.MR
E503983I9.MR
E5039S3IlO.MR
E5039S3I11.MR
E5039S3I12.MR
E5039S3I13.MR
E5039S3I14.MR
E5039S3115.MR
E5039S3Il6.MR
E5039S3Il7.MR
E5039S3118.MR
E5039S3Il9.MR
E503983120.MR
E5039S3I21.MR
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I: READ_REGISTRATION.M

% program to Read Registered PET/MR1 Images and to write out individual MRI Image Planes for SERA
close all; clear all;
%Phdr = 'rBates_c0_2e1_de7.hdr';
Phdr = input('Enter Name of registered PET header (.hdr) ﬁle in Analyze format ? ', 's'),

%Mhdr = 'T1_FLAlR2.hdr';
Mhdr = input('Enter Name of registered MR1 header (.hdr) ﬁle in Analyze Format ? ', 's');
Pirng = strcat(Phdr(l :size(Phdr,2)-3), 'img');
Mimg = strcat(Mhdr(1:size(Mhdr,2)-3), 'img');

PFID = fopen(Pimg, 'r');
MFID = fopen(Mimg, 'r');

path(path, '/ne1/mkhan/registration/SPM_99/spm99');
[DlM,VOX,SCALE,TYPE,OFFSET,ORIGlN,DESCRlP ] = spm_hread(Phdr);
[MD1M, MVOX, MSCALE, MTYPE, MOFFSET, MORIGIN, MDESCRIP ] = spm_hread(Mhdr);
P=zeros(DIM);
M=zeros(MDlM);

type = spm_typetrYPE);
Mtype = spm_typetMTYPE);
for i = l:DlM(3),
ﬁgure(i);
subplot(2,], 1)
A=fread(PFlD, [DIM(l) DIM(2)], type);
P(1:256, 1:256, i) = A;
minA = min(min(A)); maxA = max(max(A));
imshow((A-minA)/(maxA-minA));
subplot(2, 1 ,2)
MA = fread(MFID, [MDIM(1) MD1M(2)], Mtype);
M(1:256, 1:256, i) = MA;
minMA = min(min(MA)); maxMA = max(max(MA));
imshow((MA-minMA)/(maxMA-minMA));hold on;
contour((A));

Mimgout = strcat(Mimg, num25tr(i));
FID = fopen(Mimgout, 'w');
fwrite(FlD, MA, 'uint8');
fclose(FlD);
end
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J: ECATZSERA.M
%program to Convert ECAT 6.4 or 7.0 DATA into SERA Compatible Data
%lt Strips out the last frame of study and all of the planes of the study
%Written by Mohammad Khurram Khan (c) copyright 2002
clear all; close all; fclose('all'); clear; pack;fclose('all');
ﬁlename= '/ne5/bnct/bnct2/BNCT_RAW_DATA/PET/Rose/Oct98/Rose_c7_796_de5 .v';
%ﬁlename = '/neS/bnct/bnct2/BNCT_RAW_DATA/PET/Gaddis/Nov95/gadl 1 le 1d.img';
%ﬁlename= 'E:\BNCT_RAW_DATA\Gaddis\Pet\Nov95\gad1 l 10j 1d.img';
%ﬁlename=input('Enter Location and ECAT 6.4 Image Flle Name (E:\BNCT_RAW_DATA\Gaddis\..) ? ',

'S');
Image_format = input('enter l for ECAT6.4 data and 2 for ECAT7.0 data format ? ');
if Image_format ==
ﬁle_system = 'ecat6.4' ;
fpname = ﬁlename;
[ﬁd, message] = ecatﬁle('open', ﬁlename, ﬁ1e_system);
[ mh, message ]
= ecatﬁle( 'mh', ﬁd );
selmatrix= [2 47 l 0 0]; %frame number num_planes
[ vol, hd, message ] = ecatﬁle( 'read', ﬁd, selmatrix );
l=zeros(hd.mh.num_planes, 128, 128);

Psera = zeros(256,256);
for i = 1:mh.num_planes,
selmatrix= [hd.mh.num_frames i l 0 0] %frame number & plane number
[ vol, hd, message] = ecatﬁle( 'read', ﬁd, selmatrix );
l(i,12128,1:128)= vol(l:128, 1:128);
say = double(vol);
Pimgout = strcat(‘Plane', num2str(i), '.img');
FID = fopen(Pimgout, 'w');
Psera = imresize(say, [256 256], 'bilinear');
Psera = int16(Psera);
fwrite(FlD, Psera, 'intl6');
fclose(FID);
end

elseif Image_format ==
ﬁle_system = 'ecat7';
fpname = ﬁlename;
[ ﬁd, message ]
= ecatﬁle( 'open', ﬁlename, 'ecat7' );
[mh, message ]
= ecatﬁle( 'mh', ﬁd );
selmatrix= [1 1 1 0 0]; %frame number num_planes
[ vol, hd, message ] = ecatﬁle( 'read', ﬁd, selmatrix );
[ matranges, message ] = ecatﬁle( 'matranges', ﬁd );
I=zeros(mh.num_frames, 128, 128, hd.mh.num_planes);
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selmatrix=[mh.num_frames 1 l 0 0];
[vol, hd, message]=ecatﬁle('read', ﬁd, selmatrix);
for i = 1:hd.mh.num_planes,
leage = squeeze(vol(:, :, i));
say = double(PImage);
Pimgout = strcat(‘Plane', num2str(i), '.img');
FID = fopen(Pimgout, 'w');
Psera = imresize(say, [256 256], 'bilinear');
Psera = int16(Psera);
fwrite(FlD, Psera, 'intl6');
fclose(FlD);
end

else
fprintf(' Could Not Recognize File Data');
end
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K: EXAMPLE OF SERACALC INPUT FILE

VG
2000
1000
4.1100000E+00
1.8750000E+01

1.000000E-02
-2.7300000E+00
-6.5000000E+01

9.7500000E+00
-1.4500000E+02

/ne1/mkhan/BNCT/Sera/ST/Results/cg.geom
/ne1/mkhan/registration/SPM_99/GaddisNG.uv

3O
3
32
72
94
-1.50000000E+01 -1.50000000E+01
1 .00000000E+00
0
none

-l .50000000E+01

/ne1/mkhan/registration/SPM_99/GaddisNGsera.rst
/ne1/mkhan/BNCT/Sera/ST/Results/BS.source

1
0
NFGD
27_Nov_2001
$SERA_HOME/Resources/SeraMC/seraMC.mat
$SERA_HOME/Resources/SeraMC/seraMC.sigma
521 508 513 512 505 0 0 6.0143E-08 6.3150E-02 7.9110E-04 7.2700E-03 2.6800E-02 0.0000E+00
0.0000E+00
run_seraMC
iop
3 APERTURE BUFFER
0.50
edit_dir
#patient VG UTMCK T1 MRI
#date May_9_l975
#beam BMRR_12_CM
mw_min 1.0
b10_blood 1.0
refvol 1.0 0
ref_reg brain tumor target
ottocon 40 40 scalp tumor target brain
delta 0.25
eps 0.05
#Dose-Volume Histogram for Brain

in_reg brain target
b10_blood 13

rbe 1.3 1.0 3.2 3.21.010
DVbs

#Dose-Volume Histogram for tumor
in_reg tumor target

b10_blood 45.5
rbe1.31.0 3.2 3.21.010
DVbs
#Dose-Volume Histogram for Scalp
in_reg scalp

b10_blood 19
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rbe1.31.0 3.2 3.21.010
DVbs
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L: EULER_TRANSFORM8.M PROGRAM TO IMPLEMENT RIGID BODY
TRANSFORMATION/TRANSLATION

% This is a Non Linear Optimisation Code to Carry out Coordinate Transformation and Translation
% And to Find the angles of transformation. This code is developed by
% Mohammad Khurram Khan. Copy Righted 2000.

% LAST UPDATE 3/3/2000
% This Code is Extremely Robust
% Generation of Synthetic Data %
x = rand(1, 10);
y = rand(1, 10);
z = rand(1, 10);

originalpoints = [x; y; z];
X = originalpoints;
t = .2*pi; % I theta (pitc)
p = .25*pi; % phi (Yaw)
s = .3*pi; % psy (Roll)
T = [40 20 50];
T = [T( l ,l)*ones(1,size(x,2)); T(1 ,2)*ones( l ,size(y,2)); T(1,3)*ones(l,size(z,2))];;
R = [(cos(p)*cos(t)*cos(s)-sin(p)*sin(s)) (-cos(p)*cos(t)*sin(s)—sin(p)*cos(s)) cos(p)*sin(t),
(sin(p)*cos(t)*cos(s)+cos(p)*sin(s)) (-sin(p)*cos(t)*sin(s)+cos(p)*cos(s)) sin(p)*sin(t),

-sin(t)*cos(s)

sin(t)*sin(s)

cos(t) 1;

Y = R*X+T;
x0=[000];
r0=[000];
XG = [x0, r0];
% NONLINEAR UNCOSTRAINED (DIFFERENT FUNCTION) (THIS WORKS ALSO)
options=optimset('LargeScale', 'off, 'Diagnostics', 'on', 'Displa ', 'iter', 'LevenbergMarquardt', 'on');
%[X1, fval, exitﬂag, output]= fminunc('objﬁ1n8', XG, options, X, Y)

lb = [-pi -pi -pi -256 -256 -256];
ub = [pi pi pi 256 256 256 ];
[X], fval, exitﬂag, output]= fmincon('objﬁm8', XG, [],[],[],[],lb, ub, [], options, X, Y)

T0 = [X1(4:6)]; %By Now I pretty much have my Translation Vector Nailed and will use the
% and Use it again as input for the next iteration
% For Robustness, I feed X1 Results back into frnincon Just for a second iteration
XG = [XG, TO];
[X], fval, exitﬂag, output]= ﬁnincon('objfun8', XG, [],[],[],[],lb, ub, [], options, X, Y)
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%

*********************

OPTlMlSATlON

and

TRANSFORMATION

FINISHED

************************************

%
******************************************************************************************
*********

% Re GENERATION OF NEWPOINTS AFTER THE THREE ANGLES ARE FOUND
t1 = X1(1);

P1: X1(2);
sl= X1(3);
Xt = X1(4);
Yt = X1(5);
Zt = X1(6);
T = [Xt Yt Zt];
T = [T(1,1 )*ones(] ,size(x,2)); T(1,2)*ones(l ,size(y,2)); T(1 ,3)*ones( 1 ,size(z,2))];;

% FINAL MATRIX ROTATION MATRIX
R1
=
[(cos(p1)*cos(tl)*cos(sl)-sin(pl)*sin(sl))
(-cos(p1)*cos(tl)*sin(sl)-sin(pl)*cos(sl))
c0s(p1)*sin(t1),
(sin(pl)*cos(tl)*cos(s])+cos(p1)*sin(sl)) (-sin(pl)*cos(tl)*sin(sl)+cos(p1)*cos(sl)) sin(p1)*sin(t1),
-sin(tl )*cos(sl)
sin(tl)*sin(sl)
cos(tl) ];

% TO GET TO ORIGINAL UNTRANSFORMED POINTS: points = R1'*Y
% TO GET TO TRANSFORMED POINTS :
points = R1*X
points = (R1)'*(Y-T);
error = (points - originalpoints)./(originalpoints)* 100;
function F = objﬁrn7(XG, X, Y)
t1 = XG(1);

P1: XG(2);
sl= XG(3);
Xt= XG(4);
Yt = XG(5);
Zt = XG(6);
T = [Xt Yt Zt];
T = [T(l,1)*ones(1,size(X,2)); T(1 ,2)*ones(1,size(X,2)); T(1 ,3)*ones(1 ,size(X,2))];

% Guess Matrix

R1
=
[(cos(p1)*cos(tl )*cos(sl)-sin(p1)*sin(sl))
(-cos(pl)*cos(t1)*sin(sl)—sin(p1)*cos(sl))
cos(p1)*sin(t1 ),
(sin(p1)*cos(t1 )*cos(s] )+cos(p1)*sin(sl )) (-sin(p1)*cos(t1)*sin(sl)+cos(p1 )*cos(s 1 )) sin(p1)*sin(t1),
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-sin(t1)*cos(s l)

sin(tl )*sin(sl)

00501) l;

% Objective Function
T_pnts = R1'*(Y-T);

% To take new points back into original axis (X)

F = 0;

for k = 1:size(Y,l),
for i = 1:size(Y,2)
F = (T_pnts(k,i) - X(k,i) )"2 +F;
end
end

F;
Results:
>> originalpoints'

ans =

0.4514

0.6085

0.0841

0.0439

0.0158

0.4544

0.0272

0.0164

0.4418

0.3127

0.1901

0.3533

0.0129

0.5869

0.1536

0.3840

0.0576

0.6756

0.6831

0.3676

0.6992

0.0928

0.6315

0.7275

0.0353

0.7176

0.4784

0.6124

0.6927

0.5548

Transformation/Translation Vector
[.2*pi .25*pi .3*pi 40 20 50];
[.6283 .7854 .9425 40 20 50];

Constrained Optimisation Results:
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X1=

0.6283

0.7853

0.9426 40.0000 20.0000 50.0000

Points' Determined based on initial guess of

WOOOOW:

points‘

ans =

0.4514

0.6085

0.0841

0.0439

0.0158

0.4544

0.0271

0.0164

0.4418

0.3126

0.1901

0.3533

0.0128

0.5869

0.1536

0.3839

0.0576

0.6757

0.6831

0.3676

0.6992

0.0928

0.6315

0.7275

0.0353

0.7176

0.4784

0.6124

0.6927

0.5549

-0.0090

0.0003

0.0194

-0.0921

0.0117

0.0036

-0.1487

0.0113

0.0037

-0.0129

0.0010

0.0046

-0.3142

0.0003

0.0106

-0.0105

0.0032

0.0024

-0.0059

0.0005

0.0023

% error'

ans =
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-0.0435

0.0003

0.0022

-0.1144

0.0003

0.0034

-0.0066

0.0003

0.0029
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M: MR12RAW.M

close all; clear all;

%

MR12RAW.m

%

Code to Read MR] image & Convert to 8 bit RAW format image for BNCT

sprintf('%s', '********************************')

sprintf('%s', 'This is written by Mohammad K. Khan')
sprintf('%s',‘
Copyright February, 1999 ')
sprintf('%s', '*******************************1)

clear all
nn='MR12RAW.in';
nn=input('Please enter the name of input ﬁle(MR12RAW.in) ?', 's');
inputﬁd = fopen(nn, 'r');
%CHECK for the existence of ﬁle in the current directory
while (inputﬁd = -1)
sprintf('Attempt to ﬁnd MR12RAW.in in the current directory failed... Please try
again')
nn=input(' \n Enter the path to input (MR12RAW.in) ﬁle ? \n', 's');
inputﬁd = fopen(nn, 'r');
end
hh = 0; %this is a counter that will count how many image ﬁles to read
% and get pixel size
% Read the contour ﬁle names from the input ﬁle
global pixelsize plotsize FigureSelect INELfactor
n=fgetl(inputﬁd);
nt=fgetl(inputﬁd);
nt=fgetl(inputﬁd);
nt =fgetl(inputﬁd);
nt =fgetl(inputﬁd);
nt = fgetl(inputﬁd);
D = pwd;
nt=deblank(nt);
cd(nt);

while(feof(inputﬁd) ~= 1)
hh= hh+1;
n 1 =fgetl(inputﬁd);
if n1 = -1,
break;
end

nt=deblank(nl); % Gets the image ﬁle names from the input ﬁle
imageﬁles(hh) = {nt}; %names of all the mri/pet image ﬁles
imageﬁd=fopen(nt, 'r');
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%sprinthWorking on %s ﬁle... Please be patient! ..', nt)
while (imageﬁd = -l)
sprintf('Attempt to ﬁnd %s failed... Please try again', nt)
nt=input(' \n please enter the path to that ﬁle ? \n', 's');
imageﬁd = fopen(nt, 'r' ;
end
say = fread(imageﬁd, 'intl6');
k=0;
for i = 1:256,
for j = 1:256,
k=k+1;
A(i,j) = say(3952+k); % Header Lines NOT NEEDED
end
end
imagematrix(:,1+(hh-1)*256:256*hh)=A;
fclose(imageﬁd);
end

cd(D);
grayimages= ind2gray(imagematrix, gray(256));
if min(min(imagematrix)') <0;
grayimages = ind2gray(imagematrix/2, gray(256));
end
ﬁgure(l)
montage(grayimages, [256 256 hh]);
sprintf('lmage planes are number I..2..3..4 .. etc right to left and into next row')
number = input('please select an image plane to convert from MRI to BMP 8 BIT ? ');
[M = grayimages(:, 1+(number-1)*256:256*number);
[M = ﬂipud(IM);
nt = imageﬁles(number);
nt2 = strcat(nt, '.img');
nt = strcat(nt, '.bmp');
output = fopen(char(nt2), 'wb');
imwrite(lM*255, gray(255), char(nt), 'bmp');
fwrite(output, 1M'*255, 'int8'); % Convert to Raw 8 bit image

ﬁgure(2);
imshow(lM);

cd(D);
multiple= input('Would you like to convert other images Planes (n/y)?','s');
while(multiple = 'y' | 'Y')
number = input('\n please select an image plane to convert from RAW to Bitmap ? ');
IM = grayimages(:, 1+(number-1)*256:256*number);
[M = ﬂipud(IM);
nt = imageﬁles(number);
nt2 = strcat(nt, '.img');
nt = strcat(nt, '.bmp');
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output = fopen(char(ntZ), 'wb');
imwrite(lM*255, gray(255), char(nt), 'bmp');
fwrite(output, 1M'*255, 'int8'); % Convert to Raw 8 bit image
ﬁgure(2);
imshow(IM);

cd(D); .
multiple= input('\n Would you like to continue converting other images Planes (n/y)?','s')
if ((multiple = 'n') | (multiple = 'N'))
break;
end

end
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N: PET2MRI.M

%Program to read registered PET/MRI Images and to Work with SERA Output
%To Post Process the Dose based on BNL Methodology and Dose Based on boron
%biodistribution as determined from a 18F-BPA PET Image
clear all; close all;
INELfactor=[45.5 13 19]; %BNL Scaling Factor for Dose
[FID, FIDl, FID3, FID4, FIDS, FID6, ﬁiame, fnamel, ﬁrame3, uwal, r_name, Phdr, Pimg] =

ﬁle_locator;
[P_n, Mo, SO, Dim, Byt, Ndim, Sd0, Sdl , Sd2, Rloc, Xp, Yp, Zp, readas ]=qhd_read(FID);
[C, CC, z_v, xdim, ydim, 1]= cdf_read2(FID3,fname3);

I=fread(FID4, [Sdl Sd2*Sd0], 'uint8');
%Irnage Matrix
%I=fread(FID4,[Sd1 Sd2*Sd0], readas);
% Image Matrix
R=fread(FID1, [Sdl Sd2*Sd0], 'uint8'); % Corresponding Regions Information
P=Reg_petread(FID6, Phdr);
% PET Image Matrix
minI = min(min(I)); maxl = max(max(I));
I2 = (I-minI)/(maxI-min1);
A=zeros(1 :xdim, 1:ydim);
k=0;
for i = 1:xdim,

for j = 1:ydim,
k=k+1;

A(i.i)=k;
end
end
f=max(CC(:,6)); V= [5 4.5 4 3.5 3 2 1.75 1.5 1.25 1 .9 .8 .7 .6 .5 .4 .3 .2];
Contour Labels
[X, Y] = meshgrid(1:xdim, 1:ydim);
[Xi, Yi] = meshgrid(1:Sd1, 1:Sd2);
ba=zeros(size(l2));

bo=zeros(size(I2));bb=zeros(1:256, 1:256, Sd0);
for i = 1 :1,

%step through each plane
b=CC((i-1)*xdim*ydim+l :(i*xdim*ydim),6) ;b =b(A);
b=imresize(b, [256 256], 'bilinear');
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% controls %

bb(1:256, 1:256, i)=b;
%256X256
Contour Grid Size
[ba(1:256, 256*(i-1)+1:256*(i)), bo(1:256, 256*(i-1)+12256*(i))]=peak_to_average(Sd1,
Sd2, R, 12, P, i, uvval, r_name, b, INELfactor);
% ba = PET2PET adjusted dosimetry; % bo = BNL adjusted dosimetry
end
%save ba ba;
%save bo bo;
%save bb bb;

bmax=max(max(max(bb))); %maximum dose (cgy/mw-min/ppm) and unsealed boron dose
f=max(max(ba));
f2=max(max(bo));

V= [ .9 .7 .5 .3 .1];
Tablel = zeros(l, 4);
Table2 = zeros(1,4);
for i = 1:1,
format bank;

ﬁgure(i);
subplot(] ,2, 1 )
%imshow(rot90(12(1:256, 256*(i-1)+1:256*(i))), 256); colorbar('horiz'); hold on;
subimage(ﬂipud((rot90((l2(1:256, 256*(i-1)+1 :256*(i))))))); %colorbar('horiz');
bs=ﬂipud(bb(1:256, 1:256, i)/bmax);
%scale dose to BNL (for contour display)
if ( max(max(bs)) >= .2 )
format bank;

V= [ .9 .7 .5 .3 .1];
hold on; [cs, h] = contour(bs, V);clabel(cs,h,V, 'fontsize', 10, 'color', 'r'); hold off;
end
title('Original B-10 Dose Contours '); colormap('bone');
subplot(] ,2,2);

[xx yy] = meshgrid(1:256);
plotat = .75*(min(min(bs*bmax))-max(max(bs*bmax)));
h=surf(xx,yy,bs*bmax);

set(h, 'Edgecolor', 'blue');
hold on; %colormap('bone');
I=ﬂipud((rot90((l2(1 :256, 256*(i-1)+1 :256*(i))))));
h2 = warp(1:256, 1:256, plotat*ones(size(bs*bmax)), I);
hold off; colormap('bone');

set(gca, 'zlim', [plotat max(max(bs*bmax))]); title('Original B-10 Dose Rate'); zlabel('cGyEq/mw-min/ppm');
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ﬁgure(30+i);
subplot(l ,2,1)

title('MRI/PET Registered Scaled Boron Dose Rate');
subimage(ﬂipud(rot90(l2(1 :256, 256*(i-1)+1:256*(i))))); %colorbar('horiz');
%bas = ba(1:256, 256*(i-1)+1:256*(i))/bmax;
bas = ﬂipud((ba(1:256, 256*(i-1)+1:256*(i))))/f;
[II,
JJ]=ﬁnd(bas>.9);
area9=(say*str2num(Xp)*say2*str2num(Yp));
[112,
JJ2]=fmd(bas>.7);
area7=(say* str2num(Xp)*say2*str2num(Yp));
[113,
JJ3]=fmd(bas>.5);
area5=(say*str2num(Xp)*say2*str2num(Yp));
[II3,
JJ3]=fmd(bas>.3);
area3=(say* str2num(Xp)*say2*str2num(Yp));

say=size(ll,1);

say2=size(JJ,2);

say=size(112,1);

say2=size(JJ2,2);

say=size(113,1);

say2=size(JJ3,2);

say=size(113,1);

say2=size(JJ3,2);

Table1(i,1:4)=[area9 area7 area5 area3];
if (max(max(bas))>=.2 )
format bank; v1=.7*f/f2;

V= [.9 .7 .5 .3 .1];
hold on; [cs, h] = contour(bas, V);h=clabel(cs,h,V, 'fontsize', 10, 'color', 'r'); hold off;

end
subplot(l ,2,2);
[xx yy] = meshgrid(1:256);
plotat = .75*(min(min(bas*f))-max(maxﬂ>as*f)));
h=surf(xx,yy,bas*f);
set(h, 'Edgecolor', 'blue');
hold on; %colormap('bone');
I=ﬂipud((rot90((12(1:256, 256*(i-1)+1 :256*(i))))));
h2 = warp(1:256, 1:256, plotat*ones(size(bas*f)), I);
hold off; colormap('bone');
set(gca, 'zlim', [plotat max(max(bas*f))]); title('MRI/PET Registered Scaled B-10 Dose');
zlabel('cGy-Eq/mw-min')

ﬁgure(60+i)
subplot(] ,2,1)

title('Homogeneously Scaled Boron Dose');
subimage(ﬂipud(rot90(l2(1:256, 256*(i-1)+1 :256*(i))))); %colorbar('horiz');
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bos = ﬂipud((bo(1:256, 256*(i-1)+1:256*(i))))/f2;
if (max(max(bos))>=.2)
V= [.9 .7 .5 .3 .1];
hold on; [cs, h] = contour(bos, V);h=clabel(cs,h,V, 'fontsize', 8, 'color', 'r'); hold off;

end
[11,
JJ]=ﬁnd(bos>.9);
area9=(say* str2num(Xp)*say2*str2num(Yp));
[112,
JJ2]=fmd(bos>.7);
area7=(say* str2num(Xp)*say2*str2num(Yp));
[113,
JJ3]=fmd(bos>.5);
area5=(say* stanum(Xp)*say2*stanum(Yp));
[113,
JJ3]=fmd(bos>.3);
area3=(say* str2num(Xp)*say2*stanum(Yp));

say=size(ll,1);

say2=size(JJ,2);

say=size(112,1);

say2=size(J12,2);

say=size(113,1);

say2=size(JJ3 ,2);

say=size(113,1);

say2=size(JJ3,2);

Table2(i,1:4)=[area9 area7 area5 area3];

subplot(] ,2,2);

[xx yy] = meshgrid(1:256);
plotat = .75*(min(min(bos*f2))—max(max(bos*f2)));
h=surf(xx,yy,bos*f2);
set(h, 'Edgecolor', 'blue');
hold on; %colormap('bone');
I=ﬂipud((rot90((I2(1:256, 256*(i-1)+1 :256*(i))))));
h2 = warp(1:256, 1:256, plotat*ones(size(bos*f2)), I);
hold off; colormap('bone');

set(gca,

'zlim',

[plotat

max(max(bos*f2))]);

Dose');zlabe1('cGy-Eq/MW-min');

end

save Tablel Tablel;
save Table2 Table2;
save Tablel Tablel -Ascii;
save Table2 TableZ -Ascii;
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title('Homogeneously

Scaled

B-10

O:PEAK_TO_AVERAGE.M
ﬁrnction [ba, bo] = peak_to_average(Sd1, Sd2, R, 12, P, i, uvval, r_name, b, INELfactor)
% Compute Average over regions;
11 = r;
b=b;
bo=b;
reg=rot90(R(1:256, (i-1)*256+1:256*i)); b_10=b;
imagematrix=rot90(P(1:256, (i-1)*256+1:256*i)*255); %Use PET Pixel Intensity to Scale the Dose Not the MRI
Image
MRIimage =rot90(12(1:256, (i-1)*256+1 :256*i)*255);
buffer=strmatch(' buffer', r_name); buffer = uvval(buffer);
tumor_region=strmatch(' turnor', r_name);tumor_region= uvval(tumor_region);
brain_region=strmatch(' brain', r_name);brain_region= uvval(brain_region);
scalp_region=stmratch(' scalp', r_name); scalp_region=uvval(scalp_region);
target_region=strmatch(' target', r_name); target_region=uvval(target_region);
n1=0; sum1=0;
n2=0; sum2=0;

n3=0; sum3=0;
n4=0; sum4=0;

tumorimage = zeros(256); targetimage=zeros(256); targetregion = zeros(256); tumorregion=zeros(256);
%ﬁrst compute average intensities in various regions
%for k = l :2,
%two iterations/ second scale the PET dose
for i=1:256,
for j=l :256,
if (reg(i,j )=target_region)
%Target Region (main tumor mass)
n4 = n4+1;
sum4= sum4+imagematrix(i,j);
%target region PET pixel intensity sum
targetimage(i,j)=imagematrix(i,j);

targetregion(i.i)=reg(i.i);
bo(i,j)=b(i,j)*fNELfactor(1)/1NELfactor(2); %Target Region BNL Dosimetry scaling
end
if (reg(i,j)=ttnnor_region)
% Tumor Region
n1=n1+1;

suml=suml+imagematrix(i,j);
% Tumor Region PET Pixel Intensity Sum
bo(i,j)=b(i,j)*INELfactor(l)/INELfactor(2); % Tumor Region BNL Dosimetry Scaling
tumorimage(i,j)=imagematrix(i,j);
tumorregion(i,j)=reg(i,j);
end
if ( reg(i,j)= brain_region)
% Brain Region
n2=n2+1;
sum2= sum2+imagematrix(i,j);
% Brain Region PET Pixel Intensity Sum
bo(i,j)=b(i,j)*INELfactor(2)/lNELfactor(2); % Brain Region BNL Dosimetry
end

if(reg(i,j)=scalp_region) % Scalp/Skull Region
n3=n3+1;
sum3=sum3+imagematrix(i,j);

%Scalp/Skull PET Pixel Intensity

Sum
bo(i,j) = b(i,j)*INELfactor(3)/INELfactor(2); %Scalp/Skull Region BNL Dosimetry
end
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end

end
tumoraverage= suml/nl;
%tumor average PET pixel intensity
targetaverage = sum4/n4;
%target average PET pixel intensity

brainaverage= sum2/n2;

%brain average PET pixel intensity

totalbrainaverage= (tumoraverage+targetaverage+brainaverage)/3;

scalpskullav = sum3/n3;

%Scalp/Skull PET pixel intensity average

entireregion= sum(sum(imagematrix)')/(256*256);
adjusteddoseZ=zeros(256);
adjusteddoseZ=b_l0.*imagematrix/totalbrainaverage;
Tumor Average
ba=adjusteddose2;
ﬁgure(100);
subplot(6, 7, ii);
imshow(MRlimage,[100 200]); hold on;
contour(imagematrix); hold off;
subplot(6,7, ii+21);
imshow(targetimage/256); hold on;
contour(tumorimage);
hold off;
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%Peak To Average Scaling Based on PET

P: QHD_READ.M

function [P_n, Mod, SO, Dim, Byt, Ndim, SdimO, Sdirnl, Sdim2, Rloc, Xp, Yp, Zp, readas ]=qhd_read(FlD)

i=0;
while feof(FID) ~= 1
i=i+l;
f = fgetl(FID);
h = ﬁndstr(f, '=')+1;
if strmatch('Patient Name', f)=1
P_n = f(h:size(f,2));
elseif strmatch('Modality',f)=1 ;
Mod = f(h:size(f,2));
elseif strmatch('Slice Orientation', 1):];

SO = f(h:size(f,2));
elseif strmatch('Number of Dirnensions', f)=1;
Dim = f(h:size(f,2));
elseif strmatch('Bytes', 1):];

1334: f(h:size(f,2));
elseif strmatch('Number of Dirnension', t) = 1;

Ndirn = f(h:size(f,2));
elseif strmatch('Size of Dimension[0]', 1): 1;
SdimO = f(h:size(f,2));

%Number ofZ Planes

elseif strmatch('Size of Dimension[l]', f)=1;

Sdiml = f(h:size(f,2));
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elseif strmatch('Size of Dimension[2]', t) = 1;
Sdim2 = f(h:size(f,2));
elseif strmatch('Refemce Location', I) = 1;

R100 = f(h:size(f,2));
elseif strmatch('Uniform Spacing', f)=1 ;

USP = f(h:size(f,2));
elseif strmatch('X Pixel Size', 1):];

Xp = f(h:size(f,2));
elseif strmatch('Y Pixel Size', 1) = 1;

YP = f(h:size(f,2));
elseif strmatch('lmage Location[0]',f) = 1,
for k = 1:stanum(Sdim0)- l ,

if f = -1,
break
end
Zp(k) = stanum(f(h:size(f,2)));
f = fgetl(FID);
h = ﬁndstrtf, '=')+1;
end

break
end

By = str2num(Byt);
Sdiml = stanum(Sdim1);
Sdim2 = stanum(Sdim2);
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Sdim0=stanum(Sdim0);

fclose(FID);

if By = 1
readas='int8';
elseif By = 2
readas='int 1 6';
else
% readas='int8';

sprintf('l Do Not Know the structure ofthe image ﬁle for sure')
end

return
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Q: CDF_WRITE.M
function [] = cdf_write(FID3,fname3, xdim, ydim, 1, ba, CC)
CA=zeros(xdim*ydim*l, l);
cdf_name = strcat(fname3(1:size(ﬁiame3,2)-4), 'adjusted.cdf');
cdf_name2 = strcat(fname3(1:size(fname3,2)-4), BNL.cdf);
FID = fopen(cdf_name, 'w' ;
FID2 = fopen(cdf_name2, 'w');
format short e;
L=0;
for i = 1:1,
%step through each plane
b = imresize(ba(1:256, 256*(i-1)+1:256*i), [xdirn ydirn], 'bilinear');
for k = 1:xdim,
for j = 1:ydim,
L = L+1;

CA(L. 1) = b0<J);
hi = isnan(b(k,j));
if (hi = 1)
CA(L,1) = hi-l;
end

end
end
end

for i = 1:xdim*ydim*l,
%C=fscanf(FID3, '%10e2, %10e2, %10e2, %5c %10e2 %10e2 %1062 %1062 %10e2 %10e2 %10e2 %10e2
%10e2', 125)
%C=C;

x = num2str(CC(i,1), '%6.3E');
if size(x,2) < 10
fprintf(FID, ' %s', x);
fprintf(FID2, ' %s', x);
else
fprintf(FlD, '%s', x);
fprintf(FID2, '%s', x);
end
y = num2$tr(CC(i,2), '%6.3E');
if size(y,2) <10
fprintf(FID, ' %s', y);
fprintf(FID2, ' %s', y);
else
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fprintf(FID, '%s', y);
fprintf(FID2, '%s', y);
end
2 = num2311(CC(i,3), '%6.3E');
if size(z, 2) < 10
fprintf(FID, ' %s', z);
fprintf(FID2, ' %s', 2);
else
fprintf(FID, '%s', z);
fprintf(FID2, '%s', 2);
end
r = num2str(CC(i,4));
fprintf(FID, ' %s', r);
fprintf(FID2,‘ %s', r);
t = num25tr(CC(i,5), '%6.3E');
if size(t, 2) < 10
fprintf(FID, ' %s', t);
fprintf(FID2,‘ %s', t);
else
fprintf(FID, '%s', t);
fprintf(FID2,'%s', t);
end
b = num25tr(CA(i,1), '%6.3E');
b2 = num2$tr(CC(i,6),'°/o6.3E');
if size(b, 2) < 10
fprintf(FID, ' %s', b);
fprintf(FID2,’ %s', b2);
else
fprintf(FID, '%s', b);
fprintf(FID2,'%s',b2);
end

g = num2str(CC(i,7), '%6.3E');

if size(g, 2) < 10

fprintf(FID, ' %S'. g);
fprintf(FID2, ' %s', g);

else
fprintf(FID, '%s', g);
fprintf(FID2,'°/os', g);
end
n = num2str(CC(i,8), '%6.3E');

if size(n, 2) < 10
fprintf(FID, ' %s', n);
fprintf(FID2, ' %s', n);
else
fprintf(FID, '%s', n);
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fprintf(FID2, '%s', n);
end
f = num25tr(CC(i,9), '%6.3E');
if size(f, 2) < 10
fprintf(FID, ' %s', f);
fprintf(FID2, ' %s', 1);
else
fprintf(FID, '%s', f);
fprintf(FID2, '%s', 1);
end
g1 = num25tr(CC(i,10), '%6.3E');
ifsize(g1, 2) < 10
fprintf(FID, ' %s', g1);
fprintf(FID2, ' %s', g1);
else
fprintf(FID, '%s', g1);
fprintf(FID2, '%s', g1);
end
g2 = num2$tr(CC(i,l 1), '%6.3E');
if size(g2, 2) < 10
fprintf(FID, ' %s', g2);
fprintf(FID2, ' %s', g2);
else
fprintf(FID, '%s', g2);
fprintf(FID2, '%s', g2);
end

th = num25tr(CC(i,l2), '%6.3E'); ‘
if size(th, 2) < 10
fprintf(FID, ' %s', th);
fprintf(FID2, ' %s', th);
else
fprintf(FID, '%s', th);
fprintf(FID2, '%s', th);
end
0 = num25tr(CC(i,13), '%6.3E');
if size(o, 2) < 10
fprintf(FID, ' %s\n', o);
fprintf(FID2, ' %s\n', 0);
else
fprintf(FID, '%s\n', o);
fprintf(FID2, %s\n', 0);
end

end

fclose(FlD);
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R: FILE_LOCATOR.M

function [FID, FID], FID3, FID4, FID5, FID6, ﬁiame, ﬁramel, ﬁrame3, uvval, r_name, Phdr, Pimg] = ﬁle_locator

fname= input('please enter name of .qhd header ﬁle name ?', 's');
%ﬁrame = 'G1_MRI_Presurgery.qhd';
while isempty(ﬁndstr('.qhd', ﬁrame)) = 1
fname = input('please enter a valid .qhd ﬁle name ?', 's');
end
FID = fopen(ﬁrame);
while FID = -1
FID = fopen(frrame);
if FID = -1
sprintf('Could Not Locate File in the present directory')
fname = input('please enter name of qhd header ﬁle ?', 's')
end
end
imname=strcat(fname(1 :size(fname,2)—3 ), 'qim');
FID4=fopen(imname);

while FID4 = -l
FID4 = fopen(imname);

if FID4 = -1
sprintf('Could Not Locate File in the present directory')
imname = input('please enter name of image (.qim) ﬁle ?', 's')
end
end

ﬁrame2= input('please enter name of .uvh ﬁle ?', 's');
%frrame 1 ='G 1_MRI_Presurgery.uvh'
while isempty(ﬁndstr('.uvh', frram82)) = l
fname2 = input('please enter a valid .uvh ﬁle name ?',‘s');
end
FID2 = fopen(ﬁrame2);
while FID2 = -1
FID2 = fopen(fname2);
if FID2 = -1
sprintf('Could Not Locate File in the present directory')
ﬁrame2 = input('please enter name of .uvh ﬁle ?', 's')
end
end
fname1=fname2(l , l :size(ﬁrame2,2)- l );
F1D1=fopen(fname1);
while FIDI = -l
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FIDl = fopen(frramel);

if FIDl = -l
sprintf('Could Not Locate File in the present directory')
ﬁramel = input('please enter name of .uv ﬁle ?', 's')
end
end

fname3=input('please enter name of .cdf ﬁle ?', 's');
%fname3 = 'G1_MRI_Presurgery.cdf';
while isempty(ﬁndstr('.cdf', ﬁrame3)) = 1
ﬁrame3 = input('please enter a valid .cdf ﬁle name ?', 's');
end
FID3 = fopen(ﬁrame3);
while FID3 = -1
FID3 = fopen(ﬁrame3);
if FID3 = -1
sprintf('Could Not Locate File in the present directory')
fname3 = input('please enter name of .cdf ﬁle ?', 's')
end
end

[uwal, r_name] = uvh_read(FID2);

% get Name of SPM Registered PET Image File
Phdr= input('please enter name of registered PET image in Analyze Format (.hdr) ?', '5');
while isempty(ﬁndstr('.hdr', Phdr)) = 1
Phdr = input('please enter a valid PET Analyze .hdr ﬁle name ?', 's');
end
FID5 = fopen(Phdr);
while FID5 = -l
FID5 = fopen(Phdr);
if FID5 = -1
sprintf('Could Not Locate the registered PET Analyze Format File in the present directory')
Phdr = input('please enter name of a valid PET .hdr header ﬁle ?', 's')
end
end

Pimg=strcat(Phdr(1 :size(Phdr,2)-3), 'img');
FID6 = fopen(Pimg);

while FID6 = -1
FID6 = fopen(Pirng);
if FID6 = -1
sprintf('Could Not Locate the registered PET Analyze Format File in the present directory')
Pirng = input('please enter name of a valid PET .hdr header ﬁle ?', 's')

end
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end

function [uvval, r_name]=uvh_read(FID2)

r=0;
while feof(FlD2)=——0
line = fgetl(FID2);
i=strmatch('begin:', line);
if isempty(i)=0
r=r+1;

%input('found begin')
r_name(r)=cellstr(line( l , 7:size(line,2)) );
line = fgetl(FID2);
uvval(r) = stanum(1ine(1, 10:size(line,2)));
end
end
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s: CDF_WRITE.M
function [] = cdf_write(FID3,ﬁrame3, xdim, ydim, 1, ba, CC)
CA=zeros(xdim*ydim*l, 1);
cdf_name = strcat(fname3(1:size(fname3,2)4), adjusted.cdf);

cdf_name2 = strcat(fname3(l :size(ﬁrame3,2)-4), BNL.cdf);
FID = fopen(cdf_name, 'w');
FID2 = fopen(cdf_name2, 'w');
format short 8;
L=0;
for i = 1:],
%step through each plane
b = imresize(ba(1:256, 256*(i-l)+1:256*i), [xdirn ydim], 'bilinear');
for k = 1:xdim,
for j = 1:ydim,
L = L+1;

mm = baa);
hi = isnan(b(k,j));
if (hi = 1)
CA(L,1) = hi-l;
end

end
end
end

for i = 1:xdim*ydim*l,

%C=fscanf(FID3, '%1082, %lOe2, %lOe2, %5c %lOe2 %lOe2 %lOe2 %lOe2 %1082 %lOe2 %lOe2 %lOe2
%lOe2', 125)
%C = C';
x = num2$tr(CC(i,1), '%6.3E');
if size(x,2) < 10
fprintf(FID, ' %s', x);
fprintf(FID2, ' %s', x);
else
fprintf(FID, '%s', x);
fprintf(FID2, '%s', x);
end
y = num25tr(CC(i,2), '%6.3E');
if size(y,2) <10
fprintf(FID, ' %s', y);
fprintf(FID2, ' %s', y);
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else
fprintf(FID, '%s', y);
fprintf(FID2, '%s', y);
end

2 = num2$tr(CC(i,3), '%6.3E');
if size(z, 2) < 10

lprintﬂFID, ' %s', z);
fprintf(FID2, '%s', 2);
else
fprintf(FID, '%s', z);
fprintf(FID2, '%s', 2);
end
r = num23tr(CC(i,4));
fprintf(FID, ' %s', r);
fprintf(FID2,’ %s', r);
t = num25tr(CC(i,5), '%6.3E');
if size(t, 2) < 10
fprintf(FID, ' %s', t);
fprintf(FID2,‘ %s', t);
else
fprintf(FID, '%s', t);

fprintf(FID2,'%s', t);
end
b = num25tr(CA(i,l), '%6.3E');
b2 = num2511(CC(i,6),'°/o6.3E');
if size(b, 2) < 10
fprintf(FID, ' %s', b);
fpﬁntﬂFIDZ,‘ %s', b2);
else

fprintf(FID, '%s', b);
fprintf(FID2,'°/os',b2);
end

g = num2511(CC(i,7), '%6.3E');
if size(g, 2) < 10

fprintf(FID, ' %s', g);
fprintf(FID2, ' %s', g);
else
fprintf(FID, '%s', g);
fprintf(FID2,'%s', g);
end

n = num25tr(CC(i,8), '%6.3E');
if size(n, 2) < 10

fprintf(FID, '%s', n);
fprintf(FID2, ' %s', n);
else
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fprintf(FID, '%s', n);

fprintf(FIDZ, '%s', 0);
end
f = num281r(CC(i,9), '%6.3E');

if size(f, 2) < 10

fprintf(FID, ' %s', f);
fprintf(FIDZ, ' %s', 0;
else
fprintf(FID, '%s', I);
fprintf(FID2, '%s', 0;
end

gl = num25tr(CC(i,10), '%6.3E');
if size(gl, 2) < 10
fprintf(FID, ' %s', g1);

fprintf(FID2, ' %s', g1);
else
fprintf(FID, '%s', g1);
fprintf(FID2, '%s', g1);
end

g2 = num28tr(CC(i,l 1), '%6.3E');
if size(g2, 2) < 10
fprintf(FID, ' %s', g2);
fprintf(FID2, ' %s', g2);
else
fprintf(FID, '%s', g2);

fprintf(FID2, '%s', g2);
end

th = num2$tr(CC(i,12), '%6.3E');
if size(th, 2) < 10
fprintf(FID, ' %s', th);

fprintf(FID2, ' %s', th);
else
fprintf(FID, '%s', th);
fprintf(FID2, '%s', th);
end

0 = num25tr(CC(i,13), '%6.3E');
if size(o, 2) < 10
fprintf(FID, ' %s\n', o);
fprintf(FIDZ, ' %s\n', 0);
else

fprintf(FID, '%s\n', o);
fprintf(FID2, '%s\n', 0);
end
end

fclose(FlD);
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T: DOSE CONTOURS AND 3D IMAGES OF OTHER PATIENTS.
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Original B-10 Dose Contours

Figure 1A:
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For Patient BP
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Patient EG:

Original B-10 Dose Contours
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3D View of The Heterogeneously Scaled Boron Dose
Rate for Patient EG
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